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ABSTRACT 
Bioactive Poly(ethylene glycol)-based Hydrogels for Characterization of 
Matrix Influences on a Lung Cancer Metastasis Model 
by 
Bartley Joseph Gill 
 Pathological changes to tumor extracellular matrix (ECM) composition, 
mechanics, and architecture promote cancer progression and metastasis.  Exploration of 
tumor-ECM interactions using in vitro matrix-mimetic culture systems has largely been 
restricted to naturally-derived matrix materials that permit limited experimental control.  
Such study of a novel lung adenocarcinoma model in Matrigel™ (MG) has suggested key 
matrix cues that mediate epithelial-mesenchymal transition (EMT) and metastasis.  In this 
thesis work, synthetic hydrogel scaffolds based on poly(ethylene glycol) (PEG) featuring 
high experimental control and modular bioactivity were used to study matrix influences 
on the EMT-prone model line 344SQ.   
Encapsulation of 344SQ cells in PEG hydrogels modified for cell adhesivity and 
cell-mediated enzymatic degradability induced formation of lumenized, polarized spheres 
mimicking the epithelial phenotype observed in three-dimensional MG.  Tuning matrix 
stiffness, adhesive ligand concentration, and ligand spatial presentation altered epithelial 
morphogenesis.  Exploration of the EMT phenotype of PEG-encapsulated 344SQ cells 
revealed TGFβ-initiated changes in morphology, polarity, expression levels of EMT 
marker genes and their epigenetic controller, and the organization of cell-secreted ECM.  
Notably, a potent role for adhesive ligand was illuminated as matrices with low PEG-
 
 
RGDS concentration even in the absence of TGFβ induced formation of spheres with a 
post-EMT phenotype by several of these measures.  A matrix-invasive phenotype was 
also revealed by altering matrix structural parameters and tuned with incorporation of an 
alternative protease-cleavable sequence.  Finally, the influence of cell-cell contacts was 
explored by covalent incorporation of cadherin proteins into the matrix.  Matrix-tethered 
E- and -N-cadherin affected 344SQ sphere development in otherwise non-cell-adhesive 
matrices and modulated polarity and the degree of TGFβ response.  Further, in 344SQ 
with a knockdown of the essential polarity-determining protein Scribble, matrix-tethered 
cadherin influenced the formation of a phenotype with partially normalized epithelial 
polarity with corresponding differences in membrane localization of cell-expressed E-
cadherin.   
Overall, this thesis demonstrates the utility of the more experimentally 
controllable PEG system in studying ECM influences on cancer progression with 
findings providing greater insight into stromal biomechanical, biochemical, and cell-cell 
factors that mediate lung adenocarcinoma epithelial morphogenesis and EMT.  These 
contributions help advance the state of the field towards a goal of developing new 
metastasis-targeting cancer therapeutics. 
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1. Introduction and Background 
 Excluding surgery-curative non-melanoma skin cancer, there are over 1.6 million 
new cancer diagnoses each year in the United States with an individual lifetime incidence 
of at least one form of cancer approximately 40% for men and women
1
.  With more than 
1500 Americans dying per day, cancer is ultimately implicated in 1 in 4 deaths.  Lung 
cancer specifically is the second most common cancer in men and women and is the 
leading cause of cancer-related mortality, responsible for over 25% of cancer deaths.  
While lung cancer mortality rates have been slowly declining, this decline is mostly 
attributable to long-term trends in smoking cessation, and the rate still remains high due 
to the limited availability of lung cancer detection and treatment options, particularly for 
patients with metastatic disease
1
. 
 While cancer development and progression was traditionally thought to result 
solely from sequential accumulation of mutations in proto- or anti-oncogenes and related 
proteins, mounting research over the past few decades has illuminated a much more 
complex picture, wherein tumorigenesis is regulated by networks of genetic, epigenetic, 
protein, and other molecular interactions
2
.  These networks are dynamic and both 
positively and negatively regulated, preventing or promoting the switching of epithelial 
cells between phenotypic states of differing malignant potential.  One such prominent 
influence outside of the traditionally studied cell-intrinsic genetic dysregulation is the 
extracellular matrix (ECM), which may prove important not just to a more complete 
understanding of tumor formation, but as central to the understanding of how tumors 
invade and metastasize, the primary cause of cancer-related death
3
. 
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 This chapter first provides an overview of the myriad ECM properties that 
influence the behavior of ECM-resident cells and examines important pathological 
changes to these properties that contribute to cancer development and progression.  In 
particular, the changes to ECM composition, organization, stiffness, and both solid and 
fluid tumor pressures as well as the role of pathological stromal support cells will be 
reviewed.  Then, current in vitro approaches to modeling and studying these influences 
on 2D culture substrates and in naturally derived 3D matrices are discussed.  Following 
this foundational overview, a synthetic poly(ethylene glycol)-based hydrogel system that 
avoids key limitations of these other culture systems will be proposed as a tool to further 
study matrix cues on epithelial-mesenchymal transition and metastasis of a newly 
characterized lung adenocarcinoma model.  This dissertation will first deploy the PEG 
system to recapitulate important phenotypic behaviors derived from 3D culture and study 
new matrix biochemical and biomechanical factors that influence the epithelial 
morphogenesis of a model metastasis-prone line.  It will then examine the phenotypic 
response of the lung cancer model and its matrix interaction in the face of metastasis-
inducing soluble signals and probe for the role of cadherin cell contacts in modulating 
polarity and morphogenesis.  Overall, this thesis establishes a new, versatile matrix-
mimetic tool with which ECM influences on cancer pathogenesis can be studied with 
high experimental control and contributes to a greater understanding of how matrix cues 
work to promote or inhibit cancer metastasis. 
 
1.1  The ECM in Health and Cancer 
The ECM is the 3D environment that provides structural support for cells and 
tissues, facilitating attachment of cells and providing substrates for migration.  Beyond 
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this structural support, the ECM, in concert with other stromal support cells, performs a 
number of vital roles, controlling diffusion of nutrients and waste, mediating growth 
factor, hormone and other cell signaling effectors, and affecting a wide variety of cell 
behaviors, including growth, proliferation, differentiation, and apoptosis.  The ECM is 
composed of a large variety of molecules whose combination, organization, and 
modifications regulate these processes and help define the structure and function of 
different tissues
4
.   
 Principal ECM constituents include the collagen family, a group of over 20 
molecules with specialized functions and tissue locations.  Collagen molecules provide a 
wealth of cell-interactive binding sites to facilitate matrix bioactivity and some organize 
to form fibrils and networks of larger fibers to provide major tissue mechanical support
5
.  
Other major ECM proteins and their notable functions include laminin, a key basement 
membrane constituent and a key mediator of matrix interactivity for epithelial cells
6
; 
elastin, arranged into elastic fibers to facilitate tissue recoil mechanics
4
; and fibronectin, a 
glycoprotein vital for cell adhesion that distinctively interacts with several other ECM 
components
7
.  In addition to these components, the polysaccharide-based 
glycosaminoglycans are covalently linked to protein backbones to form proteoglycans 
that provide for further structural support, cell interactivity, growth factor sequestration, 
and organization of other ECM constituents, amongst other diverse functions
8
. 
Along with other adhesive or structural glycoproteins, ECM-associated growth 
factors, and stromal support cells, these major ECM components come together to form a 
stroma that is vital in both the development and maintenance of healthy tissue.  The 
stroma also plays a key role in disease processes, including cancer.  The stroma-tumor 
4 
 
relationship is an area of increasingly important focus in cancer research as investigators 
strive to further understand its role in the tumorigenic regulatory network and metastasis, 
and explore it as a target of new cancer therapeutics
2
. 
 
1.1.1  ECM Properties Influence Cell Behavior: Overview 
 The ECM features both important biochemical and physical properties that 
influence cells as well as the ability for cells to remodel these properties (Fig. 1-1).  The 
ECM sequesters growth factors, acting as a reservoir for growth factor-related signaling 
in resident cells, controlling their diffusive range, and altering binding affinity by 
enhancing or limiting assessable binding sites
9–12
.  This ability can create a concentration 
Figure 1-1: Physical and biochemical properties of the ECM influence cell behavior.   
These influences include anchorage to the basement membrane (BM) and other ECM 
proteins (1) and BM action as a migration barrier (2).  Physical and architectural ECM cues 
can facilitate migration (3). The ECM sequesters growth factors (GFs, 4), in part to modulate 
a concentration gradient, and selectively binds certain GFs to assist cell binding as co-
receptors (5) or presenters (6).  ECM molecules themselves also may have GF-like domains.  
Finally, cells sense the biomechanical forces of the ECM (7) to exert a wide variety of gene 
expression and behavioral changes. Adapted from Lu, et al.
44
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gradient to tune cell behaviors like migration or polarity, or can help modulate dosage of 
particularly potent growth factors whose small concentration changes elicit drastic 
phenotypic changes, as in cell differentiation, for example
13
.  The ECM also assists in 
maturation of ligands, storing factors in inactivated forms or activating secreted inactive 
precursors.  TGF-β, for example, is often secreted in an inactive form and activated in the 
ECM by MMP-related proteolysis or other mechanisms
14
. 
 Beyond modulation of non-ECM proteins, the structural ECM proteins 
themselves play a role in biochemical influence of cells through several mechanisms.  
Fragments of ECM proteins can function as precursors for biologically active signaling 
ligands that exert effects upon proteolytic processing
15–18
.  Many ECM proteins, such as 
laminin, tenascin and thrombospondin, also feature growth-factor-like domains that may 
exert signaling effects with or without proteolysis
19,20
.  Finally, integrins and other 
adhesion-related receptors that bind ECM proteins are themselves signal transduction 
receptors, activating the Rho/ROCK and MAPK signaling pathways amongst many 
others to yield a wide-variety of intracellular consequences
9
. 
 The physical properties of the ECM, including its porosity, topography and 
rigidity, also play a key role in cell behaviors.  In modulating cell migration, it can act as 
a barrier or a facilitator.  For example, the densely structured basement membrane, 
predominantly composed of components laminin and collagen IV, notably acts as a key 
migration barrier both in development and in inflammatory, fibrotic and neoplastic 
disease processes
21
.  Topographic cues like alignment of collagen fibers can enhance 
directional migration through growth factor signaling- or mechanics-related effects
22,23
.  
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In addition, a plethora of evidence indicates that cells sense matrix architecture and 
rigidity with these physical cues initiating both direct and indirect responses.   
 Cells sense underlying matrix rigidity through mechanotransduction of ECM-
bound integrins.  Tension from focal adhesions formed at the site of integrin binding is 
transmitted across integrin receptors to intracellular cytoskeletal components and the 
nucleus, activating several different intracellular signaling pathways (Rho/ROCK, ERK, 
MAP, etc.)
24
.  The tension-related changes that result are first made evident by changes in 
easily observable cell behaviors like cell spreading and migration; investigators have 
demonstrated that stiffer matrices generally lead to increased cell spreading with more 
organized and mature cytoskeletal elements
25,26
 and modulated lamellapodia activity and 
cell motility
27,28
.  Substrate elasticity can have profound effects on other cell functions 
essential to overall function of tissues.  In cardiomyocytes, for example, an intermediate 
matrix stiffness promotes myotube elongation and striation
29
 and peak contractile 
functionality
30
.  Further, matrix stiffness plays a key role in stem cell differentiation, with 
osteogenic precursors
31
, neurogenic precursors
32
, and multipotent mesenchymal stem 
cells
33
, amongst many others demonstrating altered differentiation on substrates of 
varying elasticities, with peak lineage specificity often occurring on substrates whose 
elasticities closely match that of the tissue where cells of that lineage typically reside in 
vivo (Fig 1-2)
34
.  Studies have implicated ECM architectural control over cell shape in 
regulation of similar cell processes.  Size and geometric restrictions on cell shape alter 
growth and apoptosis
35
, cytoskeletal arrangement
36
, gene expression and protein 
synthesis
37
, and stem cell differentiation
38,39
, acting primarily through RhoA GTPase and 
its effector ROCK.  In addition to this physical influence on differentiation, cues from 
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certain ECM molecules have proven essential for the maintenance of stemness in the 
stem cell “niche;” laminin in the subventricular zone of the brain, for example, engages 
α6β1 integrin on neural stem cells to maintain their adherence and self-renewal
40
. 
 Cells can remodel the ECM to alter these biochemical and physical properties by 
producing different amounts of the ECM structural proteins themselves, secreting 
molecules that alter the structure or function of ECM proteins already present, or 
releasing proteases that degrade matrix components.  Secreted matrix metalloproteinases 
(MMPs), for example, target a variety of large structural proteins like fibronectin, laminin 
and the collagens in addition to certain proteoglycans
41
.  They also exhibit key roles in 
cleaving growth factor precursor proteins and the pro-forms of other MMPs
42
.  Beyond 
secretion and degradation of ECM molecules, cells can also alter their organization and 
Figure 1-2: Cells sense and respond to physical features of their environment: 
Differentiation. (A) Mesenchymal stem cells (MSCs) cultured on polyacrylamide gels of varying 
stiffnesses demonstrate different matrix elasticity-related neurogenic, myogenic, and osteogenic 
lineage-specificity as shown by lineage-specific immunostaining (arrows). Scale bar = 5 µm. 
Adapted from Engler, et al.
33
 (B) MSCs also show cell shape-related osteogenic or adipogenic 
differentiation on differently sized microcontact printed adhesive patterns. Oil red O (red stain), 
alkaline phosphatase (purple), scale bar = 50 µm. Adapted from McBeath, et al.
38 
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topography; the posttranslational cross-linking of collagen in the ECM is mediated by 
action of lysyl oxidase (LOX) and lysyl hydroxylase, altering tissue mechanics and 
collagen fiber orientation
43
.  Regulation of ECM remodeling is controlled at multiple 
levels, both transcriptionally and post-translationally, to yield not only a specific 
remodeling response and one that is controlled temporally, but also one specialized at 
certain subcellular locations
44
.  For instance, MMPs localize specifically to invadopodia 
to facilitate movement through the matrix by the migrating cell
45
.  Remodeling can be 
further regulated by secretion of proteases that degrade other ECM-targeting proteases or 
secretion of inhibitors, like the TIMPs family of proteins that block MMP action
44
.   
 Given that ECM biochemical and physical properties exert potent influence over 
such a wide variety of cell functions and that cells are able to remodel the matrix and 
these resulting matrix-derived influences in myriad regulated ways, it is easy to see how a 
dynamic cell-ECM interaction can be vital to tissue and organism function, development, 
and disease.  Among developmental processes, cell-ECM dynamics are essential to 
processes such as epithelial branching where local concentrations of ECM molecules and 
ECM degradation determines epithelial branch location, bifurcation, and overall 
direction
42,46,47
.  In multiple disease processes, ECM properties are altered in pathologic 
ways as either a cause or result of the disease pathogenesis.  For example, it has been 
long-recognized that diseased tissues are often stiffer and fibrotic, more concentrated in 
ECM components relative to their healthy counterparts
48
.  ECM in aging tissue is stiffer 
as well, but also inappropriately organized and mechanically compromised, contributing 
to tissue dysfunction in age-related diseases
49
.  Increased stiffness of the ECM arterial 
wall contributes to arterial disease and is a strong and sensitive early marker of 
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atherosclerosis
50
.  Finally, increasing research has focused on changes to ECM physical 
properties, architecture, and composition in tumors.  These pathologic ECM changes and 
how they work in concert with abnormal stromal cell activity and the genomic instability 
of tumor cells themselves to promote cancer progression will now be reviewed. 
 
1.1.2  ECM in Cancer Initiation and Progression 
 Mounting evidence indicates that the stroma is essential to cancer development 
and progression. Tumor cells and their microenvironment surroundings act together as an 
“organ-like tissue” with constituents that display different characteristics than normal 
tissue, but also necessarily change with time to permit progression and metastasis (Fig. 1-
3A)
3,51
.  In vivo transplantation experiments in mice have soundly demonstrated this 
essential role for a healthy or diseased stroma in epithelial cancer development.  In the 
chemical carcinogen N-nitrosomethylurea model, fat-pad transplantation of mammary 
epithelial cells not exposed to the carcinogen prior to implantation neoplastically 
transform when placed into carcinogen-exposed stroma
52
.  Similar results were seen in a 
prostate model, where an activated stroma promoted the transformation of a non-
tumorigenic prostate line
53
.  The converse situation has also been studied; when 
carcinogen-exposed cells are transplanted into healthy, unexposed stroma, they do not 
always form tumors and are readily able to form ducts with normal growth patterns 
despite their neoplastic transformation
52,54,55
. 
 In addition, experiments have shown that the 3D architecture of epithelial tissue is 
heavily influenced by the underlying mesenchyme.  Studies decades ago demonstrated 
that isolated mammary epithelial cells maintain milk protein secretion, but display a 
salivary  
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gland-like morphology when recombined with isolate salivary gland mesenchyme
56
.  In 
normal development, epithelial tissue growth and architecture is in large part dictated by 
the remodeling of underlying mesenchyme, specifically the basement membrane (BM), 
and the dynamics between its focal degradation or secretion
57,58
.  The BM has also long 
been recognized as a vital player in cancer progression.  Ultrastructural changes occur in 
Figure 1-3: The ECM in cancer.  (A) Tumorigenesis proceeds in concert with pathological changes to 
the stroma with prominent changes in ECM concentration and architecture. Fibroblast-derived ECM 
(brown), cell nuclei (green), from Cukierman and Bassi
3
. (B) In addition to these changes in ECM 
protein concentration/stiffness (1) and organization (2), growing tumors themselves generate solid 
stresses (3), generating radial and compressive forces (4).  Interstitial fluid pressure increases due to 
pathological tumor-associated angiogenesis, resulting in a directional fluid flux (5) that tumors can 
exploit by producing chemokine concentration gradients to facilitate directional migration (6). Finally, 
there is also enhanced matrix stress-induce myofibroblast differentiation (7) and lymphatic chemokine 
secretion (8).  Adapted from Shieh
90
. 
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the BM in early tumorigenesis prior to formation of sizable tumors with areas of altered 
BM thickening, altered relationship to other ECM components, and the appearance of gap 
regions
59–61
.  BM breach and these resulting discontinuities are a long-recognized 
hallmark of transition from carcinoma in situ to invasive carcinoma and metastasis
21
,  but 
these breaks are not a universal sign of neoplastic advancement of the epithelial 
compartment.  For example, different tumors from the same metastatic murine mammary 
cancer model differ in the number and size of BM breaks
62
, and intact BMs are 
sometimes found surrounding metastatic tumors at the site of implantation or even in 
some heavily malignant primary tumors despite significant transformation of these tumor 
cells
60,63,64
.  Thus, these BM changes may be the result of other more complex 
microenvironmental interactions in addition to tumor-guided remodeling. 
 The BM as an ECM-related barrier is only one part of the broader role that the 
ECM plays in migration and invasion.  3D migration of tumor cells through ECM, for 
example, is a complex and coordinated process that requires cell-ECM interactions that 
are both identity-specific and spatially controlled.  Cells form invadopodia at their 
leading edge that require relatively stiff ECM with a high density of integrin-binding 
sequences at distant ends for attachment
65
.  These invadopodia express proteases like 
membrane-type 1 MMP at intensely localized foci at the lateral-posterior areas of 
pseudopodia to degrade sufficiently wide tracks through the matrix for movement of the 
cell body bulk
66
.  Meanwhile, more diffuse proteolytic activity also occurs in areas 
posterior to invadopodia near the cell body and generates fragments of collagen, laminin 
and fibronectin, which help compete for integrin binding sites with still-incorporated 
ECM, facilitating cell detachment and further migration 
66–68
.  This matrix proteolysis 
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also helps release sequestered growth and chemotactic factors.  Finally, ECM remodeling 
during rear retraction of the cell body leaves collagen fibers aligned and oriented in the 
direction of migration, creating collagen tracts that decrease resistance to favor additional 
migration
69
. 
 Beyond factors directly related to cancer cell migration, tumor ECM composition 
and structure are dramatically different than normal ECM and can influence this invasion 
process and many other behaviors
70
.  Even before they were widely studied in vitro, 
excess ECM production or abnormal remodeling in cancer was noted in patients, revealed 
clinically by enhanced radiographic tumor density measurements
71,72
.  In breast cancer, 
for example, enhanced mammanographic measurement of breast tissue reflect elevated 
collagen and proteoglycan levels and has been demonstrated as a prognostic indicator of 
disease severity and treatment response
48,73
.  A variety of ECM components have been 
shown to be present in tumor ECM at higher concentrations than in normal tissue 
including collagens I, II, III, V and IX
74–77
.  ECM remodeling enzymes are also 
upregulated or dysregulated in tumor ECMs, with reports finding overexpression of 
haparanases and many MMPs in various cancers
42,78
.  Beyond ECM protein 
concentrations, architecture is also altered.  Likely owing to increased concentration of 
LOX
79,80
, collagen I in tumor ECM is highly linearized compared to its healthy 
counterparts and is oriented in specific patterns adjacent to the tumor epithelium or 
projecting perpendicularly into the tissue
23,81,82
.  This increased collagen density and/or 
its altered organization has been found to promote tumor metastasis or recurrence 
following tumor excision
83,84
. 
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 These changes in non-soluble ECM dynamics are accompanied by changes in 
tumor stromal fluid flow (Fig. 1-3B).  Increased interstitial fluid pressure (IFP) is found 
in tumors primarily due to higher concentrations of new, poorly functioning and leaky 
vasculature derived from enhanced tumor angiogenic signaling
85
.  Higher IFP may have a 
direct effect on the tumor itself, increasing cell proliferation or promoting the section of 
additional angiogenic factors
86,87
, but also works in concert with increased 
lympangiogenesis to enhance overall fluid flux through the tumor stroma
88
.  Increased 
flow around tumors acts to increase fluid shear stress, realigning fibroblasts around 
tumors and promoting their differentiation into tumor-associated myofibroblasts
89,90
.  
Critically, it also acts to promote the formation of chemokine and growth factor 
concentration gradients, with the flow of chemokines from the high pressure pericellular 
environment to lower pressure lymphatics providing a potential metastasis guidance 
cue
91,92
.  In addition to the stress generated by the high IFP, the growing tumors 
themselves generate a great deal of solid stress, upwards of 10 kPa in some in vitro 
models
93
.  This tumor stress may also work to enhance myofibroblast differentiation and 
activity and thereby promote a positive feedback loop to further enhance environmental 
stresses through myofibroblast-mediated ECM protein secretion or cell contraction
90,94
. 
 These tumor stresses, working in concert with altered  ECM secretion, cross-
linking and remodeling, leave the tumor stroma substantially stiffer than normal ECM, 
and most studies find that this stiffness potentiates malignant events
90,95
.  Normal breast 
tissue, for example, has a Young’s Modulus of ~0.15 kPa, increasing several fold to 
around 4 kPa in advanced malignancy
96
, and women with mammographically dense 
breasts are several times likelier to develop breast cancer
71
.  Altered matrix elasticity may 
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in part explain the results of in vivo transplantation studies; lack of pathologic stiffening 
in normal host mesenchyme likely contributed to the reversion of neoplastically 
transformed implanted cells to normal epithelial organization
52,54,55
.  Initial in vitro 
exploration decades ago using natural matrices suggested a potent role for matrix 
stiffness in cancer behavior as mammary epithelial cells on softer, floating collagen gels 
respond to lactogenic hormones to form differentiated, polarized acini, but those on glass 
or plastic surfaces or stiffer, tethered collagen gels form proliferating colonies with 
compromised polarity
97,98
.  In a more recent report by Paszek, et al., mammary epithelial 
cells formed small, growth-arrested, polarized lumenized acini in soft BM-based 
matrices, but when stiffness was increased with cross-linked collagen, this organization 
was lost, lumen formation was inhibited, and adherens junctions were destabilized (Fig. 
1-4)
99
.  This process was found to be associated with increased integrin clustering with 
observed changes mediated by enhanced ERK and ROCK activation.  The clarity of 
conclusions drawn from this and similar systems are uncertain, however, due to poor 
control of biochemistry with the alteration of matrix stiffness and other problems, 
discussed at length in later sections of this thesis.  Beyond direct effects on the cells, a 
stiffer ECM may also influence other metastasis-relevant ECM constituents; for example, 
when a silicone membrane culture system with cultured myofibroblasts was stiffened and 
stretched, latent TGFβ became exposed and activated, potentiated by enhanced 
myofibroblast contraction
100
. 
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1.1.3  Extrinsic Cellular Influences on Cancer Progression 
 Other cells in the tumor stroma, which signal through ECM proteins, by paracrine 
mechanisms, or via cell-cell contacts, have a profound influence on the inhibition of 
tumor formation and progression.  Beyond being primarily responsible for secreting the 
BMs that constrain epithelial cells to tissue boundaries
101
, they may play a more direct 
role in other ways.  In normal breast tissue, for example, myoepithelial cells secrete a 
relatively higher concentration of proteinase inhibitors like TIMPs and angiogenic 
inhibitors that help prevent breast cancer invasion and angiogenesis promotion
102
.  
Normal fibroblasts also act to limit the growth rate of tumor cells when present at 
sufficient ratios
103
 and help to normalize duct structure and polarity
104
, both directly 
through paracrine signaling and more indirectly through mediation of  ECM constituents 
Figure 1-4: Matrix rigidity regulates growth and morphogenesis in a MG breast cancer model.   
(Left) MCF10A cells in MG stiffened with increasing collagen concentrations showed enhanced 
growth, loss of lumenized morphology, and disruption of polarity at higher matrix elasticities with 
(Right) matrix rigidity postulated to induce Rho-generated cytoskeletal tension to promote focal 
adhesion assembly and increase growth factor-dependent ERK activation. α6β4 integrin (red), β-catenin 
(green), DAPI (blue). Adapted from Paszek et al.
99
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Table 1-1: Growth factors and signaling proteins differentially expressed by 
stromal cells in tumorigenesis. Adapted from Bhowmick, et al.
109 
to alter epithelial cell integrin-ECM interaction.  This anti-neoplastic control in part 
explains the protective effect that normal stroma can exert over grafted neoplastic cells to 
prevent tumor at graft sites
52,55
. 
 In cancerous stroma, however, not only are protective measures eroded, but 
tumor-associated fibroblasts (TAFs) actively contribute to tumor growth and spread.  
Genes for a number of secreted proteins are differentially expressed in TAFs including 
ECM proteins, cytokines, growth factors, proteases, and cell surface receptors
105
, and 
they work to enhance the growth and oncogenic potential of neighboring epithelia via 
activation of myriad growth factor signaling pathways (Table 1-1)
106–109
.  Notably, TAFs 
Soluble factors Cells expressed Responding cells Possible role 
HGF and MSP Fibroblasts Epithelia + Proliferation 
+ Transformation 
+ Morphogenic 
IGF-1, IGF-2 Fibroblasts Epithelia (breast) - Apoptosis 
+ Proliferation 
EGF and  
TGF-α 
Epithelia and 
fibroblasts 
Epithelia + Proliferation 
+ Morphogenic 
TGF-β1, 
 -β2, -β3 
Epithelia and 
fibroblasts 
Epithelia and  
fibroblasts 
- Proliferation 
+/- Apoptosis  
+ Morphogenic 
FGF7 / KGF Fibroblasts Epithelia + Proliferation 
+ Transformation 
IL6, LIF,  
oncostatin M 
Fibroblasts Epithelia (colonic) + Proliferation 
+ Transformation 
FGF2 Fibroblasts Epithelia + Proliferation 
+ Transformation 
FGF10 Fibroblasts Epithelia + Proliferation 
NGF Fibroblasts Epithelia + Transformation 
SDF-1α (CXCL12) Fibroblasts Epithelia  
(glioblastoma) 
+ Proliferation 
+ Transformation 
Wnt1, Wnt3 Fibroblasts Epithelia + Proliferation 
+ Transformation 
MMP-1, MMP-7 Fibroblasts ECM and growth-factor 
activation in the  
stroma affect epithelia 
+/- Proliferation 
+/- Apoptosis 
+ Morphogenic 
IL6, interleukin 6; LIF, leukemia inhibitory factor; NGF, nerve growth factor; SDF-1α, stromal 
cell-derived factor 1α 
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also express higher levels of fibroblast activation protein, which has been shown to 
induce tumor growth
110
 and secrete high levels of tenascin-C, a marker of desmoplastic  
stroma with anti-adhesive, fibronectin-blocking properties
111
.  TAFs also enhance tumor 
angiogenesis by secreting elevated amounts of VEGF and bFGF
112,113
.  Finally, TAFs  
overproduce several ECM components including collagens I, VI and XV and hyaluronan, 
amongst others
107,114–116
, promoting to tumorogenesis, but show limited production of 
laminin-1, contributing to BM breakdown
117
.  All of these changes together significantly 
alter the behavior of adjacent epithelium.  For example, mammary epithelial cells 
overlayed on disrupted myoepithelial cell layers show altered expression of proliferation 
and tumor progression marker genes, microsatellite instability, increased invasion into the 
stroma, and enhanced angiogenesis
118,119
.  TAFs may also play a role in metastatic 
disease; bone-marrow-derived cells have been found to colonize sites of metastasis prior 
to the arrival of tumor cells, potentially working to establish a “pre-metastatic niche” in 
new stroma that is more permissive to metastases implantation and growth
120,121
. 
 Of additional importance in the cellular component of tumor stroma is the role of 
cell-cell contacts on tumor progression.  Within epithelial tumor cells themselves, a loss 
of cell-cell adhesion permits disaggregation of tumor cells to facilitate matrix invasion 
and metastasis.  Cadherins, acting with their cytosolic effectors α-, β- and γ-catenin, are 
one of the main cell-cell adhesion molecules that is altered in tumors
122
.  In vitro 
evaluation of a number of model lines for different epithelial cancers showed a 
correlation between E-cadherin expression and invasiveness, with constitutive expression 
of E-cadherin in the more malignant lines abrogating their invasive ability and restoring 
epithelial phenotype
123,124
.  Similar observations have been reported in vivo for breast
125
, 
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nasopharyngeal
126
, prostate
127
, and lung cancers
128
, amongst others, with decreased levels 
of E-cadherin found in tumors and a lack of stable E-cadherin expression generally 
correlating with metastatic phenotype and poor patient prognosis
129
.  In human patients, 
aberrant E-cadherin expression or the combination of aberrant E-cadherin and catenin 
expression has been shown in some studies to be an independent prognostic marker for 
the presence of occult lymph node or distant metastases in patients initially classified as 
having no metastatic involvement and, to a lesser extent, overall survival
130–134
.  In 
contrast to E-cadherin, N-cadherin expression correlates to more malignant and invasive 
tumors, acting to increase invasion and metastasis in part through enhanced sensitivity to 
FGF-induced MMP-9 secretion and promotion of  adhesion to endothelial cells to 
facilitate metastasis
135
. 
 Beyond a more apparent role in promoting cell aggregation to hinder tumor cell 
invasion and metastasis, the E-cadherin/catenin complex may play more signaling-related 
roles in cancer progression (Fig. 1-5).  Much evidence exists for a mitotic role of E-
cadherin’s intracellular binding partner β-catenin.  The importance of β-catenin is mostly 
related to its role in the Wnt signaling pathway, with its disrupted function in cancer 
commonly altering its cytosolic sequestration and breakdown
136–138
.  When left free in the 
cytosol at high concentrations, β-catenin translocates to the nucleus where it binds to 
transcription factors LEF and TCF to exert a pro-mitotic effect, activating genes that 
inhibit apoptosis and promoting cell proliferation- and migration-related genes including 
c-myc and cyclinD1
122,139,140
.  While the complete role of E-cadherin in free β-catenin 
TCF/LEF-related action is still unclear, the growth inhibitory effects of undisrupted E-
cadherin binding show a clear correlation with a reduction in β-catenin/TCF activity, and 
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it likely does interfere to some degree with this Wnt-related signaling by decreasing the 
available β-catenin nuclear pool141–143.  E-cadherin binding may also inhibit cell 
proliferation through cell arrest resulting from activation of the cyclin-dependent kinase 
inhibitor p27
144
 or may interfere with EGF receptor-mediated growth signaling in a 
separate β-catenin-dependent mechanism unrelated to TCF/LEF action145. 
 
 
 
 
 
 
Figure 1-5: E-cadherin mediates Wnt-related β-catenin action. Free β-catenin is typically 
maintained at low levels in the cytosol due to degradation by the GSK3β-APC-Axin complex (1).  
When degradation is inhibited by activated Wnt signaling (2), free β-catenin translocates into the 
nucleus (3) and in conjunction with LEF/TCF transcription factors promotes the transcription of 
several pro-mitotic genes (4).  β-catenin also forms a complex with the cytosolic portion of E-
cadherin and other catenins (5) such that when E-cadherin binding is disrupted, it is released (6), 
increasing its available nuclear pool.  Adapted from McVicar and Trinchieri.
138
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1.2  Tissue Engineering Approaches to Modeling Tumor ECM 
 Some initial understanding of the physical, chemical, and stromal cellular factors 
that promote tumorigenesis can be gleaned by the study of extracted tumor tissue and use 
of in vivo transplantation models, but a more complete understanding is obtained through 
the use of in vitro culture platforms that model tumor ECM
146
.  Ideally such platforms 
would permit study of specific ECM cues of interest, enabling the discovery of specific 
causal relationships between matrix factors and notable cancer cell phenotypes and 
facilitating the screening of potential new therapeutic agents that target these 
relationships.  2D culture substrates like tissue culture polystyrene, glass, and similar 
surfaces with or without cell-adhesive protein coatings have been used to further some 
research into environmental tumor cues, but they suffer several important drawbacks that 
limit the scope of study and the extent to which conclusions can be appropriately 
translated to actual in vivo processes.   
 This section will first review the many limitations of 2D culture in studying cell 
behavior in general and in cancer pathogenesis in particular.  It will then provide an 
overview of naturally derived biomaterials that support the three-dimensional culture that 
more accurately models physiologic tissue architecture and certain cell-matrix processes, 
but also presents experimental problems related to their natural source.  Finally, it will 
describe synthetic systems that have been used to model cancer ECM and propose the use 
of a bioactive hydrogel system based on poly(ethylene glycol).  These hydrogels improve 
on other synthetic systems and enable versatile study of matrix influences on cancer 
progression with high experimental control. 
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1.2.1 Key Differences in 2D vs. 3D in Modeling Tumor ECM 
 In modeling important biochemical, structural, and stromal cell-derived influences 
of the tumor ECM environment, there are several important limitations of 2D culture 
platforms related to key differences in cell behavior resulting from a spatial environment 
that is different from the 3D tissue matrix (Fig. 1-6).  Most obviously, differences in the 
spatial organization of cell-ECM binding resulting from lack of adhesive ECM 
surrounding cells on all sides lead to major changes in cell structure and shape with 
concomitant changes in cell metabolism and gene expression
147–150
.  Expression, 
composition, and clustering of integrins and other cell surface receptors is heavily 
influenced by the proximity of culture nutrients, growth factors and other ligands, 
presenting a potential problem with 2D culture where these influences are strongest on 
the culture media side of the cell, away from the underlying adhesive surface where they 
need to act to exert their effects
151,152
.  Due to these issues, and because only a small 
proportion of the cell in 2D culture is able to bind to ECM and other cells, cell 
Figure 1-6: Microenvironmental factors differently affect cell behavior in 2D vs. 3D culture.  
Multiple aspects of a cell’s interaction with its microenvironment are more physiologically 
appropriate in a 3D context including cell shape (with loss of polarity in 2D), gene expression, 
growth, morphogenesis (notably, vessel sprouting and gland branching), motility (single vs. 
collective cell motility patterns), and differentiation.  From Yamada and Cukierman.
150
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polarization is non-physiological. Polarity is a critical feature to model effectively in the 
culture of epithelial cancer cells.  Abnormal polarized integrin binding and the resultant 
abnormal mechanotransduction dramatically influences intracellular signaling, gene 
expression, and phenotypic fate
146,153
.  
 Two additional key differences between 2D and 3D culture regard molecular 
gradients and migration.  Gradients of growth factors and nutrients are impossible to 
establish in a physiologically appropriate way in conventional 2D cultures, but are 
essential to cell proliferation, migration, and differentiation, and other cellular processes 
that are vital to model appropriately in cancer
154
.  With migration in particular, not only 
are the chemotactic influences altered in 2D, but the frank physical nature is completely 
different; migrating 2D cells encounter little matrix-derived resistance to migration and 
exhibit dramatic temporal and spatial differences in integrin expression, focal contact 
formation and breakage, and secretion of proteases and other ECM molecules during 
remodeling
66,152
.  These migration and remodeling differences found in single cells have 
ever greater implications when attempting to model migration over larger organizational 
scales and longer time scales like that in cancer metastasis. 
 These and other differences have contributed to the finding of differences in key 
phenotypic behavior between 2D or 3D culture of cancer models.  For example, 
metabolism of a hepatoma model was found altered in 3D culture compared to 2D 
monolayer with enhanced glycolysis and production of lactic acid in 3D
147
.  Expression 
of important angiogenesis genes like VEGF or HIF-2 and important chemokines like IL-8 
are upregulated in 3D culture in a melanoma model compared to 2D levels and are more 
comparable to observed in in vivo human tumors
148
.  Finally, cancer models in 3D show 
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key differences in susceptibility to cancer therapy with tumor cells exhibiting altered 
apoptosis due to death receptor ligand therapy
155
 and radiotherapy
156
 and altered 
sensitivity to interferons or other chemotherapeutic agents
157
.  For example, scaffold-less 
spheroid culture of a breast cancer model, absent of any potential scaffold-related 
diffusion barriers, showed a higher IC50 of cisplatin compared to 2D monolayer culture 
due to differences in TGFβ production and the upregulation of drug resistance 
responses
158
. 
 Perhaps most critically, 2D cultures largely lack a stromal component, which 
proves essential to modeling cancer as the majority of tissues that give rise to epithelial 
tumors are composed of non-epithelial stroma (80% by volume in the breast, for 
example).  All of these stromal effects are unaccounted for in traditional 2D culture 
methods
159
.  In addition to lacking ECM structural and growth factor components, 2D 
culture of cancer cells largely prevents modeling of the cellular heterogeneity found in 
the tumor environment.  3D culture enables modeling of mixed cell populations found in 
different compartments (epithelial vs. stromal) or of epithelial tumor cells with different 
phenotypes (proliferating, apoptotic, necrotic, etc.) that result from the more physiologic 
3D mass transport and biochemical gradients
159
.  Because of this and all of the above 
reasons, study in 3D cell culture systems provides much more biologically relevant 
information and offer far better hope for the discovery and characterization of key 
matrix-tumor interactions that are of true significance for cancer patients.  Such natural 
and synthetic 3D systems will now be reviewed. 
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1.2.2 Natural Biomaterials for Tumor Microenvironment Engineering 
 Natural materials such as collagen, fibrin, and MG have been widely used as 
scaffolds in tissue engineering applications as they are derived from or are themselves 
components of the natural ECM and as such offer a cell-friendly 3D environment, 
providing for ample cell adhesion and proliferation
160,161
.  In general, they can be 
modified and degraded by most cell types to permit migration with cells replacing their 
surroundings with cell-secreted matrix.  Further, these matrices facilitate substantial 
cellular interaction by offering a wealth of sites for integrin binding and a reservoir of 
growth factors that may help provide the complex biochemical cues endemic to native 
ECM.  Finally, the mechanical properties of collagen gels and MG can be altered with the 
addition of collagen or non-integrative crosslinkers during formation for studies 
examining cellular response to matrix elasticity
99,162
. 
 As 3D substrates for the study of ECM influences on cancer models specifically, 
MG with and without collagen crosslinking has been widely used and has resulted in 
important findings.  Matrices like MG, derived from reconstituted BM from the 
Engelbreth-Holm-Swarm tumor, were used decades ago in early 3D studies from the 
Bissell group and others to illuminate important morphological and functional behaviors 
(Fig. 1-7).  In these studies, first done using harvested non-transformed mammary 
epithelial cells and then using transformed breast lines, MG-cultured cells form 
functional hollow spheres with distinct polar compartments and feature BM formation 
and vectorial secretion of milk proteins
163,164
.  Gels composed of collagen I were also 
early tools to study epithelial morphogenesis and important 3D structural characteristics 
with mammary cells embedded within or under collagen forming similar functional duct-
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like structures depending on cell type and culture arrangement
97,165,166
.  Collagen is the 
most abundant ECM protein, rich in cell-interactive ligands with a fibular nature 
providing key architectural cues.  As such, reconstituted collagen matrices have been 
used extensively in vitro to evaluate a variety of other cancer model behaviors, notably 
migration and invasion
167
. 
 In the past several years, use of these matrices has facilitated several important 
discoveries regarding tumor-ECM interactions.  Investigators have further probed the 
unique morphologic changes that epithelial cells adopt when embedded in MG or 
collagen, studying the differences in structure and BM secretion due to different degrees 
of malignancy
168
, the combination of localized apoptosis and inter-cellular cavitation that 
occurs to form lumenized structures
169,170
, and the nature of migration and invasion into 
Figure 1-7: Mammary cells form lumen-containing structures when cultured on a 3D BM-based 
matrix. Primary mammary cells cultured in the presence of lactogenic hormones and imaged by SEM 
rapidly adhered at 3h (A), and organized together to form large clumps with large regions of the culture 
area cleared by 24h (B).  By 4-6 days, cells formed lumenized spheroids (C) completely surrounded by a 
fibrillar matrix (D, close-up of C). Scale bar = 100 µm (A-C), 25 µm (D). Modified from Barcellos-Hoff, 
et al.
164
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the matrix under certain cellular or matrix conditions
135,171–173
.  The Weaver and Bissell 
groups, amongst others, have used these matrices to identify key ECM molecules related 
to tumor formation and progression; for example, the important role for integrins β1 and 
β4 in maintenance of epithelial polarity or reversion of a malignant phenotype
174–177
 and 
the interaction of these integrins and others with extracellular laminin to regulate this 
process
117,175,178,179
.  BM-based matrices have helped elucidate the importance of various 
growth factors in impacting cancer model organization and progression, such as 
hepatocyte growth factor (HGF) in MDCK cells and EGF in breast tumor lines
180,181
, and 
key regulatory genes involved in 3D cancer cell growth and invasion
182,183
.  Further, the 
unique structure that cancer cells adopt in these matrices and their resultant integrin 
organization have illuminated mechanisms of chemotherapeutic resistance.  For example, 
NFkB activation from integrin β4 ligation in 3D polarized mammary structures yields 
resistance to apoptosis-inducing agents regardless of malignant potential of the cells (Fig. 
1-8)
176
.  Finally, primarily using breast model lines, in vitro exploration into the influence 
of matrix stiffness on tumor progression was pioneered in collagen or MG/collagen 
mixtures stiffened with increased collagen concentration or crosslinking.  These stiffer 
natural matrices perturbed epithelial polarity and lumen formation and led to enhanced 
cell growth, focal adhesion formation, and integrin clustering with increased matrix 
invasiveness, all regulated by Rho-ROCK and FAK-ERK signaling pathways
43,99,184
. 
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1.2.3 Synthetic Biomaterials for Tumor Microenvironment Engineering 
 While the ease of use, ready availability, and high bioactivity of the naturally-
derived matrices facilitated this work, complex proteinaceous natural matrices suffer 
important limitations.  The ease of degradation of natural matrices permits study of cell 
migration and matrix invasion, but may be a liability for longer-term studies that require 
Figure 1-8: Polarized mammary epithelial cells (MECs) in 3D BM matrices resist apoptosis-
inducing agents.  Non-malignant S-1 MECs and malignant T4-2 MECs were examined under 
different polarized conditions (A) for a polarity influence in response to several apoptosis-inducing 
chemotherapeutics (B).  Markers of polarity show that readily polarizing S-1 cells lose their polarity 
upon exposure to an E-cadherin blocking antibody (left) and non-polarizing T4-2 exhibit polar 
reversion upon exposure to a β1 integrin blocking antibody (right). (B) In both cases, cells display a 
resistance to apoptotic agents when in the organized, polarized state as indicated by apoptotic 
labeling. Scale bar = 10 µm.  Adapted from Weaver, et al.
176
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the matrix to remain intact.  MG batch-to-batch variability and growth factor 
contamination and the variability in collagen gel properties based on minor changes 
preparation methods can make comparisons between studies difficult
162,185–187
.  
Additionally, MG and collagen matrices exhibit weak mechanical strength (E = 0.1 - 10 
kPa), limiting their relevance in the study of higher range elasticities that may be more 
typical of cancerous soft tissue (E = 1 - 100 kPa) or stiffer sites of common metastasis 
like bone (E >> 100 kPa)
188,189
.  Further, this fragility may present handling difficulties 
when transitioning to more involved experimental manipulations; for example, more 
complex methods used to pattern bioactivity.  In addition, while complex proteinaceous 
natural matrices are highly bioactive, there is limited experimental control over this 
bioactivity with variable bioactivity between different natural matrices resulting in 
differences in adhesion, cytoskeletal arrangement, and migration in the same pool of 
cells
190
.  Finally, they feature a critical flaw in that the adjustment of matrix mechanics 
almost always alters matrix biochemistry, presenting a significant confounder, 
particularly in studies that strive to parse out the relative importance of ECM ligand and 
stiffness influences
189,191,192
. 
 Tissue engineers have sought to avoid these problems by pioneering the 
development of scaffolds composed of synthetic materials, typically polymers, with some 
of these scaffolds permitting more precise experimental control over mechanical 
properties, degradation, and cell-matrix interactions.  Polymers in the polyester group like 
poly(lactic acid) or its copolymer with poly(glycolic acid), poly(lactic-co-glycolic acid) 
(PLG), have been widely used in the field in part because of their predictable and tunable 
degradation and the ability to tune their modulus by altering the amount of copolymer 
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used
193,194
.  Other traditionally used synthetic scaffolds include those based on the 
polyurethanes or polydimethoxysiloxane, given their biocompatibility, versatility, and 
partial control over mechanical properties
195
.  Synthetic matrices made of polyacrylamide 
(PA) have been used extensively in two-dimensional studies examining substrate 
stiffness-related effects on cell behavior and differentiation primarily because they offer 
precise control of elastic modulus over a wide range
27,33
. 
 3D culture of cancer models already has begun to transition to the realm of 
synthetic scaffolds.  For example, an oral squamous cell carcinoma model cultured in a 
porous PLG scaffold formed in vivo-like tumors with high angiogenic capacity and 
chemotherapy resistance
196
.  Scaffolds composed of PLG or other polyesters have been 
used to study growth, morphology, and chemotherapy response in many other cancer 
models, including other breast lines
197
, osteosarcoma
198
, glioblastoma multiforme
199
, and 
leukemia
200
.  PA gels, meanwhile, have been widely used in two-dimensional cancer 
models to further the study of cancer response to matrix rigidity or illuminate new cancer 
migration findings
201–203
. 
 In general these traditional synthetic materials suffer from more limited 
bioactivity compared to natural biomaterials.  Any bioactivity present, such as cell 
adhesion, typically relies on nonspecific adsorption of proteins from the media.  This 
nonspecific adsorption can make the engineering and study of specific ECM growth 
factors or other matrix constituents a challenge.  Further, the traditional polyester 
scaffolds and similar materials often require an additional and potentially unphysiological 
porogen processing step to create a porous matrix amenable to 3D cell seeding and 3D 
culture
204
. With other synthetic materials, notably PA, harsh crosslinking conditions or 
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monomer toxicity endanger cell viability in 3D experiments, limiting their use to two-
dimensions
205
.  Further, while polymer degradation with traditional synthetic scaffolds is 
often engineered with more predictability than natural matrices, cell-mediated 
degradation may be lacking.  This cell-directed reorganization of the matrix is a vital 
feature when studying drastic switches in cancer behavior like those that occur in EMT 
and metastasis.  In the study of cancer-microenvironment interactions, the use of 
synthetic matrices that feature the combination of high 3D biocompatibility, tunable 
mechanics, and the capability to model the full range of bioactivity that the ECM affords 
is in its infancy, with poly(ethylene glycol)-based hydrogel matrices an exciting option to 
explore in this effort.   
 
1.2.4 Poly(ethylene glycol)-based Hydrogel Matrices 
 Poly(ethylene glycol) or PEG is an FDA-approved hydrophilic polymer widely 
studied in both in vitro and in vivo tissue engineering applications and is well-suited as an 
ECM mimic in studies probing cancer-matrix interactions
187,206–208
.  PEG molecules with 
bi-terminal acrylate groups can be combined with a chemical photoinitiator and exposed 
to an activating light source to form a cross-linked hydrogel matrix, with appropriately 
mild cross-linking conditions permitting cell encapsulation into the hydrogel bulk with 
high viability, thus facilitating three-dimensional study 
209,210
.  Fully hydrated, PEG 
matrices are mostly composed of water and closely mimic soft tissues with physiologic 
diffusional and mechanical properties
189,211
.  Furthermore, in their unmodified state, PEG 
hydrogels resist nonspecific protein adsorption and subsequent cell adhesion and 
interaction 
212–214
.  This characteristic offers a “blank slate” biomaterial for which one can 
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be confident that any biologic response observed is the result of an intentionally 
engineered modification. 
 Bioactivity can be incorporated into PEG hydrogels by the inclusion of a variety 
of ligands, from oligopeptides to whole protein growth factors (Fig. 1-9).  Making use of 
well-characterized chemistry, a free amine or terminal carboxyl group in proteins or 
peptide sequences is attached to a bifunctional PEG chain forming an acryloyl-PEG-
ligand molecule that can then be incorporated into the bulk of the hydrogel matrix during 
formation
215
.  For example, the fibronectin-derived RGD peptide sequence can be added 
to the PEG hydrogels to enable basic cell adhesion and promote cell migration
216,217
.  
Other ECM-mimetic peptides, like the laminin-derived YIGSR and IKVAV and the 
elastin-derived VAPG have been incorporated into PEG hydrogels as an analogue to their 
respective ECM proteins to explore a variety of cell responses
218,219
.  Further, because 
this conjugation chemistry can be performed in aqueous solution, whole proteins can be 
incorporated without compromising protein structure and function
215,220
.  Growth factors 
Figure 1-9: Bioactive PEG-based hydrogels.  In the presence of a photoinitiator and activating light, 
cells can be encapsulated into PEG-based hydrogels with high viability.  Bioactive molecules can be 
incorporated into the matrix, like PEG-RGDS to permit cell adhesion, a degradable sequence in the 
PEG-PQ-PEG backbone to permit cell-mediated degradation, and pegylated proteins to exert matrix-
derived biochemical effects.  
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like vascular endothelial growth factor, bone morphogenetic protein-2, ephrinA1, TGFβ-
1, and many others have been incorporated into PEG hydrogels to exert matrix-derived 
biochemical signaling (Fig. 1-10)
207,210,221–223
.  The PEG conjugation reaction can be 
carefully controlled to prevent over-modification of proteins that require structure 
maintenance to signal with more complex tertiary signaling, like FGF
210
.  The covalent 
tethering of growth factors to the scaffold via PEG may make the proteins resistant to 
proteolytic degradation and endocytosis by cells and prevent loss by diffusion thus 
allowing prolonged growth factor delivery
220,224
. 
 For 3D studies examining cancer-matrix interactions and metastasis, the scaffold 
used would ideally be degradable to permit cell and tumor spheroid reorganization and 
migration.  Chemistry similar to that discussed above can be used to bind protease-
sensitive sequences to flanking acrylate-PEG chains, and the resulting molecule can be 
polymerized to form PEG-based hydrogels capable of cell-mediated degradation
225,226
.  
Such a system has been well-studied in vascular tissue engineering applications where, 
for example, MMP-sensitive hydrogels permit self-organization of an angiogenic co-
culture into a vascular network with characteristics similar to native tissues
207
.  The 
degradable sequence can be tailored to permit different degrees of reactivity with a 
variety of individual proteases, like other MMP species or plasmin, with specifically 
engineered reaction kinetics
225–227
. 
 In addition to designed bioactivity, PEG hydrogels also exhibit tunable 
mechanical properties.  Matrix elasticity can be tuned by altering the concentration of 
PEG used in the prepolymer solution or by changing the molecular weight of the PEG 
polymer chain
228
.  High molecular weight PEG yields matrices with lower crosslink 
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Figure 1-10: PEG-proteins can exert diverse biological effects. For example, (A) matrix-tethered 
PEG-VEGF promotes endothelial cell tubule formation. Scale bar is 500 μm. Adapted from Leslie-
Barbick, et al.
221
 (B) PEG-BMP2 promotes expression of osteocalcin (red) of cultured osteoblasts. 
DAPI (blue). Modified from Liu, et al.
223
 (C) Matrix-tethered PEG-TGFβ improved smooth muscle cell 
ECM secretion compared to soluble, unmodified TGFβ. Adapted from Mann, et al.222 
densities and higher water content to produce a softer substrate.  Altering these factors 
together enables relatively precise tunability of the stiffness over a broad physiologic 
range.  Further, because the system is photo-controlled, hydrogels with more complex 
arrangements of matrix elasticity can be presented to cells.  For example, hydrogels with 
a gradient of elasticity varying linearly from 2-100 kPa down the length of the gel can be 
formed through controlled mixing of two different prepolymer solutions of low and high 
molecular weight PEG during polymerization
228
.  In addition, a photomask can be 
deployed during polymerization or in subsequent manipulations to yield hydrogels with 
distinct areas of patterned stiffness, or if used in concert with separate pegylated bioactive 
species, designed areas of patterned bioactivity (Fig. 1-11)
228,229
.  Further, in place of a 
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lamp light source, a confocal laser scanning microscope can be used to incorporate 
additional patterned bioactivity like micron-scale vascular-mimetic geometries of 
angiogenic growth factors or, through use of two-photon excitation, complex and precise 
three-dimensional patterned bioactivity
230,231
.  
 Finally, because cells are incapable of interacting with the PEG itself, changing 
hydrogel stiffness by altering the concentration or molecular weight of PEG chains does 
not alter the bioactivity of the matrix.  This offers an important advantage for the PEG-
based system over natural matrices and many other synthetic materials.  The mechanics 
of the overall matrix are determined by the crosslinking properties of the base PEG 
chains while bioactivity is incorporated distinct from this process, and as such, any 
response seen in cells cultured on the matrix is the result of known changes to mechanics 
or biochemistry with little danger of unknown interaction between the two factors.  
Figure 1-11: Patterned elasticity on PEG hydrogels. (Left) PEGDA hydrogels with 
photomask-patterned elasticity with (A) dextran-fluorescein soaking into softer 20 kDa 
regions after patterning or (B) acrylated fluorescein incorporated into stiff 3.4 kDa regions 
during patterning. (Right) RAW 264.7 macrophages preferentially adhere to stiff regions 
after 48 hours. Modified from Nemir et al.
228
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Furthermore, the versatility in incorporation of bioactive peptides and proteins permits 
exploration of a wide variety of ECM factors that may play a role in tumor growth and 
metastasis with a similar high degree of experimental control.  This control, coupled with 
high biocompatibility and potential in more advanced experimental manipulations, makes 
PEG-based hydrogels an excellent matrix-mimetic platform with which to study matrix-
derived influences on cancer behavior and metastasis. 
 
1.3  Summary and Overview of Thesis  
 The stromal environment plays an essential role in a variety of cellular behaviors 
in health and disease.  Investigation into the stromal role in cancer has demonstrated that 
disruptions in tumor ECM composition, architecture, and mechanics in concert with 
pathological stromal cells are essential to cancer progression and metastasis.  Researchers 
have begun to further explore these interactions using in vitro ECM-mimetic matrix 
systems, illuminating key findings on the ECM’s role in morphogenesis, epithelial-
mesenchymal transition (EMT) and metastasis, but study has been hindered by the 
limitations in control and versatility of naturally-derived matrices. 
 In this thesis work, a bioactive, ezymatically degradable PEG-based hydrogel 
system is used study a newly characterized lung cancer model that is highly responsive to 
ECM-derived cues.  First, the PEG system is deployed to recapitulate key MG findings 
related to epithelial morphogenesis of an EMT-prone lung adenocarcinoma model line 
and further understanding of this process by examining the influence of matrix bioactivity 
and mechanics.  Next, the response of cells in the PEG system to TGFβ is investigated, 
examining the influence of matrix parameters and a protease-sensitive sequence in degree 
of matrix invasion.  Furthermore, the EMT-related remodeling of cell-secreted ECM and 
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its modulation by matrix parameters is investigated.  Finally, the PEG system is deployed 
to examine the role of cell-cell contacts in epithelial morphogenesis and EMT.  
Specifically, matrix-tethered E- and N-cadherin are used to modulate the behavior of both 
the representative metastatic model line, 344SQ, and a mutant line that is incompetent in 
morphogenesis in the absence of intercellular interactions due to a mutant polarity gene.  
Overall, this thesis advances the state of the field of ECM influences on cancer 
progression, demonstrating how the PEG system can be used to robustly study such 
extrinsic cues and deploying it to describe key matrix parameters that are important in 
guiding EMT-related morphogenetic and metastatic processes. 
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2. PEG Hydrogels for Investigation of Matrix-derived 
Influences on Lung Adenocarcinoma Epithelial Morphogenesis 
 
A significant portion of this chapter is from BJ Gill, DL Gibbons, LC Roudsari, JE Saik, 
ZH Rizvi, JD Roybal, JM Kurie, and JL West (2012).  Cancer Research, 72, 6013-23. 
 
 
2.1 Introduction 
 Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death 
with most patients diagnosed at an advanced stage.  Of the remaining patients who 
undergo curative surgery, upwards of 50% will have a disease recurrence with metastatic 
cancer at non-lung sites
232
.  One model of metastasis purposes that a subset of cells in 
primary epithelial tumors undergoes EMT characterized by loss of apical-basal epithelial 
polarity, loss of intercellular adhesions, the acquisition of mesenchymal differentiation 
properties, and subsequent migratory potential and matrix invasion
233
.  Similarly, it is 
postulated that once they reach new sites of metastatic implantation, metastatic cells 
undergo mesenchymal-epithelial transition (MET) characterized by loss of mesenchymal 
characteristics and motility, formation of extensive cell-cell contacts, and reacquisition of 
epithelial polarity
234
.  Researchers have sought to develop cell lines and matrix systems 
that effectively model EMT and MET processes in the hope that a more complete 
understanding of the matrix’s role in EMT/MET might illuminate new therapeutic 
targets. 
 
2.1.1  A Novel Lung Cancer Model with ECM-mediated EMT 
 Research into EMT and metastasis in lung cancer has been hampered by lack of 
good models to study these behaviors in animals or in in vitro systems.  Most of the 
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previous models have used human cells derived from immunodeficient animal xenograft 
studies to yield important findings regarding cell-intrinsic genetic and epigenetic 
changes, but they provide little information about the role a supportive ECM may play in 
tumor development or progression
232,235
.  To circumvent issues with these xenograft 
models, a few groups have developed genetic mouse models based on mice with mutant 
K-ras alleles in which spontaneous lung adenocarcinomas develop, but all of these 
models lack metastatic disease, the central feature of interest to study for patients with 
NSCLC.  Unsurprisingly, given the overall lack of reliable NSCLC models suitable for 
any type of study, little examination of matrix-derived influences on NSCLC behavior 
and metastasis has been done, with most studies of this kind using a group of the same 
commonly studied breast cancer model lines.  This limitation potentially risks the 
inappropriate generalization of cell line- or cancer type-specific findings to cancer more 
broadly. 
 A new panel of lung adenocarcinoma model lines has been developed to model 
metastatic lung cancer and probe for ECM-related influences on lung cancer invasion and 
metastasis (Fig. 2-1).  These tumor cell lines were derived by examining mice that were 
heterozygous for a somatically activated KRas
G12D
 allele, a germline p53
R172HΔG
 allele, or 
both
235
.  Mutant K-ras was found necessary for the development of high-frequency 
primary lung adenocarcinomas, and while the presence of the mutant p53 allele did not 
affect primary tumor development, the mutation did have a dramatic effect on the rate of 
metastases from the primary site (37% vs. 4.5%).   Metastases in KRas
G12D
/p53
R172HΔG
 
mice were found at sites frequently observed in human NSCLC patients, and displayed a 
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gene expression signature similar to that of tumors in these patients, with a stronger 
correlation to patients with particularly poor prognosis 
236
.   
 In additional findings, several cell lines developed from primary or metastatic 
tumor sites were re-injected into healthy syngeneic mice and were found to differ in their 
ability to cause new metastatic disease (vs. subcutaneous tumors) despite identical initial 
genetic abnormalities
232
.  When further studied in vitro in 3D MG assays, one 
representative metastatic cell line from this model, 344SQ, transitioned from a 
mesenchymal to epithelial phenotype, forming highly polarized, growth-arrested, 
lumenized spheres reminiscent of a lung acinus (Fig. 2-2).  Upon TGFβ exposure, these  
Figure 2-1: A genetic mouse model for metastatic lung adenocarcinoma.  (Top) Mice with 
somatically activated K-ras formed primary lung adenocarcinomas with no metastatic disease.  When 
mated with mice with a p53 mutation, the heterozygous mutations induced formation of lung 
adenocarcinoma with widespread metastatic disease, (Bottom) featuring high tumor burden in the lung 
(a), and metastases to the liver (b), parietal pleura (c), kidney(d), and heart (e). Modified from Zheng, et 
al.
235
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epithelial 344SQ structures progressed through EMT, becoming larger, losing apical-
basal polarity, and forming invasive outgrowths, coincident with alteration in expression 
of several EMT-related genes.  Meanwhile, a nonmetastatic KRas
G12D
/p53
R172HΔG
 line, 
393P, was resistant to TGFβ, requiring much longer time of exposure to cause 
morphologic changes and preserving expression of some epithelial markers.  This EMT 
response was found to be regulated by the microRNA (miR)-200 family, with miR-200 
levels much higher in 393P vs. 344SQ and falling in 344SQ upon TGFβ exposure.  The 
change occurred in concert with a rise in Zeb1, a master EMT transcription factor that 
modulates several pro-EMT proteins and forms a double negative feedback loop with 
miR-200
233,237
.  Constitutive expression of miR-200 in 344SQ prevented an increase in 
Figure 2-2: Contextual ECM cues regulate EMT of the 344SQ NSCLC model.  344SQ forms 
growth-arrested, lumenized spheres in 3D MG culture with localized expression of epithelial polarity 
markers.  Upon TGF-β1 exposure, cells proliferate, lumenization and polarity are lost, and matrix-
invasive outgrowths are formed.  This process is mediated by a double-negative feedback loop between 
miR-200 and the pro-EMT transcription factor Zeb1.  α6-integrin (red), ZO-1 (green), Torpro-3 (blue).  
Adapted from Gibbons, et al.
232
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Zeb1, blocked EMT-related gene expression and morphological changes induced by 
TGFβ exposure, and prevented metastatic disease seen with syngeneic reinjection232. 
 To summarize important findings, the KRas
G12D
/p53
R172HΔG
 393P and 344SQ 
lines showed dramatically different metastatic potential despite a common genotype, and 
the representative metastatic line (344SQ) exhibited a markedly different phenotypic 
response in vitro depending on to extracellular context (3D vs. 2D, +/- TGFβ).  These 
findings were expounded upon by a recent report that demonstrated that cells that differ 
in their metastatic capacity and miR-200 expression also differentially express a wealth 
and wide variety of cell surface and ECM matrix proteins that no-doubt play a role in 
their different matrix-related phenotypes (Fig. 2-3)
238
.  Notably, differentially expressed 
Figure 2-3: Differential expression of ECM-related proteins in 344SQ.  A global liquid 
chromatography -tandem mass spectrometry analysis found notable proteins upregulated (red) or 
downregulated (green) in metastatic 344SQ compared to non-metastatic 393P. In general, 
expression demonstrated increased secreted ECM, enhanced binding to ECM, and decreased cell-
cell adhesion.  Modified from Schliekelman, et al.
238
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proteins included integrins αv and β3, the important adhesion protein CD44, the ECM-
crosslinker LOXL2, and a variety of ECM proteins themselves including fibronectin, 
collagen VI, and several laminin subunits.  An additional study suggested that alterations 
in cell-cell contacts, specifically the Notch-Jagged signaling system, may also play a 
role
239
.  Interaction with the surrounding microenvironment of cells at the leading edge of 
in vivo 344SQ-derived tumors was found to drive a Jagged2-dependent development of a 
metastatic subpopulation.   
 Taken together, these findings suggest that the EMT and metastatic capacity of 
NSCLC is not solely dependent on cell-intrinsic chromosomal changes or somatic 
mutations, but is likely heavily influenced by physical and soluble factors of the 
surrounding ECM environment, potentially mediated through effects on miR-200.  
Further, they suggest that it may be possible to convert metastasis-prone tumor cells to a 
metastasis-incompetent state by manipulating these stromal interactions
2,232
.  This idea 
provides an exciting potential avenue for new therapeutic interventions, but requires 
much more experimental investigation into the nature of these key interactions.  The use 
of the PEG system in place of MG in the service of this investigation should circumvent 
issues with purity and the confounding of bioactivity and mechanics while providing 
robust experimental flexibility and control in probing potentially important cell-matrix 
and cell-cell interactions.  
 
2.1.2  Matrix Tools to Study Lung Adenocarcinoma Epithelial Morphogenesis and 
EMT 
 As reviewed in Chapter 1, the tumor ECM is central to growth, gene expression, 
migration and a number of other processes important to cancer pathophysiology and 
43 
 
progression.  Much research focus has been directed toward the use of in vitro matrix-
mimetic materials that can facilitate the study of features of this tumor-ECM interaction 
and matrix factors that guide tumor behavior.  Some of this work has been done using 
two-dimensional culture systems, namely polyacrylamide (PA) gels engineered with 
stiffness that is more physiological than traditional 2D culture surfaces, to provide 
glimpses on the influence of matrix stiffness on narrowly-focused facets of behavior of 
single cultured cells.  For example, an early report from Wang, et al., used PA gels to 
study differences in matrix stiffness-influenced cell proliferation and apoptosis between 
normal and neoplastically transformed cells
240
.  Other reports have sought to deploy 2D 
PA systems to study cancer cell spreading, motility, and invadopodia formation to 
suggest insight into tumor growth and migration
203,241
.  However, as described 
previously, these characteristics and many others are dramatically different in cells in 2D 
culture compared to their more physiological 3D environment.  This is of even greater 
importance in cancer as the dramatic differences in 3D matrix invasion, growth factor 
response, and intercellular organization leave conclusions based on 2D culture wanting 
and incomplete. 
 To facilitate this 3D culture, naturally-derived materials such as collagen and MG 
have been largely used due to their ready availability, biocompatibility, and rich 
presentation of cell adhesive ligands to facilitate cell culture and growth.  3D culture of 
different cancer lines in these materials has enabled modeling and study of crucial 
physiologically relevant behaviors impossible to observe in 2D culture, like formation of 
organized, multi-cellular tumor spheroids by epithelial tumors and their disruption in 
malignant progression
104,168,174,176,181
.  These matrices have also enabled more relevant 
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exploration of matrix-derived biochemical and mechanical influences on cancer 
progression, EMT, and invasion.  For example, increased collagen density and 
organization in collagen-based matrices promote tumor progression
22,23,83
, and increased 
collagen crosslinking leads to EMT and invasion
43
.  Stiffening of MG and collagen 
matrices perturbs epithelial morphogenesis of the MCF10A mammary cell line and 
promotes an invasive phenotype through alteration of integrin clustering and regulation 
of Rho activity and the FAK-ERK pathway
99,184
.  While most of the study has been 
focused on breast models, work by the Gibbons and Kurie groups using natural matrices 
has shown important matrix-related influences on lung adenocarcinoma, with model lines 
in MG showing important morphogenic responses in a 3D environment
232
, influenced by 
surrounding growth factors
238
 and binding of the Jagged-notch cell-cell signaling 
system
239
. 
 As described in Chapter 1, the use of naturally-derived material in these matrices 
presents obstacles in the reliable engineering of the matrix environment related to growth 
factor contamination, batch-to-batch variability, and key limitations in matrix mechanics 
whereby only a relatively low maximum stiffness can be achieved and the tuning of 
mechanics frequently leads to concordant changes in biochemistry.  In addition, the 
baseline level of high cell interactivity that these matrices afford makes the study of 
specific matrix-derived influences difficult.  To examine the specific influence of 
particular integrins or other cell surface receptors in these matrices, for example, one 
typically has to rely on blocking antibodies or knockdowns as a potentially inaccurate 
surrogates to actual changes to the ECM
99,174,176,239
.  In this one-sided, cell-centered 
approach, cancer cells are altered to modulate their reactivity to the ECM and the 
45 
 
response typically recorded by measuring changes to these altered cells.  This approach 
may be less physiologically relevant than one that seeks to introduce cell-extrinsic 
changes to the ECM to probe the matrix-induced response of otherwise unaltered tumor 
cells.  
 The use of synthetic matrices that attempt to avoid the pitfalls of natural matrices 
while providing a modular platform to independently probe 3D matrix cues like matrix 
stiffness or specific biochemical ligands for influence on cancer behavior is of increasing 
research focus.  One report has deployed Michael-type crosslinked hyaluronic acid-based 
(HA) hydrogels with tunable mechanical properties conjugated to a RGD-based adhesion 
peptide to influence glioma cell adhesion and behavior in 2D and 3D in an attempt to 
parse the separate effects of matrix mechanics and biochemistry
191
.  Bilayered, bioactive 
HA matrices have also been used to illuminate the unique morphologic and growth factor 
secretion changes of a prostate cancer model line resulting from 3D culture
242
.  The study 
of cancer models in systems with decoupled mechanics and bioactivity has been 
attempted in other systems including glioma and liver cells in collagen gels respectively 
stiffened with non-bioactive agarose
243
 and PEG
244
 and in breast cells in a self-
assembling peptide matrix
192
.  However, in the former cases, the bulk matrix components 
are still themselves bioactive, and in the latter, bioactivity is mediated by passive protein 
adsorption, rather than tuned with specific engineered control. 
 With high resistance to protein adsorption and non-specific cell interactions, PEG 
hydrogels offer a baseline non-interactive, but still biocompatible material with which to 
introduce and study the effect of matrix-derived influences on cancer behavior.  Because 
the system is modular, and the mechanical component is distinct from the bioactive 
46 
 
component, these matrices feature independently tunable mechanics and biochemistry 
with each factor available for testing of an independent biologic effect with high 
experimental control.  In this chapter, PEG hydrogels were used to study matrix 
influences on the behavior of lung cancer cell lines from the KRas
G12D
/p53
R172HΔG
 model 
with focus on the representative metastatic line 344SQ.  First, a PEG system featuring 
biospecific cell adhesion and cell-mediated proteolytic degradation was used to 
recapitulate this MET morphogenesis previously observed in the MG system.  Matrix 
stiffness and the concentration of cell-adhesive ligand were altered and found to 
significantly influence epithelial morphogenesis.  This influence was manifest by 
differences in the extent of lumenization, in patterns of intrasphere apoptosis and 
proliferation, and in expression of epithelial polarity markers.  Finally, a cyclic form of 
RGD was introduced in place of the linear form to further alter this matrix bioactivity-
mediated response. 
 
 
2.2 Materials and Methods 
 
2.2.1 Cell Culture   
The 344SQ, 393P, and 344P cell lines were derived from KRas
G12D
/p53
R172HΔG
 
mice as described previously in Gibbons, et al. and Zheng, et al.
232,235
.  The 344SQ_429 
cells are derived from 344SQ parental cells and contain a constitutive expression vector 
encoding the miR-200b_a_429 locus).  Cells and cell-laden hydrogels were cultured in a 
humidified atmosphere at 37˚C and 5% CO2 in RPMI 1640 (Mediatech, Manassas, VA) 
with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA), 10 μg/ml 
gentamicin and 0.25 μg/ml amphotericin B (Invitrogen, Carlsbad, CA).   
47 
 
 
 
 
2.2.2 Synthesis and Purification of PEG-RGDS and PEG-PQ-PEG 
Bioactive hydrogel constituents were first synthesized (Fig. 2-4).  Monoacrylate-
poly(ethylene glycol)-succinimidyl carboxymethyl (PEG-SCM; Laysan Bio, Arab, AL) 
and Arg-Gly-Asp-Ser peptide (RGDS; American Peptide, Sunnyvale, CA) were 
dissolved separately in dimethyl sulfoxide (DMSO; Cambridge Isotope Laboratories, 
Andover, MA), and then the PEG-SCM solution was slowly added to the RGDS solution 
at a molar ratio of 1:1.2 (PEG-SCM:RGDS).  A small volume of N, N-
Diisopropylethylamine (DIPEA; Sigma, St. Louis, MO) was added to that mixture at a 
molar ratio 1:2 PEG-SCM: DIPEA.  The resulting solution was mixed, reacted overnight 
on a rocker, and dialyzed against deionized water in a 3500 MWCO regenerated cellulose 
membrane (Spectrum Laboratories, Rancho Dominguez, CA) to remove unreacted 
products and organic solvents.  In a separate reaction, the same process was used to 
conjugate a cyclic form of RGD (c(RGDfk), Creative Peptide, Shirley, NY) to synthesize 
Figure 2-4: Bioactivity of PEG matrix. A, bioactive peptides are reacted with monoacrylate-PEG-
succinimidyl carboxymethyl (SCM)  to form B, pegylated peptides: linear and cyclic forms of PEG-
RGDS to permit cell adhesion and PEG-PQ-PEG that serves as a matrix backbone susceptible to 
cell-mediated degradation via cleavage by MMP-2 and -9 (cleavage cite at red arrow). 
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the PEG-c(RGDfK) molecule.   
The MMP-sensitive peptide GGGPQGIWGQGK (PQ) was similarly reacted to 
form PEG-PQ-PEG (“PEG-PQ”);  PEG-PQ was synthesized to make the backbone of the 
hydrogel network susceptible to cleavage by secreted MMP-2 and -9, enabling cell-
mediated matrix degradation and remodeling
207,245
.  First, the PQ peptide was synthesized 
via standard Fmoc chemistry on an APEX 396 solid phase peptide synthesizer (Aapptec, 
Louisville, KY) and characterized with MALDI-TOF.  The PQ peptide was then 
conjugated to PEG-SCM following a similar procedure as PEG-RGDS, but with a 2.1:1 
molar ratio PEG-SCM:PQ.  Following lyophilization, conjugation of PEG-peptide 
products were confirmed using gel permeation chromatography (GPC; Varian, Inc., Palo 
Alto, CA) with PEG-peptides dissolved in dimethylformamide (DMF) with 0.1% (w/v) 
ammonium acetate and compared to PEG-SCM standards. 
 
2.2.3 Cell Encapsulation in Hydrogels 
Polymer mixtures were prepared with PEG-PQ and PEG-RGDS in 10 mM 
HEPES buffered saline (HBS; pH 8.5) with 1.5% v/v triethanolamine (TEOA, Fluka 
BioChemika, St. Louis, MO), 3.5 µl /ml N-vinylpyrrolidone (NVP, Sigma) and 10 µM 
eosin Y photoinitiator (Sigma), and the solutions were sterilely filtered.  For initial 
experiments recapitulating 3D morphogenesis, PEG-PQ was mixed at 10% (w/v) and 
linear PEG-RGDS added at 3.5 mM.  344SQ cells were pelleted by centrifugation at 500 
x g for 4 min and then resuspended in the polymer solution at 1500 cell/µl (1.5 M 
cell/ml) unless otherwise noted. 
 For easy handling, hydrogels were formed attached to a methacrylated coverglass 
base.  Methacrylated coverglass was made by etching a glass coverslip with piranha 
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solution (30% v/v 9 M H2O2 and 70% v/v 37.5 N H2SO4) and reacting with 85 mM 3-
(Trimethoxysilyl)propyl methacrylate (Fluka) in 95% ethanol (pH 4.5) overnight.  Under 
sterile conditions, hydrogel disks were fabricated by sandwiching a 5 µl droplet of 
polymer solution containing cells between a glass slide and a methacrylated glass 
coverslip separated by two 380 µm thick polydimethylsiloxane spacers (Fig. 2-5).  The 
set-up was then immediately exposed to high intensity white light for 30 s (Fiber-Lite 
Series 180, 150 W halogen, Dolan Jenner), leading to hydrogel polymerization and 
covalent linkage to the methacrylated coverglass base.  High cell viability was confirmed 
24 h after encapsulation (2 µM calcein AM and 4 µM ethidium homodimer, Live/Dead 
Kit, Invitrogen). 
 
2.2.4 Mechanical Testing 
For material compressive properties, acellular hydrogel disks were formed as 
above using 5, 10 or 15 % (w/v) PEG-PQ solutions.  For comparison, MG samples were 
Figure 2-5: Hydrogel fabrication schematic. Matrix components are mixed with cells and 
eosin Y photoinitiator and polymerized under white light to form a PEG hydrogel attached to a 
coverslip for handling.  Encapsulated cells interact with bioactive hydrogel components.  
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prepared as in Gibbons, et al. using a chamber plate with removable walls
232
.  Sample 
dimensions were obtained using digital calipers prior to subjecting samples (n = 4 per 
formulation) to compressive testing using an Instron Model 3340 mounted with a 10 N 
load cell.  Instron Series IX/s software was used for testing control and data acquisition as 
uniaxial compressive strain was applied at 0.5 mm/min.  Force-elongation data was 
converted to stress-strain data with corrected cross-sectional area and plotted to derive the 
elastic modulus from the slope of the linear portion of the curve. 
 
2.2.5 344SQ Sphere Lumenization and Size 
344SQ cells were encapsulated in hydrogels with varied PEG-PQ concentration 
(5, 10, or 15 % (w/v)) and fixed 3.5 mM linear PEG-RGDS or with fixed 5% PEG-PQ 
concentration and varied PEG-RGDS concentration (1, 3.5 or 7 mM) to assess for matrix-
related influences on the size and degree of lumenization of cell spheres.  Hydrogel 
samples (n = 5 per formulation) were imaged every 2 days on an Axiovert 135 inverted 
fluorescent microscope (Zeiss, Oberkochen, Germany) and sphere diameter was 
measured using Image J (NIH).  Lumenization scoring was done blinded to grouping and, 
for initial experiments with linear PEG-RGDS, quantified as the number of spheres 
exhibiting central clearing on brightfield images over total spheres formed.  Both size and 
lumenization data were expressed as means for all spheres in a given hydrogel sample.  
Further, size data from spheres across all hydrogel samples of a particular formulation 
were pooled and organized into histograms to better visualize matrix formulation-related 
variation in sphere organization.   
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2.2.6 Immunohistochemistry 
Hydrogels with encapsulated cells were fixed in 3.7% paraformaldehyde (EMS, 
Hatfield, PA) for 45 min, permeabilized with 0.25% (v/v) Triton X-100 (Sigma) for 10 
min and blocked overnight at 4˚C with 5% (v/v) donkey serum (Sigma).  Samples were 
then incubated with the following primary antibodies overnight at 4˚C: for polarity 
staining - mouse anti-β-catenin (BD Biosciences, San Jose, CA), mouse α6-integrin 
(Chemicon/EMD Millipore, Billerica, MA) and rabbit anti-ZO-1 (Invitrogen); for 
apoptosis and proliferation staining - rabbit anti-cleaved caspase-3 (Cell Signaling, 
Danvers, MA) and goat anti-ki-67 (Santa Cruz, Dallas, TX).  Following an 8 h rinse in 
PBS + 0.01% (v/v) Tween (Sigma), samples were incubated overnight at 4 ˚C with either 
an Alexafluor 488 or 555 tagged donkey anti-rabbit, -mouse or –goat secondary antibody 
(Invitrogen).  Samples were counterstained overnight with a 2 µM DAPI solution to 
visualize cell nuclei and 0.11 μM Alexafluor 647 phalloidin (Invitrogen) to visualize 
actin organization and then imaged using a Zeiss 5Live confocal microscope.   
 
2.2.7 Epithelial Morphogenesis of 344SQ in Matrices with Cyclic PEG-RGDS  
As above, 344SQ were encapsulated in hydrogels with fixed 5% PEG-PQ 
concentration, but with varied PEG-c(RGDfK) concentrations (1, 3.5 or 7 mM).  5% 
PEG-PQ gels with the same concentrations of linear PEG-RGDS were also used as 
controls.  Hydrogel samples (n = 3 per formulation) were cultured for 12 days, stained as 
above for polarity markers, and imaged on a Zeiss 5Live confocal microscope to assess 
for differences in sphere size and epithelial morphogenesis.  Mean sphere size was 
measured using ImageJ, evaluated as sphere diameter across maximum cross-section on 
the phalloidin channel (~80-100 spheres per gel sample), and expressed as means for all 
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spheres in a given hydrogel sample.  To better characterize subtle morphologic 
differences in samples of these mixed sphere populations, a different lumenization 
scoring method was deployed using the finer nuclear and polarity marker spatial 
information afforded by confocal imaging (epithelial score or E-score method).  E-score 
criteria and example images are summarized in Table 2-1.  Lumenization percentages 
were expressed as a mean for all spheres in a given hydrogel sample and evaluated as the 
sum of percentage of spheres with E-score = 3, 4, or 5 over total sphere number.  Size 
and lumenization data were evaluated for significance by ANOVA with Tukey’s HSD 
post-hoc test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2-1: E-score Criteria.  
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2.3 Results and Discussion 
 
2.3.1 Material Characterization 
Reaction of PEG-SCM with RGDS and PQ peptides created pegylated peptides 
that could be incorporated to render hydrogels bioactive.  The efficiency of these 
conjugation reactions was determined by GPC which separates species by size and 
outputs signal from an evaporative light scattering detector (Fig. 2-6).  Demonstrating a 
left-shifted peak of pegylated products compared to unconjugated PEG-SCM, GPC plots 
of PEG-RGDS and PEG-PQ showed conjugation efficiencies of greater than 90%, 
consistent with previous work in the laboratory. 
 
2.3.2 Mechanical Testing 
Because of the potential for scaffold physical properties to influence cancer cell 
behavior, a series of hydrogels with increasing PEG-PQ concentration were subjected to 
uniaxial compressive mechanical testing to determine the elastic moduli, a measure of 
material stiffness (Fig. 2-7).  PEG-PQ matrices (5%, 10% and 15%) had compressive 
moduli of 21 ± 6, 42 ± 8 and 55 ± 11 kPa, respectively.  To provide context with previous 
Figure 2-6: GPC analysis of PEG-peptide conjugates. Trace of conjugated PEG-peptide 
products (red) for (A) PEG-PQ and (B) PEG-RGDS with overlayed trace of unmodified acryl-
PEG-SCM (white) shows near 100% conjugation efficiency for reactions.  
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work, MG samples were also tested and found to be much softer than these PEG 
formulations with a compressive modulus of ~2.5 kPa.  Encapsulation of cells did not 
significantly change the difference in elastic moduli between hydrogels of different PEG-
PQ concentrations (Fig. 2-8). 
 
2.3.3 3D Culture in Bioactive PEG Hydrogels Recapitulates MG Morphology of 
KRas
G12D 
/ p53
R172HΔG
 Model Cell Lines 
Cell adhesion in the PEG hydrogel was facilitated by incorporation of the RGD 
peptide as a scaffold pendant group.  The RGD sequence is a motif found in fibronectin 
and other ECM molecules that is well-characterized in use in synthetic matrices to 
promote baseline adhesive bioactivity via ligation of a number of integrin pairs including 
αvβ3, αvβ5, and α5β1 
246
.  Meanwhile, cell-mediated proteolytic degradation of the 
hydrogel was permitted by incorporation of the MMP-2- and -9-degradable PQ sequence 
into the hydrogel backbone PEG chains.  Parental 344SQ lung adenocarcinoma cells 
Figure 2-7: PEG matrix mechanical properties. Elastic moduli derived from uniaxial 
compressive testing demonstrate matrix stiffness can be tuned by altering weight percent 
PEG incorporated in the polymer mixture.  All PEG matrices are stiffer than MG (p<0.01).  
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were encapsulated in PEG-based hydrogel matrices by mixing them with the PEG-PQ 
and PEG-RGDS components in buffer in the presence of the photoinitiator eosin Y.   
The mild crosslinking resulting from exposure to white light enabled high cell 
viability and, over several days in culture, cells proliferated and began to form 
multicellular spheres.  After 7-10 days in culture, the cell clusters in PEG hydrogels (10% 
PEG-PQ/3.5 mM linear PEG-RGDS) showed central clearing and formation of a lumen 
surrounded by an organized layer of single cells reminiscent of the lung acinus (Fig. 2-9).  
The morphology of these lumenized spheres closely mirrored that of 344SQ cells in MG.  
Cells encapsulated in the PEG-based matrix formulation generally formed smaller 
spheres (~40 µm) than those in MG (~80 µm) and took longer to lumenize (7-10 days vs. 
6-8 days, not shown) 
232
.  To assess the extent of epithelial morphogenesis, structures 
were stained for epithelial polarity markers: α6-integrin marking the basal surface and 
Figure 2-8: Difference in matrix mechanical properties unchanged with incorporation of 
cells. Elastic moduli derived from uniaxial compressive testing of 5% (gray bars) and 10% (black 
bars) PEG-PQ hydrogels without cells, with cells at day 1 in culture, and with cells at day 12 in 
culture shows that the difference in mechanical properties between bulk hydrogels of different 
PEG-PQ weight percent is unchanged with encapsulation of cells. Differences between 5% and 
10% acellular and (+) cell groups are not statistically significant.  
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zonula occludens-1 (ZO-1) for apical tight junctions.  Lumenized PEG-encapsulated 
spheres showed distinct separation of polarity markers, demonstrating clear formation of 
apical-basal polarity (Fig. 2-9C-D).  This staining pattern was comparable to that seen for 
MG-encapsulated structures and suggested a MET with extensive cell-cell contact 
reformation and polarity restoration. 
To demonstrate the PEG system as a reliable 3D culture platform across cancer 
models, other adenocarcinoma lines previously studied in MG were encapsulated and 
stained for epithelial polarity markers β-catenin (lateral) and ZO-1 (Fig. 2-10).  The cell 
lines tested include 393P, a KRas
G12D
/p53
R172HΔG
 line that does not widely metastasize 
when reintroduced into syngeneic mice and expresses lower levels of EMT markers.  
Figure 2-9: 344SQ culture in PEG matrix recapitulates 3D culture in Matrigel (MG). A and 
B, brightfield images of 344SQ cells encapsulated in MG (A) or a 10% PEG-PQ/3.5 mM PEG-
RGDS matrix (B) after 10 days in culture show sphere lumenization. C and D, staining for 
basolateral marker α6-integrin (red) and apical marker ZO-1 (green) in 344SQ cells encapsulated 
in MG (C) and PEG (D) indicate that spheres have adopted organized epithelial polarity. DAPI 
(blue) staining used for visualization of cell nuclei. Scale bar = 50 μm.  
57 
 
Also tested was another metastatic line derived from a primary tumor of 
KRas
G12D
/p53
R172HΔG
 mice (344P) and a transfectant based on the 344SQ line 
(344SQ.429) that constitutively expresses the miR200b_a_429 locus to prevent EMT and 
metastatic changes with TGFβ treatment.  In the PEG hydrogel system (10% PEG-PQ/3.5 
mM linear PEG-RGDS), both the 344P and 344SQ.429 lines formed lumenized spheres 
and expressed markers of epithelial polarity in appropriate patterns, mimicking their 
response in 3D MG.  Meanwhile, cells from the metastasis-incompetent 393P cell line 
generally formed large, disorganized cell aggregates with no clear epithelial organization, 
typical of its behavior in MG. 
 We have confirmed that a PEG-based system, with simple bioactivity 
incorporated through the use of cell-adhesive PEG-RGDS and enzyme-degradable PEG-
PQ backbone was able to recapitulate interesting morphological phenomenon observed 
with 3D culture of the KRas
G12D
/p53
R172HΔG
 model lines.  Notably, encapsulation in the 
PEG system induced MET in 344SQ cells to form lumenized, polarized spheres similar to 
that observed in MG.  This observation was important as it suggests that this distinctive 
behavior is not dependent on excess bioactivity from residual growth factors or the 
Figure 2-10: Other lung adenocarcinoma lines in PEG matrices. Staining for polarity markers β-
catenin (red) and ZO-1 (green) of 344P (A), 429 (B) and 393P (C) cells encapsulated in PEG-PQ 
matrices recapitulate morphology and polarity seen in 3D MG culture (Gibbons, et al.). DAPI (blue). 
Scale bar = 50 μm. 
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presence of highly bioactive ECM components like laminin found in high concentrations 
in MG, but is simply a result of the innate differentiation capacity of these cells in a 
three-dimensional environment.  This observation also established the PEG system as a 
reliable platform to study matrix-derived influences on the cancer cell behavior. 
 
2.3.4 Matrix Stiffness Influences Epithelial Morphogenesis 
 Having established that a PEG-based system was capable of recapitulating 
epithelialization behavior exhibited by 344SQ in 3D MG culture, we sought to examine 
the influence of key matrix parameters on this behavior.  One such parameter, matrix 
stiffness, has been widely studied in 3D cancer models in naturally-derived matrices
83,99
 
with some initial study in synthetic matrices with better controlled mechanics and 
biochemistry
191,192,244
.  Examination of 344SQ in MG suggests that it is highly 
susceptible to extrinsic matrix cues like elasticity
232
, but the role of stiffness has yet to be 
specifically studied due to limitations in altering MG stiffness in a biochemically neutral 
fashion. 
 To probe for these influences in the PEG system, the concentration of PEG-PQ, 
which forms the bulk of the material, was varied at 5%, 10% or 15% while maintaining 
the cell-adhesive PEG-RGDS at a fixed 3.5 mM.  Utilizing higher polymer 
concentrations increased crosslink density and decreased mesh size, leading to a stiffer 
matrix.  Multicellular spheres formed in all matrix formulations, but spheres showed 
important differences in morphology and epithelialization behavior (Fig. 2-11A-C), with 
larger spheres and a lower percentage of lumenized structures forming in the softer, 5% 
PEG-PQ matrices.  By monitoring sphere diameter with time (Fig. 2-11D), it is evident 
that the structures underwent rapid growth in the first few days of culture regardless of 
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matrix stiffness, but growth persisted through day 8 only in the softer matrix (21 kPa), 
eventually yielding spheres that were significantly larger relative to the other 
formulations (~80 µm in 21 kPa hydrogels vs. ~35 µm in the other formulations).  
Quantifying the percentage of spheres that showed cells arranged around a completely 
cleared central lumen, an inverse relationship between stiffness and sphere lumenization 
was found (Fig. 2-11E); while all matrices exhibited increasing sphere lumenization 
throughout the culture period, fewer encapsulated spheres were lumenized in the 21 kPa 
matrix (35%) compared to the 42 kPa matrix (50%).  It was also observed that spheres in 
the 21 kPa matrix tended to be more heterogeneous in regards to size and morphology 
relative to the stiffer matrix formulations; this observation was reflected when diameter 
Figure 2-11: Matrix stiffness influences epithelial morphogenesis. A-C, brightfield images of 
spheres at 12 days in culture in 5% PEG-PQ (A, 21 kPa), 10% PEG-PQ (B, 42 kPa) and 15% PEG-
PQ (C, 55 kPa) matrices with 3.5 mM PEG-RGDS show differences in sphere size and 
lumenization. D, significantly larger spheres form in the softer hydrogel (Day 12, 21 kPa vs. others, 
p<0.01) while E, a higher degree of lumenization occurred in stiffer matrices (Day 12, 42 kPa 
compared to 21 kPa, p<0.05). Scale bar = 100 μm.  
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data was pooled and plotted in a histogram showing much greater variation in structure 
size in the softer 21 kPa, 5% gel relative to stiffer formulations (Fig. 2-12). 
 Although the matrices examined in this study ranged from 21 to 55 kPa, the PEG 
system can be tailored in future studies for either softer or stiffer matrices by varying the 
concentration of PEG base component or employing a PEG chain with a different number 
of monomer repeats and molecular weight
228,247
.  Although all of the hydrogels tested 
were stiffer than MG-based matrices, all were capable of supporting 344SQ culture and 
lumenized structure formation, suggesting that the comparatively softer environment of 
MG is not required for epithelial morphogenesis.  Any alteration in cell behavior related 
to this softer environment may be compensated for by the excessive bioactivity afforded 
by the ligand-rich MG.   
 Observed sphere size differences were explored further under confocal 
microscopy in samples stained with DAPI and phalloidin, respectively used to identify 
nuclei for cell counts and to stain membrane-associated actin for cell area measurements 
(Fig. 2-13).  Images taken at central sphere cross-sections indicated that the cells that 
compose spheres in 21 kPa matrices were slightly larger than those in 42 kPa matrices 
(87.5 ± 22.7 µm
2
 vs. 63.6 ± 8 µm
2
, not significant).  More notably, the number of cells in 
Figure 2-12: Spheres in stiffer matrices form a more homogeneous population. Histograms of 
pooled size data for all spheres in all hydrogel samples show much greater heterogeneity in sphere 
development in softer, 5% hydrogels (A) compared to stiffer formulations (B-C).  
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21 kPa matrix spheres was significantly greater than that in 42 kPa matrix spheres (22 ± 4 
vs. 13 ± 2, p < 0.05).  Both of these factors contributed to overall differences observed in 
sphere diameter.  This sphere size difference may also be reflective of a difference in 
epithelial organization; work in other systems suggests that a transition to larger, less 
uniform structure indicates loss of epithelialization 
99
. 
Samples of spheres grown in the hydrogel matrices were stained for markers of 
proliferation and apoptosis as well as polarity markers to more closely assess matrix 
stiffness-related influences in sphere development and extent of epithelialization (Fig. 2-
14).  Ki-67 staining revealed diffuse proliferation throughout spheres encapsulated in soft 
matrices at day 4 (Fig. 2-14A), while spheres in stiffer matrices exhibited a more 
localized peripheral staining pattern (Fig. 2-14B).  Proliferation persisted though day 6 in  
Figure 2-13: Cell area and cell number contribute to sphere size differences observed between 
5% and 10% hydrogels.  A-B, DAPI (blue) and phalloidin (green) stained spheres in 5% (A) and 
10% (B) hydrogels taken at maximum sphere cross-section show (C) a trend in smaller cell area 
derived from the phalloidin data and (D) significantly fewer number of nuclei derived from DAPI 
count in the 10% matrix compared to the 5% matrix (*p<0.05). Scale bar = 50 μm.  
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21 kPa matrices (Fig. 2-14C), but decreased in stiffer matrices as spheres became more 
completely lumenized (Fig. 2-14D).  These patterns may have contributed to the 
significant cell number differences between spheres in differently stiff gels.  Proliferation 
observations correlated with differences in apoptosis as spheres in softer matrices showed 
unlocalized caspase-3 activity (Fig. 2-14C), whereas spheres in stiffer matrices showed 
strong core caspase activity (Fig. 2-14D).   
 After several days in culture, spheres in soft and stiff matrices showed differences 
in epithelial polarity (Fig. 2-15).  At day 6 the epithelial markers β-catenin (lateral) and 
ZO-1 (apical) remained disorganized in softer matrices (Fig. 2-15A), whereas spheres in 
stiffer matrices (Fig. 2-15B) showed peripheral nuclear alignment and polar organization, 
albeit incomplete as β-catenin persisted on the apical edge.  By day 12, however, 
lumenized spheres were found in both soft (Fig. 2-15C) and stiff (Fig. 2-15D) matrices, 
Figure 2-14: Matrix stiffness influences apoptosis and proliferation in developing spheres.  A-
D, staining for cleaved caspsase-3 (red) and ki-67 (yellow) at day 4 (A and B) and day 6 (C and D) 
in 5% (A and C) and 10% (B and D) hydrogels show earlier localization of proliferation at sphere 
periphery (B) in the stiffer hydrogel and high core apoptosis activity to induce more rapid 
lumenization (D) compared to diffuse proliferation activity (A) and unlocalized apoptosis (C) in 
softer hydrogels. DAPI (cyan), scale bar = 50 μm. 
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with lumenized spheres exhibiting a high degree of epithelial organization and clear 
segregation of polar markers. 
 Given this data on differences between 21 kPa and 42 kPa matrices on the rate 
and extent of lumenization and differences in sphere development and polar organization, 
our data on balance suggests that 344SQ epithelial structures were more organized in 
stiffer matrices.  This result runs counter to much of the work in the field that suggests 
high matrix stiffness favors less tumor organization and enhanced progression
43,99,184
.  
The disparity may simply highlight the unpredictability of natural matrix biochemistry.  
Despite best efforts to incorporate similar bioactivity or mechanics, other investigators 
have demonstrated that the same cells behave differently when cultured on MG or other 
materials including collagen
172
, naturally derived materials like small intestinal 
Figure 2-15: Matrix stiffness influences degree of epithelial polarity. A-D, staining for polarity 
markers β-catenin (red) and ZO-1 (yellow) at day 6 (A and B) and day 12 (C and D) in 5% (A and C) 
and 10% (B and D) PEG-PQ hydrogels shows polar organization in spheres in only stiff hydrogels (B) 
at early timepoints compared to disorganization in softer hydrogels (A) while at later timepoints 
lumenized spheres in both softer and stiffer matrices show a high degree of organized polarity (C and 
D) with a notable absence of basolateral β-catenin on the apical edge.  DAPI (cyan), scale bar = 50 μm  
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submucosa
248
, and PA
249
, suggesting it is very difficult to control for bioactivity in 
complex proteinaceous natural matrices like MG. 
 Our work was also motivated by a desire to disentangle mechanics from 
bioactivity, a difficult task with natural matrices in which mechanics and ligand density 
often change concordantly. Discerning the independent contribution of these factors is 
important given that collagen density, organization and crosslinking are thought to 
promote tumor progression
23,43,83
.  Indeed, when investigators have deployed synthetic 
systems like PA with better control over biochemistry and biomechanics, in some cases 
certain cancer cells actually adopt a more benign, differentiated state on the stiffer 
substrate tested or display peak tumorogenic activity in matrices of intermediate 
stiffness
241,250,251
.  A few reports have transitioned this effort into 3D, finding a 
diminished invasive phenotype in the stiffer formulation of a HA- based gel and 
enhanced epithelialization in stiffer collagen gels crosslinked with bioinert PEG
191,244
.  
However, the 2D PA studies are restricted to two dimensions, and may offer limited 
insight into the more physiologic behaviors seen in 3D environments.  The 3D systems 
used previously are also imperfect as, despite attempts to control ligand concentration
191
 
and use bioinert crosslinkers
244
, both of the bulk matrix components used are still 
themselves bioactive, inevitably leading to biochemical changes with increased 
crosslinking and stiffening.  Unlike PA, our PEG system is a biocompatible 3D culture 
system, and it avoids the limitations of these other 3D systems as it can be stiffened in a 
purely biochemically independent fashion.  
 In addition, while the bulk of work in the field has been done using a collection of 
the same commonly studied breast cancer model lines, when other cell lines have been 
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examined, the matrix stiffness-related behavior observed is often highly dependent on the 
identity of the cell line tested or the nature and extent of its malignant 
transformation
201,250–254
.  Our KRas
G12D
/p53
R172HΔG
 lines may exhibit either a different 
response to matrix stiffness or a higher degree of rigidity-independence than the 
commonly used breast lines
201
.  Further, because very little work in the field has been 
done using cell lines that specifically and reliably model human lung adenocarcinoma, 
our work may highlight unique influences of matrix stiffness on metastatic properties of 
lung adenocarcinoma. 
 
2.3.5 Adhesive Ligand Concentration Influences Epithelial Morphogenesis 
 The influence of biochemically active matrix components on cancer model 
behavior has been demonstrated in many different systems
83,175,176,191
.  To probe for 
similar influence in our system, we next evaluated if the concentration of cell adhesive 
ligand PEG-RGDS would influence epithelial morphogenesis in the absence of changes 
to matrix stiffness.  By encapsulating 344SQ cells in matrices with a fixed 5% PEG-PQ 
concentration (21 kPa) and linear PEG-RGDS at 1 mM (Fig. 2-16A), 3.5 mM (Fig. 2-
16B) or 7 mM (Fig. 2-16C), we first examined adhesive ligand-related changes in sphere 
size and lumenization behavior.  Although spheres initially grew rapidly in all matrices, 
average sphere diameters (Fig. 2-16D) in the matrices with higher concentrations of 
adhesive ligand increased to only around 60 µm through day 6. Spheres in matrices with 
lower concentrations of adhesive ligand grew more rapidly and persistently up to 80-90 
µm in diameter.  The percentages of spheres lumenizing (Fig. 2-16E) showed a strong 
relationship with adhesive ligand concentration; spheres rapidly and more completely 
lumenized in soft matrices with 7 mM PEG-RGDS, whereas a very low percentage of 
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spheres (15%) lumenized in soft matrices with low adhesive ligand concentration even 
after 12 days in culture.  It was also observed that matrices with low PEG-RGDS 
concentration induced formation of a much more heterogeneous population of spheres, 
while incorporation of high concentrations of adhesive ligand into matrices induced 
formation of a much more homogenous sphere population (Fig. 2-17).  Supporting our 
interpretation that these changes are ligand-dependent, incorporation of varying amounts 
of PEG-RGDS did not result in changes to hydrogel mechanical properties (1 mM 18.5 ± 
4.6 kPa vs. 7 mM 19.2 ± 3.8 kPa, not statistically significant). 
 To further assess the influence of adhesive ligand concentration on epithelial 
morphogenesis, spheres in 21 kPa matrices with either 1 mM or 7 mM linear PEG-RGDS 
Figure 2-16. Adhesive ligand concentration influences epithelial morphogenesis.  A-C, brightfield 
images of spheres at 12 days in culture in 5% PEG-PQ gels with linear PEG-RGDS at a concentration 
of 1 mM (A), 3.5 mM (B) or 7 mM (C) show differences in sphere size and lumenization. D, smaller 
spheres formed in matrices with a high PEG-RGDS concentration (7 mM vs. others, p<0.01 at Day 12) 
while E, lumenization occurred more rapidly and completely in spheres encapsulated in matrices with 
higher PEG-RGDS concentrations (Day 12, 7 mM vs. others, p< 0.01, 3.5 mM vs. 1 mM, p< 0.05). 
Scale bar = 100 μm.  
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 were stained for markers of proliferation, apoptosis, and epithelial polarity (Fig. 2-18).  
While proliferation was extensive at day 4 in matrices with low PEG-RGDS 
concentration (Fig. 2-18A), it exhibited no localization pattern, whereas matrices with 
high PEG-RGDS induced more complete epithelial development with structures already 
exhibiting proliferation at the sphere periphery and central caspase-3 activity (Fig. 2-
18B).  At day 6, both sphere proliferation and apoptosis activity was scattered and diffuse 
in 1 mM PEG-RGDS matrices (Fig. 2-18C).   Meanwhile, structure in matrices with high 
PEG-RGDS developed into well-lumenized spheres by day 6 featuring negligible 
proliferative activity, lingering core caspase activity, and well-organized peripheral 
nuclei (Fig. 2-18D).   
These observed differences in sphere development led to changes in epithelial 
organization (Fig. 2-19); spheres in matrices with low PEG-RGDS concentration adopted 
disorganized morphologies by day 6 with spotty and unorganized expression of the lateral 
and apical markers, β-catenin and ZO-1, respectively (Fig. 2-19A), whereas spheres in 
matrices with high PEG-RGDS concentrations formed lumens and developed appropriate 
apical-basal polarity (Fig 2-19B).  Well-organized spheres with clearly 
Figure 2-17: Spheres in high linear PEG-RGDS matrices form a more homogeneous 
sphere population. Histograms of pooled size data demonstrate greater heterogeneity in sphere 
development in hydrogels with little adhesive ligand (A) compared to those with high 
concentrations of adhesive ligand (B).  
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segregated polar edges were widely prevalent by 12 days in 7 mM PEG-RGDS matrices 
(Fig. 2-19D). Although some spheres did lumenize in matrices with low concentrations of 
adhesive ligand, polarity markers remained disordered and morphology irregular with 
nuclei failing to arrange neatly around a clear central lumen (Fig. 2-19C). 
 As a whole, we observed a pro-organizational effect of higher concentrations of 
adhesive ligand in experiments altering PEG-RGDS concentration at a fixed matrix 
stiffness.  This result is interesting in the context of results from the bulk of the field 
showing that a higher ligand concentration, usually collagen, leads to a more aggressive 
tumors
43,83
.  This disparity suggests that the identity of ECM ligand and the integrins 
subsequently bound are crucial to understanding the effect of ECM biochemistry on  
Figure 2-18: Adhesive ligand concentration influences apoptosis and proliferation in developing 
spheres. A-D, representative images stained for cleaved caspsase-3 (red) and ki-67 (yellow) at day 4 
(A and B) and day 6 (C and D) in 5% PEG-PQ hydrogels with 1 mM (A and C) or 7 mM (B and D) 
PEG-RGDS. Early peripheral proliferation and central apoptosis localization is evident with higher 
adhesive ligand concentrations (B) followed by rapid and organized lumenization (D), while spheres 
in matrices with low adhesive ligand concentration  show a high degree of proliferation (A) and 
unlocalized apoptotic activity (C). DAPI (cyan), scale bar = 50 μm. 
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tumor progression.  While little work in this regard has been done with fibronectin, from 
which RGDS is derived, this point is driven home by the many studies showing that, in 
contrast to collagen, increased laminin concentration promotes epithelial 
morphogenesis
172,178,249
.  This difference is likely related to features of the contextual 
environment of epithelial cells in vivo, where they are often found associated with a 
laminin-rich ECM 
178
.  The PEG system has a unique advantage in that specific peptide 
sequences or domains from these large ECM molecules may be incorporated with high 
control and examined for a specific effect whereas, in other matrices, incorporation of a 
whole molecule with its multiple integrin binding sites may make the system too 
Figure 2-19: Adhesive ligand concentration influences degree of epithelial polarity. A-D, 
representative images stained for polarity markers β-catenin (red) and ZO-1 (yellow) at day 6 (A and 
B) and day 12 (C and D) in 5% matrices with PEG-RGDS at 1 mM (A and C) or 7 mM (B and D), 
show the appearance of spheres with polar organization at early timepoints in matrices with high 
adhesive ligand concentration (B) with completely polar structures widespread at later timepoints 
(D).  Spheres in hydrogels with low adhesive ligand concentration do not show organized polarity at 
early timepoints (A), and at later timepoints, spheres that do display lumenization and polarity (C) 
have adopted less organized, more irregular morphologies. DAPI (cyan), scale bar = 50 μm. 
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convoluted, leaving some matrix-derived signaling and gene expression events 
intractable. 
 
2.3.6 Adhesive Ligand Spatial Presentation Influences Epithelial Morphogenesis 
The above results suggest that enhanced 
engagement of integrins at higher PEG-RGDS 
concentrations promotes organization and 
epithelial morphogenesis of our EMT model 
line.  Work from the literature suggests that the 
RGD sequence presented in a cyclic form is far 
more effective at cell binding than when 
presented as a linear sequence (Fig. 2-20).  
When presented in solution prior to cell adhesion, free cyclic RGD-containing peptides 
are upwards of 100 times more effective at inhibiting cell adhesion through binding and 
blocking of integrins than their linear counterparts
255,256
.  Both cyclic and linear forms 
bind integrins αvβ3 and α5β1, but the cyclic form may have higher relative specificity for 
αvβ3 in addition to an overall enhanced non-integrin-specific binding
257,258
.  Because 
these integrins are highly upregulated in cancer, with possible role in facilitating tumor 
cell migration or angiogenesis of tumor-activated endothelial cells, cyclic RGD peptides 
have been explored clinically to aide in cancer imaging and therapy
259–261
.  Action of 
cyclic RGD may be of particular interest in our lung adenocarcinoma model as protein 
expression analysis revealed upregulation of both integrin αv and β3 protein subunits in 
metastatic KRas
G12D
/p53
R172HΔG
 cells compared to their non-metastatic counterparts. 
Figure 2-20: Cyclic RGD (c(RGDfK))  
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 The influence of cyclic RGD on 344SQ morphogenesis in 3D culture was 
examined in 5% PEG-PQ hydrogels at varied PEG-c(RGDfK) concentrations (1 mM, 3.5 
mM, 7 mM) and compared to control cells in matrices with linear PEG-RGDS at the 
same concentration.  Staining for polarity markers β-catenin and ZO-1 after 12 days in 
culture showed that spheres in matrices with 1 mM PEG-c(RGDfK) did not display the 
same morphogenesis abnormalities previously observed in matrices with comparable low 
levels of linear PEG-RGDS (Fig. 2-21).  Well-lumenized spheres with segregated 
polarity markers and a single cell layer around a central lumen were widespread in all 
matrices with cyclic PEG-RGD regardless of concentration.  Similarly, there were not as 
readily obvious differences in sphere size between matrices with different PEG-
c(RGDfK) concentrations as was found in matrices with linear PEG-RGDS. 
 To reveal potential subtle differences in morphogenesis between cells in matrices 
Figure 2-21: 344SQ in matrices with cyclic PEG-RGDS.  Representative images stained for 
polarity markers β-catenin (red) and ZO-1 (yellow) at day 12 in 5% matrices with PEG-c(RGDfK) at 
1 mM, 3.5 mM, or 7 mM show that spheres with well-organized polarity are widespread in all 
matrices.  Spheres with irregular morphologies were relatively uncommon with 1 mM cyclic RGD 
compared to 1 mM linear RGD matrices. DAPI (cyan), scale bar = 50 μm.  
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with cyclic or linear forms, confocal images of spheres stained with these polarity 
markers were evaluated to quantify size and lumenization (Fig. 2-22).  This analysis is 
potentially more robust than that of brightfield images as it facilitates the more accurate 
measurement of size at maximum sphere cross-sections and the scoring of lumenization 
in spheres that may not exhibit an obviously apparent completely cleared lumen.  In gels 
with cyclic RGD, sphere sizes were not significantly different between high and low 
concentrations ranging from 106 ± 15 µm in 1 mM PEG-c(RGDfK) to 89 ± 2 µm in 7 
mM PEG-c(RGDfK) matrices (p = 0.55).  This compared to much more dramatic size 
differences seen in matrices with different concentrations of linear PEG-RGDS (136 ± 21 
µm in 1 mM and 84 ± 3 µm in 7 mM, p<0.05).   
Analysis using the E-score method showed substantial lumenization with cyclic 
RGD even at a low concentration (Fig. 2-23).  There was a slightly decreased  
Figure 2-22: Sphere size is not dependent on RGD concentration with cyclic spatial 
presentation.  The significant difference in sphere sizes seen between high and low concentrations 
of RGDS with linear formulation (1 mM vs. 7 mM, p< 0.05) are not found with cyclic formulation 
(1 mM vs. 7 mM, not statistically different), suggesting more uniform epithelial morphogenesis 
with the cyclic formulation even at low concentrations (other significant differences present).  
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lumenization rate with 1 mM PEG-c(RGDfK) compared to higher-concentration amounts 
although this difference was not significant (48 ± 7% with 1 mM vs. 58 ± 2% with 7 
mM).  In 1 mM and 3.5 mM groups, lumenization was significantly enhanced in matrices 
with cyclic RGDS compared to same-concentration linear RGD (p<0.01).  Notably, the 1 
mM cyclic RGD group even showed greater lumenization than the 3.5 mM linear RGD 
group (p<0.05).  Small standard deviations in both size and lumenization levels in both 7 
mM groups suggested highly uniform sphere populations in these matrices. A comparable 
high degree of lumenization found between these groups also suggested that there is a 
limit to the pro-organizational benefit of the cyclic spatial presentation with potential 
differences overcome by increasing linear PEG-RGDS concentrations.  
Figure 2-23: Cyclic spatial presentation of RGD induces greater lumenization than linear 
RGD at low concentrations. The significantly diminished degree of lumenization at lower 
concentrations of linear PEG-RGDS is not observed in matrices with cyclic RGD (cyclic vs. linear 
1 mM and 3.5 mM, p< 0.05; cyclic 1 mM vs. other cyclic concentrations, not statistically different).  
High concentrations of linear RGD yielded comparable lumenization as cyclic RGD (linear 7 mM 
vs. all cyclic formulations).  Other significant differences present.  
 
74 
 
 Overall this data indicates that morphogenesis is enhanced with the 
presentation of adhesive ligand in cyclic form with very little required in the matrix 
to facilitate widespread organization and little difference in morphogenesis with 
higher concentrations.  The more potent pro-organizational effect of cyclic RGD 
compared to linear may reflect overall enhanced integrin binding to facilitate 
organization or a more specific effect resulting from enhanced αvβ3 selectivity.  This 
question may be worthy of further investigation especially given the upregulation of both 
αv and β3 subunits in 344SQ compared to non-metastatic KRas
G12D
/p53
R172HΔG
 cells 
238
.  
In either case, modulation of morphogenesis with altered spatial presentation of adhesive 
peptide suggests an additional matrix-derived factor influencing 344SQ MET and 
demonstrates an additional facet of the PEG system’s versatility that can be deployed to 
study matrix-related metastasis cues. 
 
2.4 Conclusion 
 The study of cancer models in in vitro 3D culture systems capable of mimicking 
the wealth of physical and biochemical cues of the tumor ECM is of critical importance 
in understanding cancer progression and metastasis.  This work presents the development 
of a PEG-based hydrogel system to support 3D culture of a lung adenocarcinoma model 
and permit the study of these matrix-derived cues.  Protease-degradable PEG hydrogels 
modified to permit biospecific cell adhesion facilitated morphogenesis of several lung 
adenocarcinoma cell lines with comparable morphology and patterns of epithelial polarity 
seen in the MG system.  Using this system, matrix stiffness and biochemistry were 
independently altered to influence morphogenesis of the representative metastatic line 
344SQ.  Critical features related to 344SQ epithelial morphogenesis were altered 
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including size, organization of epithelial polarity, and coordinated patterns of 
proliferation and apoptosis that contribute to differences in lumenization.  Further, an 
altered spatial presentation of adhesive ligand was studied and found to exert strong 
influence on morphogenesis even at relatively low concentrations.  Through these 
studies, the more experimentally controllable synthetic hydrogel system was 
demonstrated as a useful tool for the cancer biologist to examine matrix-derived 
influences on tumor development and an important improvement over the standard of the 
field. 
Moving forward, because the PEG matrix is a completely bioinert material in its 
unmodified form, this system will enable much more robust study of additional ECM 
ligands and biochemical cues that modulate EMT and invasion.  The system also can be 
used to present bioactive proteins covalently tethered to the PEG matrix in a more 
physiologic fashion than soluble media supplementation, offering the potential to study 
the effect of matrix-tethered TGFβ or the modulation of EMT with cell-cell contact 
ligands like E-cadherin, N-cadherin, or Jagged, as will be demonstrated in later chapters.  
In the chapter immediately following, the response to soluble TGFβ in 344SQ 
encapsulated in the PEG system will be studied, with the degree of EMT, cell-secreted 
ECM remodeling, and matrix invasion examined and controlled by tuning matrix 
parameters.  Finally, given the tunability of the system demonstrated with these studies, 
future studies may seek to use patterning techniques already deployed in tissue 
engineering applications with PEG hydrogels to study three-dimensional spatial 
relationships between tumors and pro-metastatic ECM cues in an entirely new area of 
investigation
230,262
.   
 
76 
 
3. Investigation of TGFβ-induced EMT and Matrix Invasion in 
PEG-encapsulated 344SQ 
 
3.1 Introduction 
 The transforming growth factor-β 
(TGFβ) superfamily of cytokines consists of 
over 30 members including both TGFβ 
isoforms, the bone morphogenetic proteins, 
and other differentiation factors that regulate 
a number of processes in development, 
normal homeostasis and disease
263,264
 (Fig. 3-
1).  For example, TGFβ1 is the key player in 
many diseases of chronic inflammation and 
fibrosis, acting directly to increase cell secretion 
of fibrotic ECM and acting indirectly to 
promote the conversion of epithelial cells to pro-fibrotic myofibroblasts
265.  TGFβ is 
important in cancer pathogenesis as well, serving two opposing roles in the progression 
of primary tumors and in EMT and metastasis (Fig. 3-2). 
 First, acting on non-metastasized primary tumors, TGFβ plays an anti-
tumorigenic role, suppressing cell proliferation and promoting apoptosis to limit tumor 
growth and working to prevent some tumor-associated inflammation
266
.  In in vivo 
models of breast, skin and other cancers, knockdown of TGFβ receptors or expression of 
dysfunctional receptors leads to epithelial hyperplasia and the increased development of 
primary tumors while overexpression of TGFβ suppressed epithelial proliferation and 
Figure 3-1: TGFβ-1.  TGFβ-1 and other members of 
the TGFβ superfamily of signaling proteins share a 
similar homodimeric structure where the central α-
helix of one monomer abuts against the concave 
surface of β-strands on the other monomer and 
interchain disulfide bonds stabilize the overall 
structure. (Adapted from Hinck, et al.
264
) 
77 
 
reduced early tumor growth
267–270.  However, induced expression of TGFβ1 at later 
disease stages led to a higher rate of malignant and invasive tumors and, especially when 
combined with other common oncogenic mutations, led to increased circulating tumor 
cells, accelerated disease progression, and widely disseminated disease to metastatic 
sites
265,267,271,272
. 
 Mounting research suggests that this second, pro-metastatic role of TGFβ is 
related to its induction of EMT in cancer cells.  TGFβ binding and subsequent 
Figure 3-2: Dual role of TGFβ in cancer. TGFβ inhibits the growth and progression of 
hyperproliferating, but more benign tumor cells (round pink).  However, in a second role, it promotes 
EMT of more transformed and advanced carcinoma cells (round red to red triangular), through multiple 
effects, priming them for metastasis.  TGFβ also influences both stromal cells (yellow triangular) and 
immune cells (green) to facilitate this role and promotes extravastation and establishment of metastatic 
colonization.  Adapted from  Heldin, et al.
265 
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phosphorylation of its serine/threonine kinase receptors activates the Smad family of 
transcription factors that initiate EMT, downregulating a number of epithelial genes and 
upregulating mesenchymal genes 
263
.  This response is mediated by a number of key 
EMT transcription factor intermediaries including Twist, Snail, Zeb1, Zeb2 and others.  
These factors regulate genes to promote a number of key EMT phenotypic changes like 
loss of cell polarity, disruption of cell-cell junctions, and initiation of a more migratory, 
mesenchymal phenotype 
233.  TGFβ also promotes important EMT-related processes 
outside of this Smad signaling cascade.  For example, via Ras activation TGFβ binding 
also activates the MAP kinase pathway, a pathway important to matrix 
mechanotransduction and motility
273.  TGFβ may also exert important effects on non-
epithelial components of the tumor stroma, particularly related to its tumor suppressive 
role, as stromal cell-specific TGFβ receptor knockouts promote enhanced epithelial 
tumor growth due to stromal cell hyperplasia and subsequent production of hepatocyte 
growth factor, amongst other effects
109,274
. 
 The EMT changes induced by TGFβ exposure promote tumor matrix invasion and 
metastasis through several mechanisms.  TGFβ induces loss of polarity proteins like Par, 
Crumbs, and Scribble and tight junction disassembly
233
.  These changes accompany 
RhoA degradation and cortical actin depolymerization, leading to disaggregation of 
tumor cells to permit invasion.  Perhaps most notably, E-cadherin expression and binding 
is dramatically decreased during EMT, promoting a similar disaggregation, with EMT 
transcription factors Snail and Zeb acting directly to decrease E-cadherin transcription 
and Twist acting indirectly to alter its cytoplasmic location
275
.  As reviewed in chapter 1, 
loss of E-cadherin binding frees β-catenin to accumulate in the cell and enter the nucleus 
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to assert transcriptional effects via the Tcf/Lef family of transcription factors, not only 
promoting increased cell proliferation, but also modulating genes related to migration and 
invasion
122,276
.   
 EMT also may induce other changes that help promote ECM invasion of tumor 
cells. The switch from E-cadherin to N-cadherin expression may promote affinity to other 
mesenchymal cells in the matrix like fibroblasts or vascular endothelial cells
277
.  N-
cadherin binding also has downstream signaling effects, increasing cell migration and 
stabilizing the FGF receptor, which leads to enhanced FGF activity and the promotion of 
cell motility and MMP secretion
278,279
.  Cell motility also is increased with EMT via other 
mechanisms, with breast cells showing increased single cell motility and directional 
movement towards blood vessels with TGFβ exposure, mediated by Smad4 and Rho 
GTPases.  Finally, matrix invasion is promoted by Snail and Zeb action increasing tumor 
cell MMP secretion, permitting matrix degradation on the leading invasion edge
280
.   
 The resulting matrix invasion by tumor cells in 3D is often mediated by 
invadopodia, specialized longer lasting podosomes that are actin- and integrin-rich and 
express and secrete important MMPs to induce invasion, prominently MT1-MMP
281,282
.  
It is likely that EMT is important for invadopodia formation and function at least in part 
because similar pro-tumorogenic growth factors induce both EMT and invadopodia 
formation.  Also, EMT modulates expression of certain invadopodia-related proteins.  
These include β1 and αvβ3 integrins that are vital to invadopodia binding and other EMT-
related downstream protein signalers like N-cadherin that also may be important for 
invadopodia function
277,283,284
.  
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Finally, TGFβ exposure and EMT alter aspects of the tumor-ECM relationship 
beyond matrix invasion.  Through direct effects on cancer cells, indirect action on ECM 
fibroblasts, or conversion of epithelial cells to myofibroblasts, TGFβ induces 
significantly increased secretion of collagen I, fibronectin, and other matrix molecules 
that may act to promote malignant phenotypes, support integrin binding on invadopodia, 
and facilitate directional migration
66,233,265
.  EMT events also modulate laminin secretion 
and remodeling, promoting its secretion as part of this hypersecretory phenotype
285
 or 
downregulating particular laminin subunits that help constitute the basement membrane 
to facilitate invasion
233
.  Disruption of organized epithelial polarity with EMT may be 
associated with significant spatial reorganization of laminin and collagen IV that 
surround epithelial structures with basement-membrane like phenotypic organization
175
.  
Similar collagen IV remodeling resulting in focal areas of basement membrane thickness 
or gaps is a hallmark of malignant and invasive tumors in vivo that have undergone 
EMT
21,60
. 
 In the KRas
G12D
/p53
R172HΔG
 lung adenocarcinoma mouse model, TGFβ has proven 
to play a central role in EMT and malignant progression.  In epithelial structures formed 
in 3D MG culture by the EMT-prone 344SQ line, TGFβ initiates EMT, inducing 
structures to become larger, lose apical-basal polarity, and form matrix-invasive 
outgrowths, coincident with alteration in expression of several EMT-related genes 
232
.  In 
this model and others, this response is mediated by the miR-200 family, with TGFβ 
activating the Akt2 serine/threonine kinase to downregulate all five members of the miR-
200 family, leading to the accumulation of Zeb1 and Zeb2 that are otherwise held at low 
levels by miR-200 inhibition 
286,287
.  Zeb2 also binds to miR-200 promoters to repress 
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their expression, completing a double-negative feedback loop whose balance can be 
demonstrably perturbed by TGFβ exposure237 (Fig. 3-3).  344SQ transfects that 
constitutively express miR200 (344SQ.429 cells) do not undergo these EMT-related 
changes and are incapable of causing metastatic disease owing to their miR200-
maintained epithelial state, imperturbable by pro-metastatic cues like TGFβ232.  In 
addition, protein expression of lines in the KRas
G12D
/p53
R172HΔG
 model with different 
EMT susceptibilities revealed that not only do these lines display differential expression 
of integrins and other proteins important for matrix invasion, but also altered expression 
of cell-secreted ECM molecules and the proteases involved in their remodeling, 
suggesting a possible matrix remodeling response in our lung adenocarcinoma model 
with TGFβ238. 
 Because of its central role in promoting tumor metastasis, TGFβ is a target of 
research interest in investigations of new cancer therapeutics.  Fc:TGFβ receptor fusion 
proteins, TGFβ antibodies, and small molecule inhibitors of TGFβ receptors have all 
Figure 3-3: Double-negative feedback loop between miR-200 and Zeb1 mediates EMT response to 
TGFβ.  High levels of miR-200 maintain a stable epithelial state in cells by inhibiting ZEB-1 which 
increases the expression of epithelial genes like E-cadherin and many others.  TGFβ increases Zeb-1 
levels which also represses miR-200 transcription to further increase Zeb1 levels.  High Zeb1 
eventually initiates an EMT response, inhibiting epithelial genes and promoting mesenchymal genes.  
This double-negative feedback system enables cells to undergo EMT or MET to switch between 
phenotypic states in response to external signals.  Modified from Bracken, et al.
237 
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demonstrated efficacy in diminishing or blocking metastasis in vivo and some are being 
investigated in clinical trials
288.  A better understanding of the role of TGFβ in EMT, 
matrix invasion and metastasis may help lead to the development of more selective or 
effective TGFβ-related cancer therapeutics.  In this chapter, the effects of TGFβ on the 
KRas
G12D
/p53
R172HΔG
 cultured in the PEG system will be explored to illuminate potential 
matrix-related influences on this response and matrix invasion.  First, EMT-related 
morphologic and epigenetic changes resulting from TGFβ exposure will be explored in 
344SQ cultured in matrices that promote epithelial morphogenesis.  Remodeling of cell-
secreted ECM coincident with these changes and the influence of matrix parameters on 
this secretion will be explored.  Finally, matrix invasion of TGFβ-treated 344SQ in the 
PEG system will be studied, both in PEG-PQ hydrogels with altered matrix parameters 
and in hydrogels featuring an alternative protease-cleavable sequence (PEG-MSM).     
 
3.2 Materials and Methods 
 
3.2.1 Cell Culture   
 344SQ derived from KRas
G12D
/p53
R172HΔG
 mice as described previously in 
Gibbons, et al. and Zheng, et al. 
232,235
.  All cells and cell-laden hydrogels were cultured 
in a humidified atmosphere at 37˚C and 5% CO2 in RPMI 1640 (Mediatech) with 10% 
fetal bovine serum (Atlanta Biologicals), 10 μg/ml gentamicin and 0.25 μg/ml 
amphotericin B (Invitrogen).   
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3.2.2 Synthesis and Purification of PEG-RGDS, PEG-PQ-PEG and PEG-MSM-
PEG 
 PEG-RGDS, PEG-c(RGDfK) and PEG-PQ-PEG (“PEG-PQ”) were synthesized 
as described in Section 2.2.2 with conjugation confirmed with GPC.  An alternative 
hydrogel backbone to PEG-PQ, PEG-MSM-PEG (“PEG-MSM”) was synthesized, 
incorporating the peptide VPMSMRGG (“MSM”) to enable enhanced degradation by 
MMP-1 and MMP-2 relative to PQ 
227
.  PEG-MSM was conjugated using an alternative 
NHS reactant, acrylate PEG-succinimidyl valerate (PEG-SVA, Laysan; Fig. 3-4).  For 
conjugation, the MSM peptide was first dissolved in a HEPBS buffer (20 mM N-(2-
Hydroxyethyl)piperazine-N'(4-butanesulfonic acid), 100 mM NaCl, 2 mM CaCl2, 2 mM 
MgCl2, pH 8.5) and the PEG-SVA powder added to this solution at a 2.1:1 PEG-
SVA:MSM molar ratio and vortexed to dissolve.  pH was maintained ~8 as the reaction 
proceeded overnight at 4˚C on a vortexer.   The resulting solution was dialyzed against 
milliQ water in a 3500 MWCO regenerated cellulose membrane to remove unreacted 
peptide and then lyophilized.  Conjugation efficiency was confirmed with GPC as in 
Section 2.2.2.  
 
 
 
 
 
 
Figure 3-4: Conjugation reaction with PEG-SVA. With reaction with PEG-SVA, bioactive species 
are covalently tethered to acrylate-PEG for hydrogel incorporation with NHS chemistry similar to that 
used in PEG-SCM reactions.  A notable difference is use of an aqueous HEPBS-based reaction buffer.  
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3.2.3 Cell Encapsulation in Hydrogels 
 Cell-laden hydrogels were prepared sterilely as in Section 2.2.3 using the same 
prepolymer solution constituents (HBS-TEOA buffer, eosin Y photoinitiator, etc.) and 
hydrogel disc fabrication methods (light exposure parameters, acrylated coverglass, etc.).  
Cells were encapsulated at 1500 cell/µl (1.5 M cell/ml) unless otherwise noted.  PEG-
RGDS and PEG-PQ concentrations were used at 3.5 mM and 5% (w/v) unless otherwise 
noted.  For invasion studies, PEG-PQ and PEG-MSM were used at lower concentrations 
as noted and exposed to white light for 45 s to ensure complete polymerization. 
 
3.2.4 Immunohistochemistry 
 Hydrogel-encapsulated cells were stained with similar methods for fixation, 
Triton-X permeabilization, blocking, and antibody incubation and rinsing as in Section 
2.2.6.  Primary antibodies used for polarity, apoptosis, and proliferation staining were the 
same as in 2.2.6.  For cell-secreted ECM staining, rabbit anti-collagen IV (Abcam, 
Cambridge, MA), chicken anti-laminin (Abcam) and rabbit anti-fibronectin (Abcam) 
were used.  Secondary antibodies were either an Alexafluor 488 or 555 tagged donkey 
anti-rabbit, -mouse or –chicken antibody (Invitrogen).  As in Section 2.2.6, samples were 
counterstained with a DAPI solution and Alexafluor 647 phalloidin (Invitrogen) and 
imaged using a Zeiss 5Live confocal microscope.   
 
3.2.5 Morphologic Response to TGFβ 
 To observe responses to TGFβ, hydrogel-encapsulated 344SQ cells were cultured 
for 12 days to allow the formation of lumenized spheres, and then 5 ng/ml TGFβ1 
(Calbiochem/EMD Millipore, Billerica, MA) was added to culture media.  TGFβ-
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supplemented media was changed every 2 days.  In some samples the TGFβ inhibitor 
SB431542 hydrate (Sigma) was added to media at 5 µM 4 hours prior to TGFβ exposure 
and with subsequent changes of TGFβ-supplemented media to block TGFβ response.  
Sphere morphological response was evaluated using samples encapsulated in 5% PEG-
PQ / 7 mM PEG-RGDS hydrogels by imaging samples on an Axiovert 135 inverted 
fluorescent microscope (Zeiss).   
 Zymography was performed to analyze for changes in MMP expression following 
TGFβ exposure using a 10% gelatin precast Ready Gel (BioRad, Hercules, CA) per 
manufacturer’s protocol.   Media samples were diluted 1:1 with loading buffer (for 1x 
concentrations of 62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 4% SDS, 0.01% 
Bromophenol Blue), and the gel was run at 100 V for 2 hours.  Following a 30-minute 
incubation in a renaturing buffer (2.5% (v/v) Triton X-100 in MilliQ H2O), the gel was 
incubated overnight in developing buffer (50 mM Tris-HCl, 0.2 M NaCl, 5 mM CaCl2, 
0.02% (w/v) Brij 35, pH 7.5) at 37˚C, stained for 1 h at RT with Coomassie blue (Sigma), 
and destained for 30 minutes with a destain solution (40% (v/v) methanol and 10% acetic 
acid (v/v) in DI H2O) before imaging on a LAS4000 Imager (Fujifilm, Tokyo, Japan). 
 TGFβ-treated samples were also stained for polarity markers and imaged with 
confocal microscopy to monitor loss of polar organization.  344SQ in 5% PEG-PQ 
samples with different PEG-RGDS concentrations (1 mM, 3.5 mM and 7 mM) with and 
without TGFβ exposure were also stained and imaged to analyze changes in cell number 
and sphere size.  Using ImageJ, cell number was quantified as the number of nuclei per 
sphere at maximum sphere cross-section using a threshholded DAPI channel and sphere 
size was quantified as sphere diameter at maximum sphere cross-section using the 
86 
 
Phalloidin channel.  These factors were also analyzed for TGFβ-exposed samples treated 
with TGFβ inhibitor. 
 
3.2.6 Quantitative RT-PCR Analysis  
 RNA from TGFβ-exposed samples and unexposed controls was analyzed with 
RT-PCR for changes in expression of miR200 and EMT markers.  344SQ cells were 
encapsulated at 3000 cells/µl in hydrogels with matrix formulations with changing or 
fixed matrix stiffness and PEG-RGD concentration (5%, 10% or 15% PEG-PQ + 3.5 mM 
PEG-RGDS or 5% PEG-PQ + 1 mM, 3.5 mM or 7 mM PEG-RGDS, n = 6 per 
formulation) and cultured for 10 days, after which half of the samples were treated for 4 
days with TGFβ1 with daily supplemented media changes (5 ng/ml).  Hydrogels were 
then digested with proteinase K (15 mg/ml, Calbiochem) for 2 min at room temperature, 
and placed on ice prior to total RNA extraction with Trizol (Invitrogen) per 
manufacturer’s protocol.  Q-PCR was performed on a 7500 Fast Real-Time PCR System 
(Applied Biosystems, Carlsbad, CA). The analysis of the miR-200 family levels (miR-
200a, -200b, -200c) and the mRNA for CDH1, CDH2, VIM, CRB3 and ZEB1 were 
performed using TaqMan MiR assays (Applied Biosystems) and the data expressed 
relative to same-sample controls for miR-16 or L32, respectively. 
 
3.2.7 Quantifying Cell-secreted ECM and Remodeling with TGFβ 
To analyze changes in cell-secreted ECM, 344SQ in 5% PEG-PQ and 3.5 MM 
PEG-RGDS with or without TGFβ treatment were stained for collagen IV or laminin 
with DAPI/phalloidin counterstain.  Differences in collagen IV spatial organization were 
first quantified using images taken at maximum sphere cross-section using the Radial 
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Profile plug-in for ImageJ (NIH) that analyzes staining signal intensity in a series of 
concentric radial regions of interest from the center to periphery of a user-defined area 
around a sphere.  Radial profile values were normalized to intrasphere minimum 
background, and to describe radial organization, values from the outer 10% of radial 
sections were compared with the inner 90% of radial sections.  Quantification was also 
done using z-stack projections of sphere collagen IV signal made with the max-project 
function in ImageJ.  To evaluate ECM coverage around spheres, ROIs of sphere area 
were made using the projection of phalloidin channel, and the percent area of positive 
staining signal of a threshholded collagen IV projection over this area was analyzed.  
Differences in collagen IV organization were also analyzed using these methods in 
spheres in 5% PEG-PQ matrices with 1 mM or 7 mM PEG-RGDS with and without 
TGFβ treatment. 
 
3.2.8 Evaluating Matrix Invasion 
 344SQ cells were encapsulated in 2% PEG-PQ hydrogels with 7 mM PEG-
RGDS, cultured for 12 days and then treated with 5 ng/ml TGFβ for 4 days to assess 
invasive response.  Samples were fixed, stained for DAPI and phalloidin and imaged on 
confocal.  Images taken at maximum sphere cross-sections were measured for sphere size 
(sphere diameter) and extent of lumenization (by E-score method, Fig. 2-3).  Further, 
given the mixed populations observed, several phenotypic metrics of invasion were 
measured blinded to group per examples in Fig. 3-5.  Spheres were scored for: scalloped 
edges, positive if sphere edges puckered outward around sphere periphery; degree of 
single-cell invasion, positive if extensions of single cells were observed migrating off of 
sphere peripheries, commonly evident by a fine peri-spheroid haze in the phalloidin 
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channel; and multicellular pseudopod formation, positive if two or more cells formed an 
invasive matrix ingrowth greater than one-cell width off of the main sphere bulk.  Values 
were quantified as the number of spheres positive for the invasion metric over total 
spheres measured and expressed as means per hydrogel sample.  Furthermore, the 
number of distinct multicellular pseudopods were measured per sphere (scored as zero for 
spheres not featuring the characteristic) and expressed as a mean pseudopod number per 
sphere for a given hydrogel condition.   
 Some 2% PEG-PQ hydrogel samples were made with 15 mM linear PEG-RGDS 
or 7 mM cyclic PEG-RGDS, cultured for 12 days, and exposed to TGFβ.  These spheres 
were imaged on an Axiovert 135 inverted fluorescent microscope (Zeiss) to note 
differences in invasive phenotype before and after treatment.  Cells were also 
Figure 3-5: Invasion Metrics. For analysis of invasive phenotype, confocal images of 
DAPI/phallodin stained images were scored for phenotypic characteristics seen in representative 
images: scalloped or ruffled edges (A, D), fine, single-cell invasion (B, E) and/or multicellular 
invasive pseudopod formation (C, F). Scale bar = 50 µm.  
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encapsulated in 2% PEG-MSM and 3% PEG-MSM matrices with 7 mM PEG-RGDS and 
cultured in a similar fashion to assess differences in matrix invasion using these metrics.   
 
3.3 Results and Discussion 
 
3.3.1 TGFβ Induces EMT-related Morphologic Changes 
 Consistent with 344SQ’s metastatic behavior in vivo, TGFβ has been shown to 
initiate EMT in well-organized structures of 344SQ cultured in MG through 
downregulation of miR-200 family members, inducing hyperproliferation, lumen filling 
and matrix invasion 
232
.  Probing for similar changes in spheres encapsulated in a PEG-
based matrix, lumenized spheres were allowed to form in matrices composed of 5% PEG-
PQ with 7 mM PEG-RGDS and then exposed to soluble TGFβ (Fig. 3-6).  After 1 day of 
exposure (Fig. 3-6B), spheres began to lose organization and lumen clarity with epithelial 
organization continuing to diminish through 4 days of exposure (Fig. 3-6C) at which 
point lumens were completely filled.  After 4 days of exposure, 0% of spheres were 
lumenized.  Staining for polarity markers showed that polar organization was lost with 
unlocalized expression of β-catenin and ZO-1 throughout TGFβ-exposed spheres (Fig. 3-
Figure 3-6: PEG-encapsulated structures show EMT-related morphologic changes with exposure 
to TGFβ. Brightfield images of lumenized spheres encapsulated in a 5% PEG-PQ, 7 mM PEG-RGDS 
hydrogel at 12 days in culture prior to 5 ng/ml TGFβ exposure (A) show breakdown of lumen 
organization after 1 day of treatment (B) and complete lumen filling and loss of organization after 4 
days (C).  Scale bar = 50 μm.  
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7A).  Meanwhile, staining for Ki-67 and caspase-3 showed that these polarity changes 
were not accompanied by any organized patterns of proliferation or apoptosis activity as 
both stains showed random and unlocalized activity (Fig. 3-7B).  However, per 
zymography results, TGFβ response was not accompanied by a large increase in MMP 
expression (Fig. 3-7C). 
 Loss of lumenization and abrogation of organized epithelial polarity with TGFβ 
were completely blocked with treatment with the TGFβ inhibitor SB431542 (Fig. 3-8A).  
Examination of sphere size and nuclei number with analysis of confocal images showed 
sphere sizes and the number of nuclei per sphere increased with TGFβ treatment 
consistent with enhanced proliferation and loss of tight cell-cell association seen in with 
EMT.  These changes were prevented by exposure of the TGFβ inhibitor with TGFβ 
Figure 3-7: Characterization of post-TGFβ phenotype of 344SQ in PEG. A, representative image of 
a sphere in a 5% PEG-PQ, 7 mM PEG-RGDS hydrogel following 5 days of TGFβ stained for polarity 
markers β-catenin (red) and ZO-1 (yellow) shows loss of localization of polarity markers.  Similar loss 
of polarity was seen following TGFβ regardless of matrix formulation.  B, staining for cleaved caspase-
3 (red) and ki-67 (yellow) shows that cells exhibit randomly organized apoptotic and proliferative 
activity following TGFβ. DAPI (cyan), scale bars = 50 μm. C, gelatin zymogram using media samples 
from PEG-encapsulated 344SQ cells before and after 5 days of TGFβ shows that the levels of MMP-2 
and MMP-9 secreted, as indicated by clear bands at 62 kDa and 92 kDa, respectively, remained largely 
unchanged with treatment.  
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treatment (Fig. 3-8B).  The influence of matrix adhesive ligand concentration on the 
TGFβ response was also examined in matrices with different PEG-RGDS concentration 
(Fig 3-8C-D).  Prior to TGFβ treatment, matrices with a low, 1 mM PEG-RGDS 
concentration yielded larger spheres with greater number of nuclei than matrices with 
higher concentrations.  This data is consistent with differences in epithelial polarity and  
sphere development previously observed (Section 2.3.5).  Following TGFβ treatment  
 
 
Figure 3-8: TGFβ phenotype with TGFβ-inhibitor and altered [PEG-RGDS].  A, TGFβ-exposed 
344SQ spheres remain lumenized with polar organization in the presence of the TGFβ-inhibitor 
SB431542 with (B) no changes in sphere size and nuclei number (B). β-catenin (red), ZO-1 (yellow)  
and DAPI (cyan), scale bar = 50 μm.  C-D, both sphere size and nuclei number increase from –TGFβ 
baseline regardless of PEG-RGDS concentration indicating an EMT response (for both size and nuclei 
number, all same-concentration +/- TGFβ pairs, p < 0.05 except in the 1 mM group).  Altering PEG-
RGDS concentration led to differences in the metrics as both are increased in low PEG-RGSD matrices 
prior to TGFβ, and a greater post-TGFβ change from baseline is seen in the higher PEG-RGDS group 
(1 mM vs. 7 mM, -TGFβ, p < 0.05, amongst other significant differences). 
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spheres grew larger, and lumen filling and hyperproliferation contributed to an increase     
in nuclei number per sphere regardless of matrix formulation.   The difference between 
pre- and post-TGFβ morphology was least profound in matrices with low concentrations 
of PEG-RGDS with spheres in the 1 mM group exhibiting lower percent increases in size 
and cell number than higher groups (for example, >120% increase in nuclei number for 7 
mM group vs. ~50% for 1 mM).   
 This data shows a clear response to TGFβ with lumen filling, polarity marker de-
localization and cellular hyperproliferation indicating loss of epithelial phenotype 
consistent with morphologic changes observed with 344SQ in MG and in other cancer 
models.  While secretory MMP levels did not noticeably increase with TGFβ, dramatic 
increases in sphere sizes suggest enhanced localized gel degradation and matrix 
remodeling.  EMT-related morphologic changes were observed regardless of matrix 
composition, but these changes were less substantial in matrices with 1 mM PEG-RGDS.  
This observation suggests that the degree of EMT response is influenced by matrix 
parameters or that matrices with low PEG-RGDS induced formation of a more 
mesenchymal phenotypic baseline even in the absence of TGFβ despite the pro-epithelial 
influence of culture in three-dimensions. 
 
3.3.2 TGFβ Induces EMT Epigenetic Changes 
 To examine EMT-related microRNAs that may relate to this TGFβ response, 
quantitative RT-PCR was performed to measure the changes in miR-200 levels and EMT 
markers following TGFβ treatment of spheres in matrices with different formulations 
(fixed PEG-RGDS and varied PEG-PQ or fixed PEG-PQ and varied PEG-RGDS).  
Regardless of matrix composition, levels of the most well-studied miR-200 family 
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member, miR-200b, were elevated prior to TGFβ and fell after exposure, coincident with 
the morphologic changes observed (Fig. 3-9A-B).  This pattern is similar to that seen in 
MG-encapsulated spheres and is consistent with the proposed double-negative feedback 
loop model between miR-200 and TGFβ-influenced ZEB1 (Fig. 3-3)232,237 .  Levels of 
miR-200a and miR-200c followed a similar pattern of decreased expression (Fig. 3-9C-
Figure 3-9: PEG-encapsulated structures show epigenetic changes with TGFβ. A-B, q-PCR 
data for miR-200b before (black bars) and after (gray bars) TGFβ in matrices with 3.5 mM PEG-
RGDS and varied stiffness (A) and matrices with fixed 5% PEG-PQ stiffness and varied PEG-
RGDS concentration (B) show a decrease in miR-200b. (For every formulation, before vs. after, p 
< 0.01). C-D, q-PCR data for miR-200a and miR-200c before (black bars) and after (gray bars) 
TGFβ treatment in these show a similar pattern of decreased expression as miR-200b indicating 
widespread epigenetic changes as these miR200 family members are found on different 
chromosomal loci. miR-200 expressed relative to miR16 levels.  
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D), indicating widespread epigenetic changes following TGFβ as miR-200b and miR-
200c are found at two different chromosomal loci.  
 q-PCR also was used to probe for changes in expression of marker genes that are 
regulated by EMT-related transcription factors and help drive the EMT response.  The 
epithelial markers analyzed include the seminal marker E-cadherin (CDH1) as well as the 
tight junction associated polarity marker Crumbs protein homolog 3 (CRB3).  
Mesenchymal markers include N-cadherin (CDH2), the mesenchymal intermediate 
filament vimentin (VIM), and Zeb1 itself.  In all matrices following TGFβ treatment, 
fold-change expression of epithelial marker genes decreased and expression of 
mesenchymal marker genes generally increased indicating an extensive EMT response 
(Fig. 3-10 and Fig. 3-11).  Notably, changes in EMT marker gene expression were less 
profound in the 1 mM PEG-RGDS group as Zeb levels were comparable before and after 
TGFβ treatment and vimentin levels actually showed a slight decrease with treatment 
(Fig. 3-11).  This data is consistent with morphologic data of polarity stains and sphere 
parameters data showing blunted EMT response in this matrix formulation relative to 
others with less epithelial phenotype present even in the absence of TGFβ.  
 Overall, we observed a repression of miR-200 levels following TGFβ exposure 
and concomitant shift in EMT marker gene expression in the PEG system.  To begin 
with, this finding is significant as it demonstrates an ability to harvest and collect RNA 
from a three-dimensional synthetic system, a non-trivial challenge to overcome when 
transitioning from natural to synthetic matrices.  Furthermore, these epigenetic and gene 
expression changes demonstrate that the PEG-encapsulated cells engage physiological 
regulators of EMT, and that PEG is a useful 3D platform with which to study 
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Figure 3-10: PEG-encapsulated structures show changes in expression of EMT-associated genes 
with exposure to TGFβ.  Fold change in mRNA of EMT-related genes with TGFβ treatment in 
matrices with 3.5 mM PEG-RGDS and varied stiffness (A-C) and matrices with fixed 5% PEG-PQ 
concentration and varied PEG-RGDS concentration (D-F) show decreased expression of epithelial 
genes (CDH1 and CRB3) and increased expression of mesenchymal genes (CHD2, VIM, ZEB1) in all 
matrix formulations following exposure consistent with EMT-related genetic changes seen in 344SQ in 
MG cultures.  Fold change mRNA relative to L32 mRNA. 
Figure 3-11: Spheres in 1 mM PEG-RGDS matrices show tempered EMT gene expression 
response.  mRNA levels  from 344SQ in 5% PEG-PQ with 1 mM PEG-RGDS show significantly 
decreased expression of epithelial genes CDH1 and CRB3 and significantly increased expression of the 
mesenchymal gene CDH2, but expression of Zeb1 is unchanged and expression of VIM  actually falls, 
suggesting an incomplete or tempered EMT response (**p < 0.01, -TGFβ vs. +TGFβ).  Other matrix 
formulations showed uniformly expected responses. Levels relative to L32 mRNA.  
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transcriptional events in response to extracellular signals.  Together with morphologic 
observations and staining data, this data also indicates that PEG-encapsulated 344SQ 
undergo a dramatic EMT response and one that can be modified by altering certain 
matrix parameters. 
 
3.3.3 TGFβ Induces Remodeling of Cell-secreted ECM 
 Following EMT, cells remodel their ECM environment, hypersecreting some 
ECM components like fibronectin and laminin to ligate integrins and assist in migration 
and degrading others like basement membrane-associated collagen IV to enable invasion 
66,265
.  To probe for similar ECM remodeling in 344SQ, spheres cultured in PEG matrices 
were stained for collagen IV, laminin, and fibronectin before and after TGFβ exposure 
and analyzed for changes in amount and organization.  Staining 344SQ cultured in 5% 
PEG-PQ / 3.5 mM PEG-RGDS matrices at day 12 in culture (Fig. 3-12) revealed that 
collagen IV was organized in a strong, contiguous band around sphere peripheries prior 
to TGFβ exposure with the pattern suggestive of a contiguous basement membrane 
around epithelial glands  (Fig. 3-12A).  Following 4 days of TGFβ treatment, collagen IV 
organization changed dramatically (Fig. 3-12B).  While spheres still stain positively for 
its presence, its tightly organized peripheral location was lost with no uniform band 
present around spheres and secretion evident between cells (Fig. 3-12B).  These changes 
in collagen IV organization were abrogated with concomitant use of the TGFβ inhibitor 
SB431542 with TGFβ treatment (Fig. 3-12C).  
 Collagen IV spatial organization was first quantified using a radial profile method 
where signal intensity is measured in concentric radial regions of interest from the sphere 
center to periphery in images taken at maximum sphere cross-sections.  In comparing 
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means of outer and inner 10% of these radial sections, collagen IV location shows a 
significant preference for sphere periphery in the absence of TGFβ or with both TGFβ 
and its inhibitor (Fig. 3-12D-E).  TGFβ-treated spheres showed no spatial collagen IV 
preference with comparable staining in both inner and outer radial sections.   
 Investigators studying other cancer spheroid models have used a different method 
to characterize ECM remodeling, analyzing projections of sphere z-stacks to examine the 
extent of 3D sphere coverage
175
.  Analyzing spheres using a similar method in our 
system, prior to TGFβ exposure collagen IV projected evenly over the entire sphere 
Figure 3-12: Collagen IV radial organization altered with TGFβ exposure. A-B, 344SQ cultured in 
5% PEG-PQ / 3.5 mM PEG-RGDS hydrogels show (A) well-organized and intact band of collagen IV 
deposition around sphere periphery prior to TGFβ exposure that is (B) lost after 4 days of TGFβ as 
collagen IV features fractured expression throughout sphere interior.  C, these changes are prevented 
with concomitant use of TGFβ inhibitor. DAPI (cyan), phalloidin (yellow), scale bar = 50 μm.  D-E, 
quantifying radial profiles shows (D) significantly greater collagen IV intensity in outer radial sections 
in spheres not exposed to TGFβ or with TGFβ + inhibitor with comparable spatial location in TGFβ-
treated spheres and (E) ratios of radial spatial signal showing no spatial preference (* p < 0.05 in outer 
vs. inner sections or +TGFβ alone vs. other groups).  
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surface with comprehensive coverage (Fig. 3-13A).  Following exposure it exhibited 
spotty and uneven coverage in sphere projections suggesting significant remodeling with 
EMT (Fig. 3-13B).  These changes were prevented with the TGFβ-inhibitor SB431542.  
Quantifying mean fluorescence over sphere projection, there was no difference between 
groups in overall collagen IV signal intensity (Fig. 3-13C).  However, in quantifying 
positive collagen IV pixels over total sphere projection area, total collagen IV coverage is 
significantly decreased in TGFβ groups relative to no TGFβ and TGFβ inhibitor groups 
(Fig. 3-13D).  This data along with the radial profile data suggests that TGFβ-exposed 
spheres exhibit areas of focal collagen IV degradation and remodeling with uneven 
 
 
Figure 3-13: Collagen IV sphere coverage altered with TGFβ. A-B, z-stack projections collagen IV 
(red) through entire depth of 344SQ spheres cultured in 5% PEG-PQ / 3.5 mM PEG-RGDS hydrogels 
show (A) even deposition around spheres prior to exposure that is (B) remodeled after 4 days of TGFβ 
leaving intense, spotty  deposition in some areas with poor coverage in others. Scale bar = 50 μm.  C-D, 
quantifying projections, overall fluorescent intensity (C) shows no difference between groups, but 
percent of projected area positive for collagen IV (D) shows uniform deposition in untreated or TGFβ-
inhibitor groups around most of sphere surface areas with significantly less coverage in TGFβ-exposed 
spheres suggesting significant collagen IV remodeling (*p < 0.01).  
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collagen IV deposition irrespective of changes in overall secretion. 
 344SQ cells in PEG-based matrices were also examined for cell-secreted 
fibronectin and laminin to probe for similar TGFβ-induced remodeling.  Both fibronectin 
and laminin were deposited around spheres after 12 days in culture, but expression was 
not as focal and finely organized as collagen IV, showing more diffuse and variable 
deposition around and away from spheres (Fig. 3-14A and C).  Following TGFβ exposure 
there was no notable change in this organization with diffuse peri-sphere deposition 
persisting for both fibronectin and laminin (Fig.3-14B and D).  However, particularly for 
fibronectin, staining intensity was greatly enhanced, suggesting enhanced secretion 
following TGFβ exposure and EMT, consistent with other literature observations237,289. 
Figure 3-14: Fibronectin and laminin secretion in 344SQ. Staining for fibronectin (A-B) and pan-
laminin (C-D) shows diffuse peri-spheroid deposition in spheres before (A and C) and after (B and D) 
TGFβ.  There were no apparent differences in organization with TGFβ, however enhanced fluorescent 
intensity suggests enhanced secretion with EMT.  DAPI (cyan), scale bar = 50 µm.  
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 Finally, differences in ECM remodeling were analyzed in matrices with different 
PEG-RGDS concentrations to examine if previously observed differences in epithelial 
morphogenesis and EMT response are reflected in cell-secreted ECM.  344SQ cells 
cultured for 12 days in matrices with 5% PEG-PQ and 1 mM or 7 mM PEG-RGDS were 
stained for collagen IV and analyzed using both radial profile and projection methods 
(Fig. 3-15).  Prior to TGFβ exposure, spheres in high PEG-RGDS matrices exhibited 
similarly well-organized and uniform bands of collagen IV staining around sphere 
peripheries (Fig. 3-15A), while spheres in low PEG-RGDS matrices showed spotty  
 
 
 
Figure 3-15: Adhesive ligand concentration influences collagen IV deposition and remodeling. A-
B, 344SQ in 5% PEG-PQ matrices with 7 mM (A) or 1 mM (B) PEG-RGDS show differences in 
collagen IV deposition prior to TGFβ with 1 mM PEG-RGDS spheres lacking well-organized peri-
spheroid radial deposition.  Scale bar = 50 µm.  C, quantification of sphere coverage shows previously 
observed remodeling with TGFβ in the 7 mM group, but no difference with TGFβ exposure in the 1 
mM group.  D, radial profile analysis shows significant differences in 7 mM spheres between staining 
intensity in outer vs. inner radial sections prior to TGFβ that is lost with treatment, but no difference in 
spatial organization in the 1 mM group before or after treatment.  E, normalization of outer to inner 
radial intensity shows significant difference with 7 mM PEG-RGDS and a slight difference in 
localization with TGFβ in the 1 mM group (**p < 0.01, *p < 0.05). 
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collagen IV coverage with positive staining present throughout interior sphere areas (Fig. 
3-15B).  Quantifying these differences before and after TGFβ exposure in z-stack 
projections demonstrates comparably low levels of collagen IV sphere coverage in the 1 
mM group regardless of TGFβ treatment (Fig. 3-15C).  Meanwhile, sphere coverage is 
high prior to TGFβ in the 7 mM group, falling upon exposure to levels comparable to the 
1 mM group.  Similar observations are found when quantifying collagen IV radial 
profiles at sphere cross-sections, where 7 mM spheres show strong outer spatial 
localization prior to treatment and equivalent localization after exposure, whereas spheres 
in 1 mM matrices show comparable staining between inner and outer radial sections (Fig. 
3-15D).  Examining the ratios of outer to inner section staining intensity showed a 
difference spatiality in 1 mM matrices before and after TGFβ exposure, but that 
difference is far less profound that observed in 7 mM matrices (Fig. 3-15E). 
 The use of the synthetic PEG system enabled the above characterization of cell-
secreted ECM by KRas
G12D
/p53
R172HΔG
 model for the first time as previous attempts were 
hampered by confounding MG constituents composed of ECM from its naturally-derived 
matrix source.  Overall this data demonstrates an effort by 344SQ to remodel its own 
cell-secreted ECM in response to TGFβ.  Following exposure, cells focally degraded 
previously well-organized, peripherally localized collagen IV leaving collagen deposition 
localized with no readily recognizable pattern throughout the TGFβ-treated sphere.  This 
observation is consistent with observations in other spheroid cancer models and with 
collagen IV staining patterns in basement membranes of histological sections of in vivo 
tumors
21,60
.  Investigators postulate that loss of collagen IV organization in basement 
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membranes is a necessary or supportive prelude to invasion and metastasis, and EMT-
associated protein secretion changes in 344SQ may function similarly. 
 344SQ also showed increased deposition of other ECM molecules like fibronectin 
and laminin, consistent with ECM secretory behaviors following EMT
66,265
.  While other 
studies have reported changes in laminin organization with EMT, this was not observed 
with 344SQ to a degree that enabled spatial quantification.  There may be less of a 
change in laminin organization with EMT in our lung adenocarcinoma model or 
enhanced staining signal may mask subtle changes in organization.  Finally, we observed 
that adhesive matrix parameters influenced 344SQ-secreted matrix and its EMT 
remodeling.  Matrices with low PEG-RGDS concentration induced cells to secrete far 
less organized collagen IV with a spatial profile similar to that of TGFβ-exposed spheres.  
As reflected in this whole-population analysis of hundreds of spheres, this difference was 
true for lumenized as well as non-lumenized spheres in the 1 mM matrix, though as 
discussed in chapter 2, epithelial organization and E-scores were far lower in this group 
relative to matrices with higher PEG-RGDS (Sect. 2.3.5).  This data suggests that the 
outside-in matrix influences on cellular epithelial morphogenesis and genetics also 
lead to inside-out responses in how the cells themselves remodel their surrounding 
matrix environment.  
 
3.3.4 Matrix Invasion in PEG-encapsulated 344SQ 
 In the MG system one of the important responses to TGFβ is invasion into 
surrounding matrix by multicellular extensions radiating out of spheres in a phenotype 
that potentially mimics the ECM-invasive response of metastasizing primary tumors 
following EMT
232
.  We sought to develop a PEG-based matrix formulation permissive to 
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studying this invasive phenotype.  Pilot studies suggested that PEG-PQ hydrogels at the 
extreme low end of stiffness promoted invasion of TGFβ-exposed 344SQ.  Spheres in 
these matrices showed dramatic size enlargement, and the relative intra-gel locations of 
spheres changed, culminating in complete gel degradation by cells if left for several days 
under TGFβ treatment.  
To examine this enhanced degradative response further, 344SQ was encapsulated 
in very soft 2% PEG-PQ matrices with 7 mM PEG-RGDS.  Cell viability remained high 
in these hydrogels and cultured 344SQ developed into multicellular spheres, though 
significantly larger than in previously studied matrices (>150 μm diameter).  
Subjectively, overall sphere lumenization percentage was poor, consistent with previous 
observations of decreasing lumenization with decreasing gel stiffness (Sect. 2.3.4).  Some 
spheres did exhibit central cell clearing consistent with lumen formation.  However, in 
some of these lumenized spheres and in others that did not exhibit lumenization, sphere 
borders were irregular with peripheral cells in some spheres sending fine cellular 
projections into the surrounding matrix (Fig. 3-16A).  Prior to TGFβ, many structures did 
not exhibit this fine matrix invasion and overall structure shapes remained spherical (Fig. 
3-16B).  Following 4 days of TGFβ treatment, spheres not only grew larger and lost all 
degree of lumenization, but also readily formed multicellular matrix-invasive outgrowths 
with similar morphology to that observed in the MG system (Fig. 3-16C-D).  Fine, 
single-cell matrix invasion was observed both in structures exhibiting these multicellular 
pseudopods and in those that did not.  Spheres in these 2% PEG-PQ hydrogels were 
stained for DAPI and phalloidin and imaged with a confocal microscope to better 
visualize this invasive phenotype and quantify measures of invasion in this mixed 
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Figure 3-16: Matrix invasion in very soft PEG-PQ matrices.  A-B, 344SQ spheres in 2% PEG-PQ 
matrices show poor epithelial organization with some structures exhibiting fine, single-cell matrix 
invasion even in the absence of TGFβ (A).  Most structures are large with no lumen and ruffled sphere 
borders (B, polarity stains).  C-D, after 4 days of TGFβ many structures exhibit substantial matrix 
invasion with the formation of multicellular invasive pseudopods.  E, quantification of invasion metrics 
shows widespread poor structure formation before TGFβ with ruffled borders and some degree of both 
fine invasion and multicellular pseudopod invasion, both increasing substantially and featured in most 
structures after treatment.  DAPI (cyan), β-catenin (red), phalloidin (yellow), scale bars = 50 µm.  
population (Fig. 3-16E).  Many structures prior to TGFβ exposure exhibited irregular 
borders with ruffled or scalloped edges, with upwards of 20% exhibiting some degree of 
matrix invasion.  After TGFβ, however, no spheres showed regular borders with ~75% 
exhibiting some degree of invasion, commonly multiple, multicellular invasive 
pseduopods. 
 This matrix formulation was readily able to recapitulate the invasive phenotype 
observed in TGFβ-treated MG structures, but lacked a high degree of organized, 
polarized epithelial structure formation prior to exposure, exhibiting poor lumenization 
and in some cases showing matrix invasion despite lack of an EMT trigger.  Given 
previous observations of higher PEG-RGDS concentrations and the cyclic formulation of 
PEG-RGDS promoting epithelialization (Sect. 2.3.6), an effort was made to deploy these 
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adhesive parameters in soft 2% PEG-PQ matrices to normalize pre-TGFβ structures (Fig. 
3-17).  Incorporation of high concentrations of PEG-RGDS (15 mM, Fig. 3-17A) or a 7 
mM concentration of PEG-c(RGDfK) (Fig. 3-17C) induced the widespread formation of 
lumenized spheres in these soft hydrogels, rescuing the organized epithelial phenotype.  
In both cases TGFβ exposure induced many EMT-related morphogenic changes 
including loss of lumenization and polarity, increased sphere sizes, and irregular, 
scalloped sphere borders (Fig. 3-17B and D).  However, spheres did not form the 
multicellular invasive pseudopods observed in TGFβ-exposed spheres in 2% PEG-PQ 
hydrogels with lower PEG-RGDS concentrations or MG.  It seems that rescuing  
 
 
Figure 3-17: Pre-TGFβ epithelial organization rescued with alteration of matrix adhesive 
properties. 344SQ at day 12 in culture in 2% PEG-PQ hydrogels with  15 mM linear PEG-RGDS (A-
B) or 7 mM PEG-c(RGDfK) (C-D) exhibit normalization of epithelial structure  prior to TGFβ (A, C) 
with the presence of well-organized lumenized spheres and no degree of pre-EMT matrix invasion.  
Following TGFβ treatment (B, D) spheres exhibit an EMT response similar to that observed in stiffer 
hydrogels featuring sphere enlargement, lumen filling, and ruffled borders, but limited matrix 
invasion. Scale bars = 100 μm.  
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epithelial morphogenesis in these soft matrices with these approaches also restored the 
post-TGFβ phenotype observed in stiffer matrices. 
 Finally, in an effort to capture broader MMP susceptibility and in the event that 
invadopodia require faster kinetics in matrix degradation for proper formation, an 
alternative protease sequence to PQ was used in the PEG matrix backbone.  The MSM 
sequence was recently characterized for vascular tissue engineering applications in a 
similar PEG system as the one used here
227
.  It features a greater than two-fold increased 
kinetic reaction parameter (kcat) for MMP-2 and captures substantial MMP-1 reactivity 
that PQ lacks (MMP-1 kcat ≈ 7.9 vs. 0.65 s
-1
).  These altered reactivities enabled more 
rapid hydrogel degradation in the presence of MMP-1 and MMP-2 and substantially 
greater fibroblast and endothelial cell migration and matrix invasion
227
. 
 The MSM peptide was synthesized, pegylated, and polymerized with 7 mM PEG-
RGDS and encapsulated 344SQ to probe for invasion, first at the 2% concentration that 
previously supported multicellular invasion in PEG-PQ hydrogels (Fig. 3-18).  Prior to 
TGFβ, structures generally were large and did not widely lumenize consistent with 
observations previously made in soft matrices, but sphere morphology was also more 
normalized than in 2% PEG-PQ (Fig. 3-18A and C).  Upon quantification of invasive 
metrics prior to TGFβ, it was observed that comparatively fewer structures in 2% PEG-
MSM exhibited irregular edges, structures rarely showed fine, single-cell matrix 
invasion, and no structures featured multicellular invasive pseudopods (Fig. 3-18E and 
G).  While no structures formed epithelial spheres with high organization (E-score = 5), a 
higher percentage of pre-TGFβ spheres did form structures with some degree of lumen 
(E-score ≥3) in PEG-MSM than PEG-PQ (26.1±3.6% vs.10.4 ± 5.5%, p<0.05).  
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Figure 3-18: PEG-MSM matrices permit substantial matrix invasion with TGFβ. A-B, 344SQ 
spheres in 2% PEG-MSM matrices show better organization than spheres in 2% PEG-PQ with some 
central clearing, crisp borders and no invasion in the absence of TGFβ.  Structures are large, but 
generally show some degree of polar organization (B, polarity stains).  C-D, structures exhibit 
significant matrix invasion with multicellular invasive pseudopods after 4 days of TGFβ. E, 
quantification of invasion metrics before TGFβ shows improved lumenization and a lower percentage 
of spheres with scalloped edges or single-cell invasive phenotypes than in 2% PEG-PQ.  F-G, 
quantification of metrics after TGFβ shows comparable degrees of invasion with treatment in between 
matrices, with a notable similarity in both the percentage of spheres with multicellular pseudopods and 
their average number per sphere.  A and C, scale bars = 100 μm, B and D, scale bar = 50 μm; DAPI 
(cyan), β-catenin (red), phalloidin (yellow).  
 More regular pre-TGFβ structures may have formed in PEG-MSM due to slight 
differences in component acrylation or conjugation efficiency or there may have been 
differences in the structure of constituent amino acids that led to minor differences in 
hydrogel polymerization.  These differences may have resulted in a more structurally 
supportive gel in PEG-MSM vs. PEG-PQ despite the same low 2% concentration.  
Following TGFβ treatment, however, spheres formed similar multicellular invasive 
pseudopods in PEG-MSM as in PEG-PQ (Fig. 3-18 B and D).  TGFβ-treated spheres 
exhibited a similar degree of positivity for the invasive metrics including a similar 
percentage of spheres with multicellular invasive pseudopods (Fig. 3-18F-G).  TGFβ-
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treated PEG-MSM samples also showed a similar number of multicellular invasion 
pseudopods per sphere (Fig. 3-19).  This comparable degree of post-TGFβ invasion 
despite greater normalization of sphere structure without substantial invasion before 
treatment suggests that the greater degradation of the MSM sequence left the matrix more 
susceptible to EMT-induced cell-mediated matrix invasion. 
 While the MSM sequence enabled a highly invasive post-TGFβ phenotype in 
these 2% PEG-MSM matrices, epithelial structure was still abnormal likely due to low 
matrix stiffness with poor overall lumenization rate and relatively disorganized 
lumenized structure compared to structures in stiffer matrices.  In an effort to normalize 
epithelial structure but maintain the greater protease susceptibility that MSM affords, 
344SQ were cultured in slightly stiffer 3% PEG-MSM matrices (Fig. 3-19).  In these 
matrices pre-TGFβ spheres lumenized at a much higher rate (41.7 ± 3.6% vs. 26.1 ± 3.6% 
in 2% PEG-MSM, Fig. 3-19A and C).  Some of these structures exhibited the highly 
organized lumenized phenotype (7.8 ± 6.8% with E-score = 5 in 3% PEG-MSM).  
Further, structures showed well-organized sphere edges and nearly no single-cell 
invasion pre-TGFβ.  After 4 days of TGFβ exposure, however, structures exhibited a 
phenotype similar to that observed in stiffer PEG-PQ gels, with filled lumens, loss of 
polar organization, and some degree of display of invasive metrics (Fig. 3-19 B and C), 
but few structures exhibited the multicellular invasive pseudopods reflective of 
substantial matrix invasion (Fig. 3-19D).  Thus, it seems that the presence of a more 
readily degradable sequence in the hydrogel backbone was an insufficient factor alone to 
permit a substantial grossly matrix-invasive post-TGFβ phenotype in matrices 
structurally capable of supporting widespread pre-TGFβ epithelial morphogenesis. 
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Figure 3-19: Higher PEG-MSM concentration abrogates post-TGFβ invasive phenotype.  A-B, 
344SQ spheres in 3% PEG-MSM matrices show improved lumenization in the absence of TGFβ (A), 
but generally show a similar post-TGFβ phenotype as in higher concentration PEG-PQ matrices (B). 
DAPI (cyan), β-catenin (red), phalloidin (yellow), scale bars = 50 μm. C-D, quantification of invasion 
metrics shows improved pre-TGFβ epithelial morphogenesis with some phenotypic changes after 
TGFβ in 3% PEG-MSM matrices (C), but little formation of multicellular invasive pseudopods (D).  
 Overall, the PEG system with PEG-PQ and PEG-RDGS bioactive components 
recapitulated a matrix-invasive response to TGFβ treatment, but did so at lower polymer 
concentrations where structural or other properties are not conducive to normal, non-
matrix invasive sphere development in the absence of TGFβ.  This result is first 
interesting as it describes a 3D matrix environment that is insufficient for normal 344SQ 
epithelial morphogenesis, even despite provision of relatively ample adhesive ligand (7 
mM PEG-RGDS).  Interestingly, the mechanics of these soft hydrogels are more similar 
to MG than other stiffer PEG hydrogels that facilitated substantial epithelial 
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morphogenesis.  This suggests that while the excess bioactivity or contaminating growth 
factors in MG are not absolutely required for epithelial morphogenesis, they may be 
important in structurally weaker 3D environments. 
 More structurally stable gels were formed with use of a PEG-MSM backbone at 
the same low concentration that permitted normalized sphere structure with some degree 
of lumenization while maintaining a post-TGFβ phenotype characterized by the 
formation of multicellular invasive pseudopods.  However, population-wide epithelial 
morphogenesis pre-TGFβ was still deficient relative to stiffer PEG formulations or MG.  
The use of higher concentrations or a more adhesive formulation of PEG-RGDS and an 
increase in the concentration of either backbone component were able to rescue pre-
TGFβ epithelial phenotypes.  However, these changes also abrogated post-TGFβ 
multicellular invasive pseudopod formation and matrix invasion, despite, in the case of 
PEG-MSM, the presence of a more readily degradable protease-sensitive sequence. 
 Future work may seek to modify and supplement the base PEG system to 
recapitulate matrix invasive phenotype.  First, attempts could be made to normalize 
epithelial morphogenesis in the very soft matrices that permit post-TGFβ invasion.  The 
inclusion of additional adhesive ligands, like those derived from laminin, the major MG 
constituent, may help normalize structures in these soft hydrogels.  In a different 
approach, PEG-RGDS ligands could be modified with additional specific non-cell 
interactive cleavable sequences and incorporated at high concentrations to first normalize 
epithelial morphogenesis.  Subsequently, the associated protease could be added to cleave 
this sequence to drop adhesive ligand levels to those that permit widespread pseudopod 
invasion. 
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 Another possibility is that the reductionist PEG system used here is lacking matrix 
ligands that are necessary for full and proper invadopodia function.  Modifications to the 
system can be targeted at adhesive components to facilitate greater interactivity with 
integrin ligands on leading edge of invadopodia or capture binding to other cell receptors.  
One prospect that may be worth exploring is incorporation of HA-derived sequences or 
others that can bind CD44, a cell surface molecule upregulated with EMT and important 
in cancer matrix migration
134,263,290,291
.  Another idea is modification to facilitate greater 
interactivity with the important cell-membrane bound MMP, MT1-MMP, that typically 
promotes invadopodia matrix invasion through direct matrix cleavage or to a greater 
extent, more focalized MMP-2 activation.  
 
3.4 Conclusion  
 TGFβ plays an important role in multiple aspects of tumorigenesis and is a critical 
inducer of EMT in many cancer models and the KRas
G12D
/p53
R172HΔG
 lung 
adenocarcinoma model.  In PEG-based matrices, TGFβ initiated an EMT response in 
encapsulated 344SQ with changes in morphologic characteristics, polarity markers, and 
epigenetics and gene expression.  EMT-related ECM remodeling was also characterized 
for the first time in 344SQ with notable changes in collagen IV spatial organization.  
Both this remodeling and the TGFβ-induced morphologic response were tuned by 
altering matrix adhesive ligand concentration, demonstrating matrix influences on EMT.  
Future work may seek to characterize any temporal relationship between ECM secretion 
and epithelial morphogenesis to ascertain if properly organized cell-secreted ECM 
promotes morphogenesis via subsequent integrin binding or is rather the result of 
secretion by organized spheres, and conversely, if disorganization is a prelude or result of 
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loss of epithelial morphogenesis with EMT.  Such data may also work to explain the 
relationship between poor epithelial morphogenesis and poorly organized cell-secreted 
ECM in matrices with low adhesive ligand concentration and its less profound EMT 
response. 
Finally, matrix invasion was also investigated in the PEG system with the 
formation of TGFβ-induced multicellular invasive pseudopod tuned by altering matrix 
parameters and protease susceptibility.  This invasive phenotype closely mimicked that 
seen in TGFβ-treated MG-encapsulated 344SQ.  Future work may seek to normalize pre-
TGFβ epithelial morphogenesis in advance of this invasive phenotype using the above 
approaches.  In further investigation of EMT and metastasis, additional matrix factors can 
also be introduced into the PEG system to probe for promotion or inhibition of invasion 
or invadopodia function, like ECM peptides or proteins that more specifically interact 
with specialized invadopodia integrins or cell-cell ligands like Jagged-2 whose binding 
has been shown to promote metastasis on tumor invasive edges
239
. 
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4. 344SQ in PEG-cadherin Matrices 
 
4.1 Introduction 
4.1.1 Cadherins in Cancer 
 Cadherins are membrane-spanning glycoproteins that help mediate cell-cell 
adhesion to organize tissue architecture
292
 (Fig. 4-1).  The cadherin extracellular portion 
consists of five homologous repeat domains bridged by calcium that bind to other 
cadherin ectodomains on neighboring cells.  An intracellular portion binds to a complex 
consisting of several proteins including p120-catenin, α-catenin and β-catenin, which in 
turn link to the actin cytoskeleton and help mediate intracellular signaling events
293
.  
Classically, cadherins bind more readily to like cadherin types to organize tissues; cells in 
epithelial tissues predominantly express E-cadherin to promote epithelial cell-cell 
adhesion while mesenchymal cells express a variety of other cadherins, notably N-
cadherin. 
 The significance of cadherins in cancer pathogenesis has been outlined in part in 
Chapters 1 and 3.  E-cadherin levels or function are altered in a number of epithelial 
Fig. 4-1: Cadherin Structure.  Cadherin subtypes share similar structural features consisting of 
five, calcium-dependent extracellular domains that mediate homophilic binding and an 
intercellular portion that interacts with a catenin protein complex (p120-, β- and α-catenin) as well 
as cytoskeletal components.  From Wheelock, et al.
293
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cancers including lung cancer
125,127,128
 and may serve as an independent prognostic factor 
for metastasis and survival
127,133,134.  Part of this relationship is thought to be related to β-
catenin action upon release from unbound E-cadherin complexes with free β-catenin 
working with Tcf/Lef transcription factors to promote cell proliferation and upregulate 
other genes important for tumor progression
122,140,142,143,294
 (See Fig. 1-5).  E-cadherin’s 
role in cancer is also related to cell disaggregation resulting from EMT that in turn 
facilitates tumor cell invasion and metastasis.  A key EMT transcription factor, Twist, has 
been shown to decrease E-cadherin levels and binding, leading to loss of polarity and 
increased motility and invasion with resulting disaggregation
295
.   
 The loss of E-cadherin binding likely works in concert with other pro-tumorigenic 
changes due to the gain of N-cadherin binding that results from the “cadherin switch” 
almost universally observed in EMT models
293
.  In breast and melanoma models, 
increased N-cadherin binding enhances signaling through the ERK and MAPK pathways 
to increase cancer cell motility, matrix invasion and metastasis, in part aided by enhanced 
MMP-9 secretion
135,296,297
.  Some of this effect is likely due to membrane localized N-
cadherin stabilizing the FGF receptor, augmenting normally subdued pro-invasion 
mediated normal FGF signaling
135,279
.  N-cadherin may play a role apart from those 
related to cell aggregation or matrix invasion, as homophilic adhesion of N-cadherin in a 
prostate model also showed increased levels of anti-apoptotic members of the BCL-2 
family of apoptosis mediators, enhancing cancer cell survival
298
.  Finally, in an 
interesting mechanism connecting different cell-cell contact networks, more aggressive 
growth phenotypes in a melanoma model resulting from Notch-1 binding were found to 
be regulated in part by an upregulation in N-cadherin expression
299
. This mechanism may 
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be of particular relevance to our lung adenocarcinoma model as Jagged-Notch signaling 
was found to mediate behavior of a particularly invasive subset of KRas
G12D 
/ p53
R172HΔG
 
cells
239
.  
 Because of their role in adhesion between phenotypically similar adjacent cells, it 
is unsurprising that cadherins can also be seen as key players in the establishment of cell 
polarity, a critical phenotypic characteristic relevant to tumor progression.  On a basic 
level, cadherins are a major component of adherens junctions, desmosomes, and other 
cellular junctions that are critical for organized polarity in multicellular structures 
300
.  In 
more complex polarity-related functions, E-cadherin, working with its associated bound 
cytoskeletal elements, ensures the proper targeting of vesicles containing apical and 
basolateral polarity proteins in the cell membrane
300–302
.  For example, E-cadherin 
binding has been shown to promote targeting of the cell surface protein aquaporin-3, 
important to basolateral membrane function
303
.  Also of increasing research interest is the 
relationship between cadherin binding and the localization and function of a group of 
polarity-determining factor complexes, among them the Scrib/Dlg/Lgl (Scribble/Discs 
large/Lethal giant larvae) complex
292
. 
 
4.1.2 Scribble: Polarity, Tumor Progression, and Relationship to Cadherin  
 Initially characterized in a developmental context in Drosophila, scribble helps 
regulate epithelial polarity in the Scrib/Dlg/Lgl complex by promoting lateral membrane 
identity and forming antagonizing signaling relationships with other complexes to define 
apical surfaces (Fig. 4-2).  Scribble may also be important for normal tight junction 
formation in epithelial barriers independent of lateral polarity-defining effects
304
.  
Scribble’s polarity-related role is of obvious importance to cancer as loss of its function 
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through knockdown or mislocation disrupts cell polarity and alters 3D morphogenesis.  
But scribble also has additional roles related to proliferation and tissue overgrowth that 
have led to its general designation as a tumor suppressor protein
305–307
.  Scribble interacts 
with signaling pathways related to atypical protein kinase C (aPKC) and c-Jun N-terminal 
kinase (JNK) to regulate proliferation and apoptosis in roles completely apart from 
polarity mediation
305
.  Through these mechanisms, scribble knockdown induces 
hyperproliferation and dysplasia
308
. 
 It is through these roles that scribble functions with more direct and active 
phenotypic importance in cancer progression.  In a mammary model with oncogenic Ras, 
the additional loss of scribble promoted matrix invasion through regulation of MAPK 
signaling
309
.  In separate experiments with the MCF10A breast cancer model, scribble 
was actually not found to be essential for normal spheroid polarity, but was important for 
directional cell migration
310
.  Upon induction in wound and chemotaxis experiments, 
Fig. 4-2: Multifaceted role of scribble.  Scribble interacts with other polarity complexes and 
signaling pathways associated with atypical protein kinase C (aPKC) and c-Jun N-terminal kinase 
(JNK) to regulate growth (proliferation/apoptosis) and migration in addition to polarity. Modified 
from Etienne-Manneville
305
.  
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scribble knockdowns showed impaired single-cell migrational polarity and defects in 
leading-edge lamellipodia.  In a report from a different group, the combination of 
knockdown of scribble with a second protumorigenic signal (Erb activation or pro-
inflammatory cytokine exposure) or the combined loss of two different polarity complex 
proteins promoted invasion of the MCF10A model in a MG-based matrix
311
. 
 Scribble and E-cadherin, thus, share an indirect relationship as they both influence 
cell polarity and cancer progression.  But scribble also may have a more specific 
relationship to E-cadherin binding and signaling.  In MDCK cells, scribble is recruited 
and restricted to lateral membranes at cell-cell junctions in a manner that is dependent on 
the proper binding of E-cadherin, evidenced by both E-cadherin knockdown and re-
expression assays
312
.   Furthermore, a knockdown of scribble disrupts adhesion between 
cells in a manner found to be mediated by disruption of E-cadherin binding
313
.  The 
resulting migratory, mesenchymal phenotype of scribble knockdown was mimicked with 
a separate knockdown of E-cadherin, and adhesion in scribble knockouts could be 
partially rescued with forced expression of an E-cadherin-α-catenin fusion protein.  The 
co-localization of scribble with E-cadherin at adherens junctions has been found to be 
controlled by a specialized phosphorylation state; the phosphor-form is co-expressed with 
E-cadherin-catenin complexes and the unphosphorylated form located more generally at 
other lateral membrane sites
314
.  
 Either through interaction with E-cadherin or through the other tumor suppression 
roles outlined above, scribble mutations have been shown to drive tumor induction, 
overgrowth, and invasion in both in vitro models and in vivo, typically working in concert 
with another pro-oncogenic signal like activated Ras or mutant c-myc
308,315–317
.  
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Furthermore, expression of scribble has been shown to be dysregulated in human cancers 
including breast, prostate, and many others
308,312,316,318
.  Relatively little work has been 
done characterizing scribble’s importance in lung cancer, though one study has shown 
that scribble is essential for normal epithelial cell-cell contacts in the developing mouse 
lung
319
;  scribble mutants show malformed airways with abnormal acinar lumenization 
and morphogenesis, suggesting its particular importance in lung epithelial cell polarity.   
 
4.1.3 Scribble in the KRas
G12D 
/ p53
R172HΔG
 Lung Adenocarcinoma Model 
 Some initial work has been done studying the role of scribble in epithelial 
morphogenesis and invasion of the KRas
G12D 
/ p53
R172HΔG
 model.  The behavior of the 
non-invasive and metastasis-incompetent KRas
G12D
/p53
R172HΔG
 line 393P with a 
knockdown of scribble has been studied (393P.scrib)
311
.  393P.scrib was found to be 
more migratory in a transwell assay and more invasive in MG compared to parental 
controls (Fig. 4-3).  Further, when injected into the tail vein of non-transgenic mice, 
393P.scrib readily colonized and grew metastatic tumors in host lungs while parental 
controls did not.   
 
 
 
Fig. 4-3: Scribble regulates metastatic potential of 393P.  A-B, 393P scribble knockdowns show 
enhanced in vitro (A) transwell migration and (B) invasion in a MG assay compared to parental 393P 
cells.  C-D, following tail vein injection into non-transgenic mice, 393P control cells did not colonize or 
show metastatic growth in lungs (C) while the scribble knockdowns effectively colonized, forming 
large, bilateral tumor masses with overwhelming disease burden.  Modified from Chatterjee, et al.
311 
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 Meanwhile, in unpublished data, scribble knockdown of the EMT-prone, 
representative metastatic line 344SQ (344SQ.scrib) induces formation of large, 
multicellular structures in 3D MG culture, but spheres showed no organized polarity or 
lumenization (Fig. 4-4).  Depending on the batch of MG used, 344SQ.scrib colonies also 
sometimes show a minor degree of transient matrix invasion.  miR-200 levels remain 
very low during scribble sphere morphogenesis even in the absence of TGFβ, suggesting 
a link between polarity and epigenetic control of EMT.  Additional experiments have 
been done in MG matrices crosslinked with collagen to yield enhanced matrix stiffness 
and additional collagen-mediated bioactivity.  In these matrices, 344SQ.scrib is 
remarkably more matrix-invasive with invasion blocked with antibodies against integrin 
Fig. 4-4: 344SQ.scrib shows no polar organization in MG. While 344SQ.WT forms readily 
lumenizing spheres with segregation of epithelial polarity markers over six days in 3D MG culture 
(A-C), 344SQ scribble knockdowns demonstrate sphere growth, but no lumenal clearing or polar 
organization (D-F).  344SQ.scrib spheres also show some degree of irregular borders.  ZO-1, apical 
(green); α6-integrin, basolateral (red), TORPRO3, nuclei (blue).  Images courtesy of Don Gibbons. 
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β1 (Fig. 4-5).  This observation suggests that matrix contextual cues can regulate pro-
malignant scribble effects.   
 Finally, 344SQ.scrib cells also exhibit an interesting behavior when in co-culture 
with wild-type 344SQ (344SQ.WT).  When 344SQ.scrib cells are in direct contact with 
344SQ.WT, the morphology of the resulting hybrid structure is completely epithelial-
normalized, with structures forming lumenized spheres with epithelial polarity (Fig. 4-6).  
344SQ.scrib is distinguished from 344SQ.WT in co-culture by co-expression of green 
fluorescent protein (GFP) in the vector with scribble-targeting RNAi, leaving a portion of 
hybrid spheres with positive GFP fluorescence (Fig. 4-6B).  Persistent GFP signal 
indicates that knockdown of scribble is maintained despite the apparent ability of these 
hybrid spheres to polarize.  In MG co-culture, lumenization in 344SQ.scrib-containing 
spheres is only observed when 344SQ.scrib and 344SQ.WT come together to form 
structures; spheres composed only of 344SQ.scrib cells still show no organization despite 
344SQ.WT cells cultured in the same MG sample, indicating that this phenomenon is 
likely mediated by cell-cell contacts and not paracrine signaling. 
Fig. 4-5: 344SQ.scrib morphology and metastatic phenotype regulated by matrix. A, 344SQ.scrib 
in 3D MG form disorganized spheres with some limited and variable cellular invasion into the matrix. 
B-C, in MG matrices crosslinked with collagen-1, the alteration of matrix mechanics and/or 
biochemistry with collagen incorporation induces the formation of highly invasive structures (C, 
polarity stains: ZO-1 (green), α6-integrin (red), TORPRO3 (nuclei, blue)).  Images courtesy of Don 
Gibbons. 
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 This result suggests an intriguing link between scribble regulation of polarity and 
epithelial cell-cell contacts.  Some data has demonstrated the effects of normal epithelial 
cells on contacting adjacent cells with scribble mutations, but study has largely been 
restricted to experiments in Drosophila showing a cell competition effect
320,321
.  When 
surrounded by normal cells, these scribble mutants undergo apoptosis and are apically 
extruded from epithelial cell layers with effects mediated by MAPK activation and the 
JAK/STAT signaling pathway.  In this system, the tissue overgrowth that would 
potentially result from aberrant proliferation in scribble mutants may be compensated for 
by increased cell death
307
.   Beyond these reports, however, little data exists in 
mammalian models regarding the interaction of cells with deficient or mutant scribble 
and normal epithelium or in tumor spheroid metastasis models with mixed cell 
populations like those in the above 344SQ.scrib-WT hybrids. 
 The results from other tumor models showing the co-localization and functional 
relationship between E-cadherin and scribble, as well as other data demonstrating the 
significance of cadherin binding in polarity and tumor progression, provide an intriguing 
Fig. 4-6: Epithelial normalization occurs in spheres with 344SQ.scrib and 344SQ.WT in 
contact. Representative image of a lumenized sphere in a MG co-culture of 344SQ.scrib and 
344SQ.WT (A) that is partially composed of 344SQ.scrib cells with maintenance of scribble 
knockdown in these cells apparent by GFP expression (B). 344SQ.WT cells in contact with 
344SQ.scrib in hybrid sphere do not express GFP.  Images courtesy of Don Gibbons. 
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possibility that the cadherin complexes may play a role in this cell-cell contact-mediated 
scribble regulation.  Examination of this possibility or further study of other processes 
mediating 344SQ.scrib epithelial normalization is difficult in the MG co-culture 
experiments because the requisite contact between 344SQ.WT and 344SQ.is a relatively 
rare event in whole-population co-cultures.  The PEG hydrogel system presents an 
opportunity to circumvent this problem.  Potentially important cell-cell signals can be 
pegylated and covalently incorporated in the matrix and presented for signaling to 
encapsulated 344.scrib cells as a proxy for binding by neighboring cells. 
 In this chapter, E-cadherin and N-cadherin proteins will be pegylated and 
incorporated into PEG-PQ-based hydrogels to probe for effects on the 
KRas
G12D
/p53
R172HΔG
 model lines.  First, PEG-E- and -N-cadherin will be incorporated in 
matrices with encapsulated 344SQ.WT to probe for an influence on epithelial 
morphogenesis and the loss of polarity with EMT.  The influence of PEG-cadherins on 
344SQ.WT sphere formation in matrices lacking other adhesive components will also be 
studied.  Then, the PEG-cadherin factors will be analyzed for potential pro-
epithelialization effects on the 344SQ.scrib line.  PEG-E- and -N-cadherin will 
demonstrate different influences on 344SQ.scrib polarity and lumenization, and a 
possible role for intrasphere apoptosis and differential patterns of cell-expressed cadherin 
in this effect will be explored. 
 
4.2 Materials and Methods 
4.2.1 Cell Culture   
 344SQ was derived from KRas
G12D
/p53
R172HΔG
 mice as described previously in 
Gibbons, et al. and Zheng, et al
232,235.   344SQ.scribble (“344SQ.scrib”) cells were 
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derived from 344SQ parental cells and contain a vector with expression for GFP and 
short-hairpin RNAi sequence against scribble.  The scribble RNAi sequence and the 
transfection and cell selection methods were as previously described
311,322
.  All cells and 
cell-laden hydrogels were cultured in a humidified atmosphere at 37˚C and 5% CO2 in 
RPMI 1640 (Mediatech) with 10% fetal bovine serum (Atlanta Biologicals), 10 μg/ml 
gentamicin and 0.25 μg/ml amphotericin B (Invitrogen).   
 
4.2.2 Synthesis and Purification of PEG-RGDS and PEG-PQ-PEG 
 PEG-RGDS and PEG-PQ-PEG (“PEG-PQ”) were synthesized and conjugation 
verified as described in Section 2.2.2.   
 
4.2.3 Synthesis of PEG-N- and -E-cadherin 
 To synthesize PEG-cadherin conjugates, recombinant E-cadherin/Fc chimera and 
recombinant N-cadherin/Fc chimera (both carrier-free, R&D systems) were dissolved at 
100 μg/ml using filter-sterilized HEPBS buffer (20 mM N-(2-Hydroxyethyl)piperazine-
N'(4-butanesulfonic acid), 100 mM NaCl, 2 mM CaCl2, 2 mM MgCl2, pH 8.5) and kept 
on ice.  Dissolved cadherin proteins were transferred to γ-irradiated 10,000 MWCO 
dialysis cassettes (Thermo Scientific, Waltham, MA) and dialyzed sterilely overnight 
against filter-sterilized cold HEPBS buffer at 4˚C with two buffer changes to remove the 
Tris buffer in which proteins were initially lyophilized.  Separately, acryloyl-PEG-
succinimidyl valerate (acryl-PEG-SVA, 3.4 kDa, Laysan Bio) was dissolved in HEPBS 
buffer and immediately sterilized with filtration (0.2 μm PES).  For conjugation 
following cadherin dialysis, the acryl-PEG-SVA solution was added to the separate PEG-
cadherin solutions at 20:1 molar ratio of PEG-SVA:protein and immediately vortexed 
124 
 
(Fig. 4-7).  The mixed solutions were left to react on a vortexer at 4 °C with pH checked 
after 30 minutes and 3 hours to verify pH~8.  Following complete overnight reaction, 
aliquots of undiluted PEG-cadherin conjugates were stored at -80°C in sterile, low-bind 
tubes (Eppendorf, Hamburg, Germany). 
 
4.2.4 Western Blot Determination of PEG-cadherin Conjugation Efficiency 
 To determine efficiency of the protein conjugation reaction, a Western blot was 
performed on the protein and PEG-protein conjugates. Protein samples were mixed with 
loading buffer (For 1x concentration of 50 mM Tris-HCl pH 6.8, 100 mM DTT, 1% SDS, 
0.005% Bromophenol blue, 10% glycerol), loaded at 250 ng protein per lane, and run at 
100V for 2 h on a 4-15% of 15% pre-cast Tris-HCL PA gel (ReadyGel, Biorad). Bands 
were then transferred to a nitrocellulose membrane at 80 V for 2 hours.  The blot was 
incubated overnight at 4°C in a 5% milk solution for blocking.  Following rinsing the 
next day, it was incubated for 1 hour with a 1:2000 dilution of goat anti-E-cadherin or 
1:400 sheep anti-N-cadherin antibody (R and D) in 0.1% BSA in PBST (PBS + 0.1% 
Tween-20, Sigma) , rinsed twice for 5 minutes with PBST, and then incubated with the 
secondary antibodies HRP-conjugated rabbit anti-sheep or anti-goat (Santa Cruz Bio) at 
1:2500 dilutions.  Following development by the ECL chemiluminescent Western blot 
Fig. 4-7: Cadherin conjugation.  E- and -N-cadherin are reacted with PEG-SVA via NHS chemistry 
with protein primary amines to leave pegylated proteins with one or more acrylate-PEG chains 
covalently attached. Aqueous HEPBS-based reaction buffer permits maintenance of protein structure.  
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analysis system (GE healthcare, Chalfont St. Giles, UK), chemiluminescent images of the 
blot were taken on an LAS 4000 (Fujifilm) for band visualization. 
4.2.5 Cell Encapsulation in Hydrogels 
 PEG-PQ-based cell-laden hydrogels were prepared sterilely and polymerized 
using the same specifications as in Section 2.2.3 except cells were removed from culture 
plates prior to polymer resuspension using the non-enzymatic cell dissociation solution 
Versene (Invitrogen) in place of trypsin in an effort to maintain intact cadherin 
expression on cells.  Flasks were first rinsed with -Ca / -Mg, Hank’s balanced salt 
solution (Invitrogen) and then incubated in 4 ml Versene with periodic flask agitation.  In 
samples with matrix-tethered cadherin, PEG-E- or -N-cadherin were added to the 
prepolymer mixture at 50 μg/ml unless otherwise noted (Fig. 4-8).   
 
 
 
 
 
Fig. 4-8: PEG-Cadherin Hydrogels.   Hydrogels were fabricated by mixing PEG-PQ backbone 
components with or without PEG-RGDS, pegylated cadherins, and 344SQ WT or scribble 
knockdown cells and exposing to white light in the presence of Eosin Y photoinitiator to leave 
cells encapsulated in hydrogels interacting with matrix-presented cadherins.  
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4.2.6 Immunohistochemistry 
 In the following experiments, hydrogel-encapsulated cells were evaluated with the 
same methods for fixation, Triton-X permeabilization, blocking, and antibody incubation 
as in Section 2.2.6.  Primary antibodies used for polarity, apoptosis, and proliferation 
staining were also the same as in 2.2.6.  For differences in cellular expression of E-
cadherin, mouse anti-E-Cadherin (BD) targeting the intracellular domain was used.  
Secondary antibodies and DAPI and phalloidin counterstains were used as in Section 
2.2.6.  Samples were imaged using a Zeiss 5Live confocal microscope.   
 
4.2.7 Probing Effects of PEG-cadherin on 344SQ.WT Morphogenesis  
 To observe morphologic response of 344SQ.WT to matrix-tethered cadherins in 
otherwise non-cell-adhesive PEG matrices, 344SQ.WT was first encapsulated in a 5% 
PEG-PQ hydrogels with no PEG-RGDS.  PEG-E- and -N-cadherin were incorporated at 
50 μg/ml in experimental groups compared to PEG-PQ only controls.  Samples were 
imaged on a Zeiss Axio Observer A1m inverted fluorescent microscope to evaluate 
difference in sphere formation.  The resulting brightfield images were used to measure 
structure size (structure diameter) using ImageJ and expressed as means per hydrogel 
sample. 
 To evaluate if differences in sphere formation were due to differences in viability, 
samples were stained with 2 µM calcein-AM and 10 µm ethidium homodimer at day 4 in 
culture (Live/Dead viability/cytotoxicity kit, Invitrogen) and imaged on a Zeiss Axio 
Observer A1m inverted fluorescent microscope.  Because of difficulty discriminating 
individual cells that are closely approximated in these multicellular structures, images 
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were quantified as percent green fluorescent structures over total structures measured as a 
reflective measure of cell viability. 
 The influence of PEG-cadherin on improved morphogenesis of 344SQ.WT 
encapsulated in hydrogels with PEG-RGDS capable of supporting some degree of 
morphogenesis was then examined.  344SQ.WT was encapsulated in 3% PEG-PQ 
hydrogels with 4 mM PEG-RGDS, cultured for 14 days, and then fixed and stained for 
polarity markers per Section 4.2.6.  Differences in morphogenesis and structure 
lumenization (n = 100-150 spheres per group) were evaluated using the E-score method 
(Section 2.2.7, Fig. 2-3).  
 To evaluate for potential influence of matrix-tethered cadherin on EMT response, 
additional samples were cultured for 12 days and exposed to TGFβ for 4 days.  A lower, 
but more physiological concentration of TGFβ was used (0.5 ng/ml) to expose subtler 
matrix-derived influences.  Samples were stained for polarity markers, imaged, and 
analyzed for lumenization by E-score method.  For both TGFβ-exposed and unexposed 
samples Q-PCR was also run as above for differences in expression of miR-200 and EMT 
marker RNA. 
 
4.2.8 344SQ.scrib in PEG Matrix Co-culture and in Matrices with PEG-cadherin 
 To compare 344SQ.scrib culture in the 3D PEG system to previous observations 
in the MG system, cells were first encapsulated in 10% PEG-PQ / 3.5 mM PEG-RGDS 
matrices, cultured for 12 days and imaged on an  Axiovert 135 inverted fluorescent 
microscope (Zeiss).  Hydrogel samples were also made to contain a co-culture of 
344SQ.scrib and 344SQ.WT by centrifuging the two cell populations together and 
resuspending in the same polymer solution at 1.5 M cell/ml/cell type.  Samples were 
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cultured for 12 days and imaged as above, distinguishing 344SQ.scrib by presence of the 
GFP signal. 
 To probe for pro-organizational effects of matrix-tethered cadherin on 
344SQ.scrib morphology, 344SQ.scrib were encapsulated in 5% PEG-PQ / 3.5 mM PEG-
RGDS matrices with PEG-E- or -N-cadherin at 50 μg/ml.  Samples were cultured for 12 
days, stained for expression of polarity markers, and imaged.  Confocal images were 
evaluated using the E-score method (Section 2.2.7, Fig. 2-3) for degree of sphere 
epithelialization (n = 100-200 spheres per group).  Sphere sizes were evaluated by 
measuring sphere diameters at maximum cross-section in the phalloidin channel and 
expressed as per hydrogel means.  Q-PCR was performed as above to probe for 
differences in miR-200 expression and expression of EMT marker RNA.  Changes in 
sphere development that may lead to observed differences in morphogenesis were 
assessed by staining for proliferation and apoptosis using antibodies against ki-67 and 
caspase-3 as in Section 4.2.6. 
 
 
4.2.9 Effects of Matrix-tethered Cadherin on 344SQ.scrib Cellular Cadherin 
Expression 
 344SQ.scrib samples cultured for 12 days in 5% PEG-PQ / 3.5 mM PEG-RGDS 
matrices with or without PEG-E- or -N-cadherin were stained for expression and 
localization of E-cadherin.  Samples were stained and imaged as in Section 4.2.6.  
Overall intensity of stain per sphere at maximum sphere cross-section was analyzed using 
phalloidin channel-derived sphere area ROIs in ImageJ.  Radial organization was 
analyzed using the Radial Profile plug-in as in Section 3.2.7; the intensities of inner and 
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outer 10% of radial sections were compared between groups to describe spatial 
differences in expression.  
 
4.2.10 Statistical Analysis 
  For size, E-score properties, staining localization, and all other comparisons 
between PEG-E-cadherin, PEG-N-cadherin and PEG-RGDS-only controls, statistical 
significance was determined using a one-way ANOVA with Tukey’s HSD post-hoc. 
 
4.3 Results and Discussion 
4.3.1 Western Blot Confirms PEG-cadherin Conjugations 
 PEG-PQ and PEG-RGDS matrix constituents were synthesized as in Section 
2.2.2, and PEG-E-cadherin and PEG-N-cadherin were synthesized via reaction with 
PEG-SVA as in Section 4.2.3 using a 20:1 PEG-SVA:PEG-Cadherin molar ratio.  This 
relatively low molar ratio was used to ensure maximal bioactivity of pegylated products 
without PEG chains substantially interfering with binding.  Western blotting was used to 
confirm conjugation with lanes for unpegylated cadherins and PEG-cadherin conjugates 
(Fig. 4-9).  Both E- and N-cadherin have expected bands at ~120 kDa representing the 
~88 kDa proteins linked to an IgG Fc fragment for stabilization, and double bands on the 
blot indicative of small post-translational cleavage and modification.  The PEG-E- and -
N-cadherin lanes on the blot show lack of resolution between the double bands and a 
higher molecular weight smear indicating the presence of one or more protein-bound 
PEG molecules that cause molecular size increases.  Conjugation at higher PEG-SVA 
ratios showed a more significant molecular weight shift indicating more substantial PEG 
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conjugation (not shown), but these conjugation products were not used in experiments to 
facilitate maximum bioactivity. 
 
4.3.2 Matrix-tethered Cadherin Influences Sphere Development in Matrices 
without PEG-RGDS 
 Some previous work using suspension culture suggests that 344SQ does not 
exhibit anchorage-dependent cell viability (unpublished observations).  Experiments in 
previous chapters using specific adhesion afforded by PEG-RGDS incorporation on the 
non-cell adhesive PEG-PQ background has demonstrated the influence of adhesive ligand 
on 344SQ morphogenesis and EMT, but encapsulation in a completely non-cell-adhesive 
PEG system has yet to be explored.  344SQ.WT cells were encapsulated in hydrogels 
with backbone polymer constituents only (5% PEG-PQ, Fig. 4-10A).  Over several days 
in culture cells formed a heterogeneous population, with most structures remaining 
rounded single cells or rounded clumps of a few cells and only a few structures 
Fig. 4-9: Western blots confirm PEG-cadherin conjugation.   Chemiluminescent image of Western 
blot for E-cadherin (A) and N-cadherin (B) and their associated pegylated species shows bands at ~120 
kDa associated with cadherins in protein lanes with upstream smears in PEG-proteins lanes indicating 
attachment of PEG chains that increase species size.  
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demonstrating demonstrable sphere growth.  The overall population exhibited abnormal 
development, with no structures displaying lumenization.  Polarity staining revealed 
many isolated cells and some small spheres composed of a few cells, but no degree of 
epithelial organization (Fig. 4-10D). 
 To probe for a normalization of 344SQ.WT sphere development afforded by 
binding of cells to matrix-tethered cadherins, both PEG-E- and -N-cadherin were added 
to pre-polymer mixtures with 5% PEG-PQ and no PEG-RGDS.  In both PEG-E- and -N-
cadherin matrices, cells proliferated to form spheres of considerable size, and while 
single-cell structures were still present after several days in culture, they constituted a 
noticeably decreased fraction in the population (Fig. 4-10B-C).  While structure 
morphology was more typical of spheroids seen previously in cell-adhesive PEG 
matrices, structures did not lumenize in the absence of PEG-RGDS.  There were no 
readily obvious differences between the two PEG-cadherin-constituent matrices.  
Staining for polarity markers revealed larger structures composed of more cells, with the 
nuclear arrangement in a few sphere suggesting organization, but limited organization 
and segregation of polarity markers were found in samples (Fig. 4-10E-F). 
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 To quantify some of these observed differences, structure sizes were measured 
from brightfield images.  Mean per-hydrogel sphere diameters revealed significantly 
decreased structure sizes in PEG-cadherin-free matrices with comparable structure sizes 
measured in PEG-E- and -N-cadherin hydrogels (Fig. 4-11A).  To better graphically 
represent differences in sphere populations, size measurements from all structures pooled 
across hydrogel samples were arranged in histograms (Fig. 4-11B-D).  PEG-RGDS-free 
matrices without any PEG-cadherin showed a population skewed toward the lower end of 
size ranges as expected, with over 90% of structures having diameters under 40 µm and 
Fig. 4-10: PEG-cadherin influences 344SQ.WT sphere morphology in PEG-RGDS-free matrices.  
Brightfield  images (A-C) and  polarity staining (D-F) show that 344SQ.WT in matrices composed only 
of PEG-PQ (A, D) form small, disorganized structures, many with single or a few cells.  Structures in 
matrices with PEG-E-cadherin (B, E) or PEG-N-cadherin (C, F) are larger with cell numbers more 
typical of spheres in matrices with PEG-RGDS.  Though spheres do not feature normal epithelial 
morphogenesis or polar organization, a few show evidence of radial nuclear arrangement (example, 
arrow).  β-catenin (red), ZO-1, (yellow), DAPI (blue). Scale bar = 100 μm.  
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nearly no structures over 70 µm.  Meanwhile, matrices with PEG-cadherin showed a less 
skewed population with some spheres reaching sizes upwards of 80 - 100 µm in diameter. 
 Finally, to examine if these differences were due to differences in cell viability, 
spheres in these matrices were stained for calcein AM and ethidium homodimer.  
Viability staining showed few scattered dead cells present in all matrices and expected 
high viability in multicellular spheres in PEG-cadherin matrices (Fig. 4-12A-B).  In PEG-
PQ only matrices, the small, rounded single-cell structures generally stained brightly for 
calcein AM, suggesting that cells of this observed morphology were viable, but just did  
Fig. 4-11: Sphere size differences are induced by PEG-cadherin incorporation in matrices without 
PEG-RGDS.  A, mean sphere diameter per hydrogel shows significantly decreased structure sizes in 
matrices without PEG-cadherin compared to PEG-E- and PEG-N-cadherin matrices (*p < 0.05).  B-D, 
histograms of pooled size data show that in PEG-cadherin-free matrices (B) many structures 
approximate the size of single-cells with nearly no spheres forming above 70 μm.  While small spheres 
were still widespread in PEG-cadherin matrices (C-D), many spheres were larger, with a sizable 
minority growing to 80-100 μm, a size more typical of matrices with PEG-RGDS. 
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not proliferate normally to form larger spheres (Fig. 4-12C).  While a quantification of 
true cell viability is complicated by difficulty distinguishing closely approximated cells in 
multicellular spheroids, the fraction of viable structures over the total measured was 
evaluated between gels.  While there was some variation between samples using this 
metric, there was no statistically significant difference in viability among gels with and 
without PEG-cadherin (to significance level of α = 0.05, Fig. 4-12D). 
Fig. 4-12: Live/dead staining shows morphology differences are not viability related. A-C, calcein 
AM (green) / ethidium homodimer (red) staining of PEG-RGDS-free matrices with PEG-E-cadherin 
(A), PEG-N-cadherin (B) or no PEG-cadherin (C) reveals high viability in all matrices.  The small, 
single-cell structures predominantly found in PEG-PQ-only controls were generally viable (C, example 
arrow).  D, quantification of percent viable structures per hydrogel sample shows no significant 
difference in structure viability.  Scale bar = 100 μm.  
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 In this experiment, the 344SQ cell line was studied for the first time in PEG-based 
matrices that lack integrin-engaging adhesive ligands to probe for an initial biologic 
effect of matrix-tethered cadherins.  In all matrices, including PEG-PQ-only controls, cell 
viability was maintained, but interesting differences in sphere development were found.  
344SQ’s apparent degree of substrate anchorage-independence upon loss of ECM 
binding is similarly shared with other cancer models, particularly those that are more 
malignant
323,324
.  While loss of cell-adhesive surroundings typically induces cell death in 
non-transformed cells, these malignant lines resist this apoptotic signaling, a resistance 
that is likely important for the survival of metastasizing cells that must disengage from 
the matrix to disseminate. 
 The data does indicate, however, that normal 344SQ spheroid growth and 
epithelial morphogenesis in 3D culture requires at least some degree of adhesion to the 
matrix.  Abnormal 344SQ sphere morphogenesis in matrices without adhesive ligand also 
makes sense in the context of other work in the field that has demonstrated the critical 
role of ligation of different key integrins in epithelial morphogenesis
174–176,179
, and in the 
context of previous work in our lung adenocarcinoma model demonstrating significant 
differences in integrin expression between different phenotypic states
238
.  This result 
further underscores previous data in the PEG system showing the influence of adhesive 
ligand concentration on morphogenesis (Section 2.3.5) and suggests that proper initiation 
of the 344SQ MET program in 3D culture likely depends on ligation of  sphere-
peripheral cells to properly orient 3D polarity. 
 The incorporation of PEG-cadherin had some effect normalizing sphere growth in 
PEG-RGDS matrices.  Initially, this demonstrates a biologic effect of the pegylated 
136 
 
cadherins, with incorporation appearing to afford some degree of binding to cells to exert 
noticeable morphogenesis effects.  There were, however, no readily observable 
differences between E- or N-cadherin groups in this experiment.  This is a somewhat 
surprising result given the expectation of a high degree of E-cadherin expression and 
membrane localization in the epithelial state of 344SQ in 3D culture in the absence of 
TGFβ.  It is likely that while 344SQ indeed preferentially expresses either cadherin 
depending on its EMT state
232,238
, there can be some degree of expression of multiple 
cadherin types regardless of EMT state, a typical finding in many cell types, usually 
observed as a different cadherin co-expressed with E-cadherin
293
.  The small degree of N-
cadherin expression in the epithelial state appears may have been sufficient for the degree 
of normalization of sphere growth in hydrogels with PEG-N-cadherin.  Alternatively, 
while homophilic binding between like cadherin types is stronger, cadherins are capable 
of some degree of weak heterophilic binding
325,326
, a degree that may have been sufficient 
to facilitate some normalizing interaction despite matrix presentation of an unmatched 
cadherin type. 
 Finally, while there were significant differences between PEG-RGDS-free 
hydrogels with and without PEG-cadherins incorporated, epithelial morphogenesis in 
PEG-cadherin matrices was still abnormal, with many structures remaining small or 
comprised of single-cells, no structures showing complete lumenization, and spheres 
showing very little polar organization at all.  This result suggests that while binding of 
encapsulated cells to matrix cadherins was able to at least partially restore normal growth 
patterns, proper morphogenesis may require stronger matrix adhesion or ligation of 
particular RGD-binding integrins.  This observation again highlights the importance of 
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matrix adhesive properties to 344SQ morphogenesis suggested by previous data, and the 
importance of integrin ligation seen in other cancer models. 
 
4.3.3 Matrix-tethered Cadherin Influences 344SQ.WT Epithelial Morphogenesis 
in Soft Matrices 
 We next sought to determine if the presence of PEG-cadherin in matrices that 
facilitate some degree of epithelial morphogenesis (with PEG-RGDS) in any way 
influences 344SQ.WT sphere development or EMT.  Pilot studies using stiffer 5% and 
10% PEG-PQ matrices with PEG-RGDS revealed little difference between matrices with 
and without PEG-cadherin and little difference between PEG-cadherin types.  However, 
we also sought to test if matrix-tethered cadherins exerted a subtler influence that would 
be revealed in low-stiffness matrices that do not otherwise favor widespread epithelial 
morphogenesis.  344SQ.WT cells were encapsulated in 3% PEG-PQ matrices with 4 mM 
PEG-RGDS with or without PEG-N- or -E-cadherin, cultured for 14 days, stained for 
polarity markers, and analyzed for differences in degree of epithelial morphogenesis (Fig. 
4-13A-C).  As expected based on previous data, given the low matrix stiffness and 
moderate PEG-RGDS concentrations, sphere populations as a whole were not well 
organized regardless of group.  Spheres were large, many did not lumenize, and of those 
that did show central clearing and lumenization, organization was relatively poor with 
few structures showing nuclei arranged in a single peripheral ring.  In subjective 
observations, however, spheres in the PEG-N-cadherin matrices were generally larger 
with noticeably fewer structures showing intrasphere nuclear clearing.   
Upon quantification of sphere organization using the E-score method, most 
structures did not show a well-organized lumenized phenotype (Only ~20% with E-score  
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= 4 or 5).  However, of structures with some degree of lumen (E-score ≥ 3), PEG-E-
cadherin matrices showed a significantly higher degree of lumenization compared to 
PEG-N-cadherin matrices, suggesting a cadherin-specific effect on epithelial organization 
(Fig. 4-13D).  Matrices without any PEG-cadherin showed more inter-sample variability, 
but mean lumenization percentage was closer to that of PEG-E-cadherin matrices and 
higher than that observed in PEG-N-cadherin matrices. 
Fig. 4-13: PEG-cadherin influences epithelial morphogenesis of 344SQ.WT in soft PEG-PQ 
matrices. A-C, images of 344SQ.WT in 3% PEG-PQ / 4 mM PEG-RGDS matrices with PEG-E-
cadherin (A), PEG-N-cadherin (B) or no PEG-cadherin (C) show structures forming with some degree 
of epithelial polarity and lumenization in all matrices, though less organized and larger structures in 
PEG-N-cadherin matrices. β-catenin (red), ZO-1, (yellow), DAPI (blue). Scale bar = 100 μm. D, 
comparison of the percentage of spheres per hydrogel showing some degree of lumen formation (E-
score ≥ 3) revealed significantly greater lumenization in PEG-E-cadherin matrices compared to PEG-N-
cadherin matrices (*p<0.05).  
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 Given the relationship between cadherins and cancer EMT and invasion, we next 
asked if matrix-tethered cadherin modulated the EMT effect seen in 344SQ with 
exposure to TGFβ.  Initial studies in these soft matrices with the concentration of TGFβ 
previously used showed a potent EMT response with rapid and complete loss of lumen 
and polar organization regardless of group.  Because this concentration is super-
physiologic, and in the event that subtler cadherin-related effects are revealed at less 
potent concentrations, a lower concentration of TGFβ (0.5 ng/ml) was administered to 
344SQ.WT encapsulated in 3% PEG-PQ hydrogels with PEG-cadherin.  Treatment with 
this lower concentration initiated EMT in encapsulated cells, with spheres in all groups 
showing intrasphere nuclear proliferation and a loss of at least some degree of polar 
organization (Fig. 4-14A-C).  After exposure, no structures showed remnant lumens 
featuring substantial cell clearing (no spheres with E-score = 4 or 5).  However, the EMT 
response was less complete than previously observed after 4 days of exposure as some 
structures remained at least partially lumenized (example in PEG-E-cadherin image, Fig. 
4-14A) and other structures showed some degree of persistent polar localization despite 
lumen filling (Fig 4-14B-C).   
Quantifying these changes, lumenization decreased in all groups, but was 
substantially more persistent in PEG-E-cadherin and PEG-RGDS-only hydrogels (Fig. 4-
14D).  In PEG-N-cadherin hydrogels, the percentage of lumenized structures dropped 
dramatically with fewer than 10% of structures remaining lumenized.  In comparing 
structures that show at least some degree of polar organization with or without a lumen 
present (E-score ≥ 2), there was a dramatic decrease in the percentage of these organized 
structures in the PEG-N-cadherin group as spheres more readily lost polar organization 
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with exposure to TGFβLo (Fig. 4-14E).  Spheres also lost some polar organization in 
PEG-E-cadherin and PEG-RGDS-only groups as well, but to a lesser degree, with 
upwards of 50% of spheres in PEG-E-cadherin gels still showing some organization of 
polarity markers after TGFβ exposure.  
 This experiment demonstrated a small effect of matrix-tethered cadherins on 
344SQ.WT epithelial morphogenesis.  Matrices with PEG-E-cadherin induced 
significantly greater lumenization in encapsulated spheres than in structures with PEG-N-
Fig. 4-14: PEG-cadherin influences degree of loss of epithelial phenotype induced by TGFβLo.  A-
C, images of 344SQ.WT in 3% PEG-PQ / 4 mM PEG-RGDS matrices with PEG-E-cadherin (A), PEG-
N-cadherin (B) or no PEG-cadherin (C) after 4 days of 0.5 ng/ml TGFβ exposure show a partial EMT 
response in all groups, but more persistent lumenization and epithelial organization in spheres in PEG-
E-cadherin gels compared to spheres in PEG-N-cadherin gels.  D, quantifying the percentage of 
structures with some degree of remnant lumen (E-score = 3) reveals a more dramatic decrease in the 
lumenized population in PEG-N-cadherin gels (*p < 0.05). E, comparing spheres with at least some 
degree of polar organization (E-score ≥ 2) reveals a more dramatic decrease in this sub-population upon 
TGFβLo treatment in PEG-N-cadherin gels compared to PEG-E-cadherin gels and PEG-RGDS-only 
controls. β-catenin (red), ZO-1, (yellow), DAPI (blue). Scale bar = 100 μm.  
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cadherin, and greater resistance to loss of lumenization and polar organization with EMT.  
This is consistent with literature reports demonstrating the link between E-cadherin and 
epithelial polarity and the role of N-cadherin in EMT-related phenotypic behaviors.  
However, as the PEG-RGDS-only control gels induced a similar degree of lumenization 
as the PEG-E-cadherin gels both before and after TGFβLo exposure, this pro-
epithelialization effect may be limited.   
 Alternatively, the external presentation of N-cadherin may have a more important 
role in limiting 344SQ epithelial morphogenesis and promoting polar disorganization 
than E-cadherin has in inducing the inverse.  Not only did spheres in PEG-N-cadherin 
matrices less readily form lumenized spheres, but they were also more responsive in loss 
of lumenization and polarity with a milder TGFβ-initiated EMT.  This observation 
suggests that engagement of N-cadherin induced cells to be less responsive to 3D matrix 
cues promoting epithelialization and more responsive to TGFβ-related cues promoting 
EMT. 
 It is worth noting that matrix-tethered cadherins had little effect on 344SQ.WT in 
more structurally stable matrices with higher PEG-PQ concentrations or in the face of 
more a potent EMT trigger at a higher TGFβ concentration.  Cadherin-related influences 
were revealed only in a matrix with a low concentration of PEG-PQ that otherwise does 
not favor substantial epithelial organization and at a lower TGFβ concentration that 
initiates a slower or less complete EMT.  These observations suggest that matrix cues 
related to 3D culture or stiffness and adhesive ligand concentration may be far more 
important to 344SQ MET and EMT than the engagement of cadherins, a result not 
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completely unsurprising given the potent effects previously observed in our cancer model 
and others when these factors are specifically altered.   
The data showing that PEG-E-cadherin exerted limited if any pro-epithelialization 
effects over PEG-RGDS-only matrices is interesting given the previous data 
demonstrating a substantial effect on cultured cells in matrices without PEG-RGDS 
(Section 4.3.2).  This disparity suggests that once 344SQ cells are embedded in a 3D, 
cell-adhesive environment, a pro-epithelial program is potently initiated with any 
enhancement of this potent morphologic switch difficult to promote in any 
observable way.  It is possible that any further enhancement via matrix E-cadherin 
presentation of the MET effects already afforded by 3D culture are unseen as they are 
redundant in the face of changes already occurring (i.e. cells already presenting sufficient 
E-cadherin-related signaling to one another).  Alternatively, any additional degree of 
epithelialization beyond that afforded by structural matrix cues may be limited by the 
genetic or epigenetic programming of the cells; the 344SQ line is significantly 
transformed, highly plastic, and EMT-prone, and these intrinsic influences may impose a 
maximal epithelial phenotypic limit irrespective additional matrix cues. 
 
4.3.4 Matrix-tethered Cadherin Influences 344SQ.scrib Epithelial Organization 
 Loss of the scribble polarity complex protein induces a loss of polarity and pro-
tumorigenic changes in multiple cell types and cancer models
305,308
.  In the 
KRas
G12D
/p53
R172HΔG
 model, scribble knockdown induced metastatic changes in the 
otherwise non-metastatic 393P line
311
.  Knockdown in 344SQ leads to structures without 
polarity that do not lumenize despite 3D MG culture, and are more invasive with 
enhanced metastatic phenotypes in the face of certain matrix cues.  Because of the 
143 
 
emerging relationship between scribble and cadherin proteins and given observations of 
lumenized hybrid structures when 344SQ.scrib is cultured in contact with 344SQ.WT, we 
sought to test the influence of cadherins on 344SQ.scrib with incorporation of PEG-
cadherin into matrices. 
 Initial experiments on 344SQ.scrib cells encapsulated in PEG-based hydrogels 
without PEG-cadherin showed general agreement to observations noted in MG 
experiments.  In PEG-PQ hydrogels with PEG-RGDS alone (10% PEG-PQ / 3.5 mM 
PEG-RGDS), 344SQ.scrib formed large spheres with no lumenization evident by 
brightfield microscopy and no overt indication of polar organization (Fig. 4-15A).  Co-
culture of 344SQ.scrib with 344SQ.WT was then attempted in the PEG system to mimic 
results showing lumenization when cells are in contact.  Predictably, however, the vast 
Fig. 4-15: 344SQ.scrib in PEG-based hydrogels.  A, 344SQ.scrib in culture alone in a 10% PEG-PQ / 
3.5 mM PEG-RGDS matrix forms large, multicellular spheres with no lumenization consistent with the 
polarity-inhibiting effects of scribble loss.  B-C, co-culture of 344SQ.scrib and 344SQ.WT shows 
structures composed of 344SQ.WT forming lumens (B, blue arrow) that are distinguished from 
344SQ.scrib structures (red arrow) by GFP expression in scribble knockdowns (C).  D-E, a rare 
structure (D, purple arrow) in the co-culture shows both clear lumen formation as well as GFP 
expression (E), suggesting possible normalization of epithelialization despite scribble knockdown due 
to WT cell-cell contact.  Scale bar = 100 μm.  
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majority of spheres were composed of either cell type alone, and 344SQ.scrib -
344SQ.WT contact events were rare (Fig. 4-15B-C).  Spheres with scribble knockdowns 
as evident by GFP co-expression revealed no lumenization, and the only readily evident 
lumenized structures were composed of 344SQ.WT (indicated by lack of GFP).  A very 
rare sub-population of spheres (~2 structures per hydrogel sample) featured both 
unambiguous luminal clearing and GFP expression by at least some sphere-constituent 
cells, suggesting the formation of polar, lumenized structures despite scribble knockdown 
of constituent cells (Fig. 4-15D-E).  A possible explanation for this rare phenotype is a 
normalization of 344SQ.scrib epithelialization upon 344SQ.WT contact, as previously 
observed in the MG system.  
 344SQ.scrib cells were then encapsulated in matrices with PEG-cadherin to 
examine if these cell-cell contact-related findings are cadherin-mediated and if they can 
be more readily induced in a larger sub-population of structures than in rare co-culture 
events to enable more complete study.  After 14 days in culture in 5% PEG-PQ matrices 
with or without PEG-cadherin, 344SQ.scrib in all matrices formed multicellular spheres 
with sphere populations showing a mixed epithelial phenotypic picture influenced by 
matrix-tethered cadherins.  Primarily observed in matrices with PEG-E-cadherin, a small 
subpopulation of 344SQ.scrib formed spheres with a nuclei-cleared intrasphere lumen, 
clearly defined by the segregation of polarity markers (Fig. 4-16A).  A minor, but 
substantial, sub-population of spheres formed structures with a unique pseudo-epithelial 
morphology featuring nuclei on sphere peripheries arranged with organized radial 
directionality (Fig. 4-16B).  An area just interior to this peripheral layer was free of nuclei 
and showed expression of apical polarity markers typically indicative of a luminal edge.   
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Fig. 4-16: 344SQ.scrib shows a minor degree of epithelial morphogenesis with phenotypic sub-
populations influenced by matrix-tethered cadherin.  A-C, representative images of phenotypic sub-
populations of 344SQ.scrib revealed in PEG matrices include (A) a relatively rare lumenized phenotype, 
(B) a pseudo-epithelial phenotype featuring strong radial organization of peripheral nuclei and high 
polar organization but no actual lumen, and (C) a substantial proportion of spheres with no polar 
organization.  Representative images taken from matrices with PEG-E-cadherin (A), no PEG-cadherin 
(B) and PEG-N-cadherin (C). D-F, in quantification of sub-population proportions, while sphere sizes 
showed no difference between groups (D), the PEG-E-cadherin group showed a significantly greater 
proportion of spheres with some degree of polar organization typical of the psuedo-epithelial phenotype 
(E) and a significantly greater proportion of spheres featuring a cleared lumen (F) than the PEG-N-
cadherin group. *p<0.05, **p<0.01.  β-catenin (red), ZO-1, (yellow), DAPI (blue).  Scale bar = 50 μm. 
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But these structures lacked formation of an actual lumen as cells were present all 
throughout sphere volumes with nuclei generally clustered together at central sphere 
cores.  This interesting phenotype was prominent in PEG-E-cadherin matrices, but also 
evident in PEG-RGDS-only controls.  Finally, many structures in all matrix formulations 
exhibited no organized phenotype as would be expected with knockdown of such an 
important polarity complex protein as scribble (Fig. 4-16C). 
 To quantify the subjective differences observed in these mixed populations, 
polarity marker-stained spheres were imaged on a confocal microscope and analyzed 
using the E-score method.  Sphere sizes showed a trending, but non-significant difference 
between groups with smaller spheres forming in the PEG-E-cadherin matrices relative to 
PEG-N-cadherin matrices and PEG-RGDS-only controls (Fig. 4-16D).  The radially 
organized, pseudo-epithelial morphology (Fig. 4-16B) was scored as a phenotype 
showing epithelial organization but no lumenization (E-score = 2).  Upwards of half of 
the spheres in PEG-E-cadherin groups exhibited this phenotype or greater epithelial 
lumenization, a significantly greater proportion than in spheres in the PEG-N-cadherin 
group (~25%, Fig. 4-16E).  PEG-RGDS-only matrices showed a lower proportion of 
spheres with some degree of polar organization than in matrices with PEG-E-cadherin, 
but this difference was not significantly different from either PEG-cadherin group.    
Specifically evaluating sphere lumenization (E-score ≥ 3) revealed no spheres in 
any matrix formed lumenized spheres with high organization and completely cleared 
lumen (E-score = 5) with most exhibiting an abnormal lumenized morphology with 
limited central clearing and nuclei poorly organized around small cleared lumenized 
spaces.  A minor population of spheres in PEG-E-cadherin matrices exhibited this 
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lumenized phenotype, significantly greater than the proportion of spheres in PEG-N-
cadherin matrices (12.4 ± 5.9% vs. 4.2 ± 2.2%, Fig. 4-16F).  However, lumenization in 
PEG-cadherin matrices was not significantly different than that in PEG-RGDS-only 
controls.  Control matrices showed more variability in 344SQ.scrib lumenized 
populations, but overall also featured a minor population of poorly lumenized spheres 
revealed by examination of stained confocal images that were otherwise not readily 
apparent in brightfield images of these matrices. 
 Pro-organizational changes observed in 344SQ.scrib in PEG-cadherin matrices 
were further explored by staining for markers of proliferation/apoptosis and for cellular 
expression of E-cadherin.  Staining at day 7 in culture demonstrated many spheres across 
all groups with little or no proliferative or apoptotic activity as revealed by ki-67 and 
caspase-3 staining, respectively.  This staining pattern was observed in some spheres 
despite formation of a radially organized, pseudo-epithelial phenotype (Fig. 4-17A).  
Overall, about 74% of spheres adopted this staining pattern.  This observation suggests 
that the significant polar organization in these structures was potentially due to shifting 
orientation and rearrangement of cells at the sphere periphery and sphere core without 
major apoptotic events.  Some spheres, however, did show spotty caspase activity in the 
nuclei-free areas just interior to the organized peripheral cell layers, suggesting a more 
mixed picture (Fig. 4-17B).  Those showing apoptotic activity represented about 26% of 
the total sphere population across groups.  The process of partial normalization of 
344SQ.scrib sphere polarity may therefore encompass substantial cellular rearrangement 
with some degree of cell clearing by apoptosis, but far short of the mass central apoptosis 
that leads to complete lumenization in 344SQ.WT (Sect. 2.3.4-5). 
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Some literature evidence suggests a link between E-cadherin and polarity proteins 
such as scribble with proper scribble function mediated by homophilic E-cadherin 
binding
312,313
.  Probing for E-cadherin expression and cellular localization revealed that 
344SQ.scrib cells encapsulated in matrices with PEG-E-cadherin, PEG-N-cadherin or 
PEG-RGDS-only controls were positive for an E-cadherin antibody recognizing an 
intracellular portion of the molecule.  E-cadherin expression by cells generally also 
showed a mixed phenotypic staining pattern.  Many structures in PEG-E-cadherin 
matrices showed strong staining of E-cadherin localized to basal and lateral surfaces of 
peripheral cells, typical of staining for E-cadherin as a lateral polarity marker observed in 
Fig. 4-17: PEG-encapsulated 344SQ.scrib shows mixed patterns of apoptosis / proliferation.  
Many 344SQ.scrib spheres in PEG-E-cadherin, PEG-N-cadherin and PEG-RGDS-only matrices 
demonstrated random or little proliferation with no apoptotic activity (A), but a minor population of 
spheres showed some caspase activity in the anuclear space interior to radially organized peripheral 
nuclei (B) suggesting that mixed organizational and apoptotic changes may form this unique phenotype.  
Both example images taken from PEG-E-cadherin gel, but staining phenotypes present to some degree 
in all groups. Ki-67 (proliferation, yellow), caspase-3 (apoptosis, red), DAPI (blue). Scale bar = 50 μm.  
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other reports
303,313
 (Fig. 4-18A).  Spheres in matrices with PEG-N-cadherin exhibited 
strong overall E-cadherin staining, but it was more diffusively localized with positive 
staining throughout spheres and in between membranes (Fig. 4-18B).  In matrices without 
PEG-E- or -N-cadherin, spheres displayed a more mixed staining pattern with some 
spheres showing sphere-exterior membrane-localized staining like in PEG-E-cadherin 
matrices, particularly if sphere nuclear arrangement suggested that the given sphere had 
adopted the pseudo-epithelial morphology (Fig. 4-18C). 
 To quantify differences between matrices,  images were analyzed for overall E-
cadherin expression in ImageJ and, using the Radial Profile plugin, degree of spatial 
organization, with stronger signal intensity in peripheral sphere sections suggesting the 
basolateral, membrane-localized phenotype.  Overall E-cadherin staining intensity as 
measured by phalloidin-defined sphere-area ROIs was significantly higher in spheres in 
PEG-N-cadherin matrices than in spheres in PEG-E-cadherin matrices or PEG-RGDS-
only controls (Fig. 4-18D).  However, E-cadherin expression is most biologically relevant 
if localized to the membrane and available for binding.  Therefore localized expression 
was analyzed by comparing staining intensity in outer radial sphere sections to inner 
radial sphere sections (Fig. 4-18E).  Spheres in PEG-N-cadherin matrices showed a non-
significant spatial expression imbalance showing stronger inner-sphere expression.  
Meanwhile, while both PEG-E-cadherin matrices and PEG-RGDS-only controls showed 
preferential outer sphere staining, the only significant difference between radial sections 
was found in PEG-E-cadherin matrices.  Normalizing outer radial intensity to inner-
sphere intensity to facilitate comparisons between groups, a significantly decreased  
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Fig. 4-18: PEG-cadherin influences 344SQ.scrib cellular cadherin expression and localization.  A-
C, representative images of staining for an intracellular portion of E-cadherin (green) in 344SQ.scrib 
show a (A) basolateral staining pattern in PEG-E-cadherin matrices with suggestion of membrane 
localization, (B) less organized expression in PEG-N-cadherin matrices despite ample expression, and 
(C) a mixed phenotype in PEG-RGDS-only controls with some spheres showing membrane 
localization.   DAPI (blue), scale bar = 50 μm.  D-E, quantifying differences, measurements of overall 
sphere intensity shows a high degree of E-cadherin expression by cells in PEG-N-cadherin matrices 
(D), but per radial profile analysis demonstrated statistically significant spatial preference for 
expression in outer, basolateral radial sphere sections vs. inner only in spheres in PEG-E-cadherin 
matrices (E).  F, normalizing outer to inner radial section intensity, a statistically significant spatial 
pattern preference was found in both PEG-E-cadherin and PEG-RGDS-only matrices compared to 
PEG-N-cadherin matrices. *p < 0.05, **p< 0.01.  
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preference for basal membrane E-cadherin localization was found in spheres in PEG-N-
cadherin matrices compared to the other groups (Fig. 4-18F). 
 Taken together, results from these studies indicate that matrix-tethered cadherin 
can influence the loss of epithelial polarity observed in 344SQ with knockdown of 
scribble polarity proteins.  More comprehensive study of 344SQ.scrib in PEG-based 
matrices revealed two previously unobserved morphologies: a rare lumenized 
morphology and a pseudo-polar phenotype with a relatively high degree of nuclear and 
polar organization but lacking a true lumen.  Both of these more organized forms showed 
greater prevalence in matrices with PEG-E-cadherin than those with PEG-N-cadherin.  
These phenotypes seemed to be controlled by a combination of apoptosis and non-
apoptotic cellular rearrangement and were associated with enhanced membrane 
localization of cellular-expressed E-cadherin. 
 Like the experiments with 344SQ.WT, 344SQ.scrib’s epithelial organization 
seemed to be more negatively influenced by the presence of N-cadherin in the matrix 
than positively promoted by the presence of E-cadherin because some of these pro-
epithelial phenotypes were also observed in PEG-RGDS-only control matrices.  Integrin 
binding to PEG-RGDS alone was sufficient to support some degree of this mixed 
epithelial-like population in encapsulated 344SQ.scrib.  This is an interesting finding 
given work with 344SQ.scrib in MG where no organization at all is observed despite 
ample matrix integrin engagement.  Indeed, epithelialization is so deficient in MG that 
some degree of matrix TGFβ-free invasion occurs in some cases.   
 This difference observed in the PEG system may result from more specific 
integrin binding, an avoidance of contaminating growth factors, a difference in matrix 
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mechanics or many other factors that differ among the culture platforms and may be 
worth further exploration in future experiments.  An additional ligand effect on 
344SQ.scrib not directly related to cell-cell contacts is a particular possibility given 
experiments in MG demonstrating extensive invasion in matrices crosslinked with 
collagen with this more invasive phenotype blocked with antibodies against integrin β1 
subunits (Fig. 4-5).  It is possible that if ligation of β1-related integrins facilitates 
invasion, integrins with other subunits, like β3 for example, may promote the 
development of the more typical non-invasive 344SQ.scrib spheroids.   
 The more reductionist PEG system used here with only the RGD sequence present 
may preferentially bind the 344SQ.scrib integrins that support a more growth-normalized 
spheroid morphology.  The hydrogel can be altered in future work with the addition of 
other peptide sequences that more avidly bind β1-containing integrins to better 
characterize a potential ligand effect.  Finally, an alternative mechanics-driven process is 
also possible given that the PEG matrices used with 344SQ.scrib are stiffer than the MG 
or MG-collagen matrices used in previous work with the cell line.  Future work can test if 
there is a loss of these partially polarized phenotypes in softer PEG matrices with similar 
integrin-binding properties to explore if these morphologies result from organizational 
changes in spheres due to external matrix mechanical stresses unrelated to ligand 
concentration or identity. 
 There was also a slight, but non-significant enhancement of sphere characteristics 
suggestive of more organized epithelial morphologies in PEG-E-cadherin gels compared 
to PEG-RGDS-only controls.  Given literature data linking E-cadherin to scribble 
function and the co-culture experiments showing restoration of 344SQ.scrib lumenization 
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in hybrid structures formed with 344SQ.WT (Fig. 4-6), an enhancement of 
epithelialization was expected in PEG-E-cadherin matrices over PEG-RGDS-only 
controls.  Several reasons are possible for explaining why this was not more potently 
evident.  While the literature does show a link between E-cadherin and scribble, much of 
that link has established the importance of proper E-cadherin binding in facilitating 
scribble location and function while fewer studies have documented E-cadherin’s role 
and function in the face of scribble loss
312
.  It is possible that a knockdown of scribble has 
too severe of polarity-related phenotypic consequences to be overcome by pro-
organizational effects of additional E-cadherin binding. 
 Furthermore, staining for cell-expressed E-cadherin showed some degree of 
preferential membrane location in spheres in control matrices, demonstrating that 
344SQ.scrib still expresses E-cadherin localized to cell membranes in 3D culture to 
facilitate cell-cell binding despite a scribble knockdown.  It is possible that the limited 
difference in pro-organizational phenotypes seen between PEG-E-cadherin and PEG-
RGDS-only groups may be because substantial homophilic binding between E-cadherin 
pairs on adjacent cells in 344SQ.scrib structures was already present without matrix-
tethered cadherin.  This binding may have supported a maximal pro-polar influence by E-
cadherin in the face of scribble loss with little amplification of these effects upon 
additional matrix cadherin binding.  It is also possible that even despite the use of 
relatively low PEG-SVA conjugation ratios, the pegylation of E-cadherin protein in PEG-
E-cadherin species led to a sufficient enough loss of bioactivity that its additional matrix 
incorporation caused little effect on top of the baseline effects already present from 
binding between cells of fully functional, native cell-expressed E-cadherin.  This 
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possibility, however, is less likely given the dramatic effects seen with PEG-cadherin 
incorporation in PEG-RGDS-free matrices in 344SQ.WT (Fig. 4-10); effects that were 
similarly observed in pilot studies with 344SQ.scrib in PEG-RGDS-free matrices. 
 A significant difference in organization was recorded, however, with 344SQ.scrib 
in matrices with PEG-N-cadherin, with a relative decrease in both lumenized and pseudo-
epithelial organized phenotypes and in basolateral E-cadherin spatial location.  Compared 
to E-cadherin, there is relatively little published information relating N-cadherin binding 
to scribble expression or function.  Further, while the role N-cadherin has been studied in 
reference to polarity of neuronal cells or cancers of neuronal lineage 
327–329
, limited work 
has been done establishing a causal link between N-cadherin expression and polarity in 
epithelial cells of cancers beyond correlations observed in EMT (EMT induces both 
increased N-cadherin expression and loss of polarity).  Instead, N-cadherin’s effects on 
motility and matrix invasion have been more widely studied
135,279,296
.  It is possible, if not 
likely, however, that N-cadherin binding directly influences both pro-malignant polarity 
and invasion changes, but invasion has been the focus of study as invasion-related 
observations that are more evident in naturally derived matrices may have masked subtler 
changes in polarity.  The different invasive response observed in the PEG system may 
have made observable and facilitated study of subtler polarity differences. 
 Another potential explanation for the effects seen with PEG-N-cadherin that is 
discussed at length in the literature relates to findings that increased N-cadherin binding 
in cancer typically coincides with a loss of E-cadherin binding
292
.  This possibility that 
increased N-cadherin binding influences polarity by altering E-cadherin binding and 
thereby acting through E-cadherin-related mechanisms is at least partially supported by 
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the data showing lack of E-cadherin membrane localization in spheres in PEG-N-
cadherin matrices.  Enhanced binding of N-cadherin of cells in PEG-N-cadherin matrices 
could shift the balance in the mixed cadherin expression phenotype, and the resulting 
decrease in E-cadherin binding between cells in spheres could mediate the effects on 
polar organization observed via the above E-cadherin-related mechanisms. 
In any event, it seems that additional binding of E- or N-cadherin alone is not 
sufficient to restore 344SQ.scrib lumenization, suggesting a more complex mechanistic 
picture to explain the interesting findings of lumenization in hybrid 
344SQ.WT:344SQ.scrib structures.  It is possible that other cell-cell contacts mediate the 
complete normalization of 344SQ.scrib polarity.  Jagged-notch signaling, for example, 
has been shown in the KRas
G12D
/p53
R172HΔG
 model to influence EMT and invasion
239
.  It 
is also possible that the expression of different cadherin types or a different spatial or 
temporal pattern of N- and E-cadherin expression or concentrations that are not presented 
in the matrices tested may play the decisive role. 
 
4.4 Conclusion 
 Cadherin cell-cell contacts play an important role in the establishment of proper 
epithelial polarity and in cancer progression and dissemination
292
.  In this chapter, E- and 
-N-cadherin were presented via the PEG matrix to cells of the KRas
G12D
/p53
R172HΔG
 lung 
adenocarcinoma model to probe for effects on epithelial morphogenesis and EMT, and 
the potential influence of cell-cell contact-mediated normalization of cells with polarity 
defects.  First, a dramatic effect of matrix-tethered cadherins was first found on 344SQ 
sphere morphogenesis in otherwise non-cell adhesive matrices.  In matrices with PEG-
RGDS, this effect on epithelial morphogenesis and related effects on resistance to TGFβ-
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induced EMT were subtler, but incorporation of PEG-N-cadherin in particular negatively 
influenced epithelialization.  Finally, in studies with the polarity-defective 344SQ.scrib 
line, PEG-based matrices promoted formation of partially polar-organized states, the 
degree to which was influenced by matrix-tethered cadherin, potentially mediated by 
differences in localization of cell-expressed E-cadherin. 
Additional work could be done to fully characterize the role of cadherins in the 
KRas
G12D
/p53
R172HΔG
 model.  As matrix incorporation of PEG-E- and -N-cadherin did 
have a subtle effect on aspects of both 344SQ.WT and 344SQ.scrib epithelial 
organization, additional studies may be done to establish a more causal link between its 
matrix incorporation and these effects; initial pilot experiments examining some of the 
more commonly studied downstream cadherin signaling targets (proliferation, β-catenin 
in Wnt pathway, BCL-2 pathway, etc.) were inconclusive.  Furthermore, as studies with 
blocking antibodies proved difficult given so much bound cadherin present in hydrogels, 
KRas
G12D
/p53
R172HΔG 
lines with knockdowns of these cadherin components may be worth 
exploring to further probe for a possible causal link.   
PEG-based hydrogels with or without PEG-cadherins could also be used in future 
studies to further examine other interesting findings with 344SQ.scrib unrelated to 
polarity normalization.  For instance, the profoundly different invasive phenotype 
observed in scribble knockdowns in MG matrices with collagen incorporated could be 
further explored in the PEG system for specific causal biomechanical or biochemical 
relationships.  Such work may have important implications for how cells with polarity 
loss in tumors interact with matrix cues that promote or inhibit cancer progression and 
metastasis.  Finally, future studies may also work to characterize potential cell-cell 
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interactions in addition to E- and -N-cadherin that may mediate the behavior of 
344SQ.WT:344SQ.scrib hybrid structures or special spatial or temporal relationships of 
those contacts that may mediate polar normalization despite scribble knockdown.  Such 
work may have important implications for the mechanisms by which less transformed 
tumor cell subpopulations exert metastasis-tempering influence on more malignant 
neighboring subpopulations, an intriguing avenue for exploration and potential future 
therapeutic development. 
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5. Conclusions and Future Directions 
5.1 Thesis Summary and Conclusions 
 
 Non-small cell lung cancer is the leading cause of cancer-related death largely due 
to a high incidence of metastatic disease for which few therapeutic options exist.  
Mounting research has defined a key role for the ECM in both cancer prevention and 
progression; normal ECM affords anti-neoplastic signaling from normal stromal cells and 
barrier basement membrane effects whereas a pathological ECM co-evolves with tumor 
progression that ultimately facilitates matrix invasion and metastasis.  In addition to pro-
tumorigenic signaling from TAFs, changes to tumor stroma include alterations in ECM 
protein concentration, composition, and architecture that produce important pathological 
changes in tumor ECM stiffness and growth factor signaling that promote tumor 
progression.  In the hope that a better understanding of these changes and their pro-
metastatic influence may reveal new therapeutic options, investigators have begun to 
study these extrinsic influences using cancer models cultured in in vitro matrix-mimetics.  
However, studies to probe for specific ECM influences have largely been restricted to 
naturally-derived matrix materials that afford ample cell engagement but limited 
experimental control. 
 Study of the KRas
G12D
 / p53
R172HΔG
 lung adenocarcinoma model in MG has 
demonstrated substantial contextual ECM control over metastatic behavior.  Despite a 
similar genetic background, different lines in this model are subjected to varying degrees 
of EMT/MET, matrix invasion, and metastasis mediated by culture in a three-
dimensional environment, exposure to TGFβ, epigenetic regulation by miR200, and 
differential expression of ECM-related proteins and the Jagged-Notch cell-cell contact 
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signaling system
232,238,239
.  In this thesis, the study of the KRas
G12D
 / p53
R172HΔG
 model 
was translated into a synthetic PEG matrix to eliminate potential confounders in the MG 
system resulting from growth factor contamination and poor control over scaffold 
biomechanics and biochemistry.  This PEG system featured biospecific cell adhesion and 
cell-mediated proteolytic degradation on an otherwise non-bioactive background, 
affording greater experimental control of matrix cues. 
 Epithelial morphogenesis of the EMT-prone 344SQ line was first studied in 3D 
culture in these modified PEG-based hydrogels.  Bioactivity afforded by RGD-mediated 
cell adhesion and hydrogel backbone MMP-susceptibility was sufficient for 344SQ to 
form lumenized, polarized epithelial spheres in 3D PEG culture.  Structure size, 
organization of epithelial polarity, and coordinated patterns of proliferation and apoptosis 
were altered by controlled modification of hydrogel stiffness and bioactivity, 
demonstrating key ECM influences on epithelial morphogenesis.  Further, these 
morphogenic features were also found to be dependent on the spatial presentation of 
bioactive ECM ligands with cyclic formulations of RGDS affording significantly 
different morphogenic effects. 
 Potential EMT and matrix invasion responses to TGFβ in 344SQ cells cultured in 
the PEG system were next explored in this thesis.  TGFβ plays a dual role in both 
inhibiting and promoting tumor growth and progression at different stages of 
tumorigenesis
265
.  In 344SQ and other EMT models, it acts as a promoter of EMT-related 
transcription factors and inhibitor of pro-epithelial miR-200, initiating an EMT response 
and MG matrix invasion
232,237
.  In PEG-encapsulated 344SQ, TGFβ was found to initiate 
a potent EMT response, inducing changes in sphere morphology, polarity, and expression 
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levels of both the epigenetic EMT-controller miR-200 and several EMT marker genes.  
For the first time, EMT-induced changes in cell-secreted ECM were also examined, and 
substantial organizational remodeling of basement membrane-marking collagen IV was 
found upon TGFβ exposure.  Through these studies, a more important role for ECM 
adhesive ligand concentration in EMT was also revealed as 344SQ cells in low PEG-
RGDS matrices showed a post-TGFβ phenotype with respect to genetic profile and ECM 
remodeling even in the absence of TGFβ exposure.  Finally, the last key EMT-related 
response, matrix invasion, was studied in the PEG system.  Experiments demonstrated 
that the degree and character of 344SQ matrix invasion can be tuned by altering matrix 
parameters and the protease susceptibility of the hydrogel backbone with structural 
hydrogel characteristics mediating an interplay between organized epithelial states and 
matrix-invasive phenotypes. 
 Finally, this thesis explored the potential effects on 344SQ morphogenesis and 
EMT mediated by cadherins, a family of cell-cell contacts that have been shown to play 
an important role in the establishment or breakdown of proper epithelial polarity and 
tumor dissemination
292,293
.  The key EMT-related cadherins, E- and -N-cadherin, were 
pegylated and presented via the matrix to both wild-type 344SQ cells and those with a 
knockdown of scribble, an important member of an essential polarity-determining protein 
complex
307
.  PEG-cadherin induced dramatic effects on 344SQ.WT sphere development 
in otherwise non-cell-adhesive PEG hydrogels and subtler effects on sphere polarity and 
TGFβ response in matrices with PEG-RGDS.  In studies with 344SQ.scrib, matrix-
tethered cadherins influenced the formation of spheres with partially normalized 
epithelial polarity with some degree of lumenization despite genetic limitations.  
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Significant differences in both 344SQ.WT and 344SQ.scrib epithelial organization were 
found between PEG-E-cadherin and PEG-N-cadherin matrices suggesting an identity-
specific cadherin effect, potentially mediated by what staining for intracellular E-
cadherin revealed to be dramatic differences in cell-expressed E-cadherin membrane 
localization. 
 In summary, this thesis has established the utility of the versatile PEG hydrogel 
matrix in which ECM influences on cancer progression can be studied with high 
experimental control.  Experimental findings in this thesis have contributed to a greater 
understanding of the matrix biomechanical, biochemical, and cell-cell mediated 
relationships that influence lung cancer epithelial morphogenesis and EMT.  These 
findings bring the field one step closer to an understanding of the important matrix-
related cues mediating tumor progression and metastasis with the prospect that such 
knowledge might open new therapeutic avenues to treat advanced cancers. 
 
 
5.2 Future Research Directions 
 
 This thesis represents the initial work moving the KRas
G12D
 / p53
R172HΔG
 model 
into the more experimentally controllable PEG hydrogel system.  Amongst other related 
work outlined in previous chapters, potential future studies will seek to further 
characterize the 344SQ matrix invasion response and describe a more mechanistic role 
for cadherin signaling mediating 344SQ epithelial morphogenesis and EMT.  Beyond 
these studies, future work may examine the role of additional matrix cues in lung cancer 
metastasis, including other cell-surface ligands like CD44 and cell-cell contact signaling 
systems like Jagged-Notch.  In addition, future work may deploy the PEG system to 
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study the role of other stromal cell players in metastasis like tumor-associated fibroblasts 
and blood vessels. 
 
5.2.1 CD44 in Lung Adenocarcinoma Progression and Matrix Invasion 
 CD44 is a single-chain transmembrane glycoprotein of considerable research 
interest as a marker and promoter of cancer progression
330
.  In its primary role, CD44 is a 
primary receptor for HA, a large, linear non-sulfated glycosaminoglycan that is a major 
ECM constituent.  HA binding to CD44 initiates most of its signaling activities and 
controls a large degree of non-integrin-mediated cell adhesion to the matrix
331
.  In 
addition to significant glycosylation and other post-translational modifications, CD44 
features a substantial number of variant domains whose flexible incorporation generates 
several variant splice isoforms that introduce cell- and tissue-specialized functionality.  
This structural variability in part affords CD44 the ability to bind several different ECM 
molecules including collagen, fibronectin, osteopontin, laminin, as well as major 
histocompatibility complexes
330
.  Like many of these ECM components, CD44’s 
principle binding partner, HA, is enriched in the ECM of multiple cancer types, including 
lung tumors
332
.  CD44 itself is similarly upregulated in several tumor lines and in some 
cancers, with certain splice variants inducing a metastatic phenotype
107,330,333
.  CD44 has 
also been studied as a key marker in cancer-initiating cells or cancer stem cells, the minor 
cell populations in tumors essential for tumor maintenance and progression, with CD44 
contributing to the activation of certain stem cell regulatory genes and conferring 
apoptotic resistance
331
. 
 Of particular relevance to the KRas
G12D
 / p53R
172HΔG
 lung adenocarcinoma model 
is literature indicating a role for CD44 in EMT and matrix invasion.  CD44 shows greater 
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expression upon EMT in several cancer models
291,330,332
 and potentially plays an 
important role in cell migration and matrix invasion following EMT.  In studies of 
different tumor models, CD44-HA binding promoted Rac-mediated cytoskeletal 
reorganization and cell migration
334
, tumor cells enhanced their own migration by 
generating HA fragments to interact with their upregulated CD44 receptors
68
, and CD44 
expression distinguished more invasive cell populations from otherwise similar non-
invasive populations with anti-CD44 antibodies blocking matrix invasion
290
.  And in a 
study of retinal epithelial cells, not only did CD44-HA binding promote cell motility, but 
it also activated TGFβ-related signaling to further promote EMT335.   
 A functional role for CD44 in invasion has further been suggested by data 
showing that CD44 is highly localized to invadopodia in some cell types; CD44 directly 
associates with invadopodia actin cores and its adhesion to HA on invadopodia termini 
may help initiate recruitment of other integrins and complete invadopodia assembly
283
.  
Finally, CD44-HA binding has been shown to concentrate MMPs at the cell surface, in 
particular MMP-2 and MMP-9, with increased leading edge MT1-MMP activity
331
.  
CD44’s role in EMT and invasion is likely of specific relevance to our lung 
adenocarcinoma model as protein expression analysis revealed significant upregulation in 
CD44 in metastatic KRas
G12D
 / p53
R172HΔG
 cells relative to their non-metastatic 
counterparts
336
.  
 Pilot studies in PEG hydrogels have suggested a role for CD44 in 344SQ EMT.  
344SQ.WT spheres cultured in a 5% PEG-PQ hydrogel with 7 mM PEG-RGDS show 
limited CD44 expression prior to TGFβ exposure that dramatically increases after 4 days 
of exposure with much more intense staining, preferentially localized to sphere 
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peripheries. (Fig. 5-1A-B).   Interestingly, in spheres in matrices with 1 mM PEG-RGDS, 
expression is somewhat elevated compared to 7 mM PEG-RGDS spheres even in the 
absence of TGFβ (Fig. 5-1C).  This observation reinforces previous data that suggest a 
post-EMT phenotype in gels with little adhesive ligand (Chapter 3).   
 The substantial increase in CD44 staining intensity after TGFβ exposure (Fig. 5-
1B and D) suggests a dramatic upregulation in this ECM binding ligand in 344SQ upon 
EMT.  Along with literature reports describing CD44’s role in invadopodia function and 
matrix invasion, this data suggests that CD44 may be of particular importance for 344SQ 
Fig. 5-1: CD44 expression in PEG-encapsulated 344SQ is altered with TGFβ exposure and 
PEG-RGDS concentration.  A-B, 344SQ cells encapsulated in a 5% PEG-PQ hydrogel with 7 mM 
PEG-RGDS and stained for CD44 (multi-isoform; green) reveals limited expression prior to TGFβ 
exposure (A) and much greater intensity following EMT (B), with expression localized to structure 
periphery. C-D, spheres in 5% PEG-PQ / 1 mM PEG-RGDS matrices exhibit enhanced CD44 
expression prior to TGFβ (C) compared to the 7 mM group that is similarly strong following TGFβ 
exposure (D).  DAPI counterstain (cyan), scale bar = 50 µm.  
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invasion and establishment of the metastatic phenotype following EMT.  However, the 
reductionist PEG system used in this thesis with RGD sequences alone to facilitate cell-
matrix binding does not afford cleavage of CD44 ligands, leaving the dramatically 
increased expression of CD44 in 344SQ upon EMT unable to exert a biologic effect. 
 If the role of CD44 is of high importance in 344SQ matrix invasion, this 
difference may explain why an altered matrix invasion phenotype was found in the PEG 
system compared to MG, which likely features contaminating HA or other ECM 
constituents with CD44-binding domains.  Future studies may seek to modify the PEG 
hydrogels to probe for this role of CD44.  HA peptide derivatives that bind CD44 can be 
pegylated or whole HA molecules acrylated for incorporation into the matrix to enable 
CD44 bioactivity.  Such work may unveil a more potent matrix invasion phenotype in 
PEG-cultured 344SQ cells and provide important information on an additional cell-
matrix interaction that promotes lung adenocarcinoma metastasis. 
 
5.2.2 Cell-cell Contacts in Mediating Lung Adenocarcinoma EMT 
 Paracrine and contact-mediated influences from adjacent cells are capable of both 
working to prevent cancer progression and providing pro-metastatic cues (Section 1.1.3).  
In this thesis, initial study for the role of cadherins in 344SQ behavior has been done in 
the PEG system, with focus primarily on the influence on polarity and the promotion of 
the epithelial state.  However, cadherins also play an important role in cancer metastasis; 
in particular N-cadherin, which has been shown to influence cell motility and matrix 
invasion
135,296
.  Future work may probe for a cadherin role in promoting a more 
metastatic phenotype in the KRas
G12D
 / p53
R172HΔG
 model with incorporation of PEG-
cadherin into the low concentration-PEG matrices used previously to study TGFβ-
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induced matrix invasion (Chapter 3).  Exploration of potential modulation of invasion in 
soft PEG hydrogels with matrix-tethered N- or E-cadherin may further illuminate the 
relationship between cell-cell contacts and matrix invasion. 
 Beyond the cadherins, PEG hydrogels are well-suited for examination of the role 
of other cell-cell contact mechanisms, including the Jagged-Notch system.  Notch cell-
cell signaling is important to a variety of biologic processes including tissue 
development, cell fate decisions, stem cell expansion, and cancer pathogenesis
337
.  In the 
KRas
G12D
 / p53
R172HΔG
 model, metastatic subpopulations express both Notch and Notch 
ligands, and the Notch ligand Jagged2 promotes EMT and metastasis by GATA 
transcription factor suppression of miR-200
239
.  These findings were described using the 
MG system and relied on knockdowns to probe Jagged-Notch signaling, a somewhat less 
physiological representation of how increased Jagged presentation might actually signal 
neighboring cells to promote metastasis.  In future work, the use of PEG hydrogels with 
matrix-tethered Jagged may allow for an exploration of this signaling in otherwise 
unmodified cancer cells that more accurately mimics the outside-in matrix signaling that 
might be important for EMT and invasion of metastasizing cell subpopulations of 
primary tumors. 
 
5.2.3 PEG Hydrogels to Study Cancer Angiogenesis 
 Advanced tumor growth and metastasis is promoted in part by the angiogenesis of 
a structurally deficient, but rapidly forming and expansive tumor-associated blood vessel 
network
85,90
.  Study of angiogenic signaling in the lung adenocarcinoma model has 
previously showed that VEGF Receptor-1 (Flt1) is a miR-200 target in KRas
G12D
 / 
p53
R172HΔG
 cell lines with anti-VEGF antibodies or Flt1 knockdowns decreasing growth 
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and metastasis of tumor cells
338
.  A separate K-ras activated lung adenocarcinoma cell 
line (LKR-13) showed a high expression of VEGF that was significantly augmented in 
co-culture with stromal cells
339
.  However, limited work has been done to study the 
interaction of model lung cancer cells with vessel cells in vitro or in vivo.  The PEG 
system is well-suited to the study of vessel cells and has been successfully deployed in 
vascular tissue engineering applications
207,208
.  Further, PEG hydrogels have been used in 
an in vivo mouse corneal angiogenesis assay to study host angiogenesis in the face of 
growth factor signaling from implanted hydrogels and anastomosis of this recruited host 
vasculature to implanted pre-formed vascular networks 
208,210
.   
 The differential VEGF-related signaling in KRas
G12D
 / p53
R172HΔG
 lines and the 
augmentation of angiogenic-related signaling found with co-culture of cancer-associated 
fibroblasts present intriguing areas for further study in the PEG system that is so well-
characterized in modeling angiogenesis.  To this end, pilot studies in vitro have deployed 
a dual-gel experimental set-up featuring 344SQ and vessel-forming cells in separate 
hydrogels in close approximation (Figure 5-2A).  This set-up permits compartmentalized 
vessel formation in the angiogenic gel (human umbilical vein endothelial cells (HUVEC) 
and human brain pericytes (HBP)) in the face of potential paracrine signaling from the 
cancer-laden gel (344SQ), enabling examination of potential differences in the rate of 
vessel formation, vessel structural parameters, or vessel migration with cancer co-culture.  
It also affords potential pro-tumorigenic signaling from vessel cells to cancer cells.  
Initial studies have demonstrated a degree of HUVEC/HBP in-growth from the vessel 
gels into cancer-laden gels with some association between 344SQ spheres and the 
infiltrating vessel-like structures (Fig. 5-2B).   
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 Future work in similar in vitro systems will explore differences in angiogenic and 
cancer cell behavior in the face of this co-culture signaling and elaborate potential 
angiogenesis-related mechanisms that help account for phenotypic differences in 
KRas
G12D
 / p53
R172HΔG
 lines of differing metastatic potential or miR-200 expression.  In 
addition, tumor-associated fibroblasts can be incorporated into the co-culture alone to 
probe for non-angiogenesis-related influences on lung cancer cell phenotype or in 
combination with vessel cells to further elaborate their role in aiding metastasis via 
promotion of tumor angiogenesis. Finally, future work may introduce this system into the 
in vivo corneal angiogenesis assay to study the recruitment of host vessels by KRas
G12D
 / 
p53
R172HΔG
 cells in implanted hydrogels to facilitate improved in vivo study of potential 
Fig. 5-2: Modeling lung cancer angiogenesis in PEG hydrogels.  A, schematic of a “dual gel” 
featuring the vessel-forming cells (co-culture of HUVECs (purple) and HBP pericytes (red)) in a PEG-
PQ hydrogel polymerized over a separate gel with encapsulated KRas
G12D
 / p53
R172HΔG
 cells (green) to 
enable visualization of potential differences in vessel formation, directional angiogenesis, or cancer cell 
behavior resulting from compartmentalized co-culture.  B, image of a 344SQ sphere in the cancer gel 
component of a dual gel system formed near the border with the vessel gel.  HUVEC and HBP cells 
(positive for human nuclear antigen (HuNu), red) form linear, organized vessel-like structures (top of 
image), some of which infiltrate into the cancer gel below and interact with the 344SQ sphere (HuNu 
negative, DAPI (blue) only). Phalloidin counterstain (green).  Images courtesy of Laila Roudsari. 
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metastatic events.  For example, potential intravasation of implanted cancer cells into 
recruited vessels in advance of spread throughout the host would represent a more cell-
mediated and physiological model of metastasis than that afforded by tail vein injection 
of cancer cells or other methods used in previous study. 
 
5.3 Overall Summary 
 In summary, this thesis deployed a tunable bioactive PEG hydrogel to study 
matrix influences on cancer cell behavior and progression.  Findings herein have 
provided greater insight into stromal biomechanical, biochemical, and cell-cell factors 
that guide lung adenocarcinoma epithelial morphogenesis and EMT.  These contributions 
advance an understanding of the extrinsic matrix influences that mediate invasion and 
dissemination of cancer and bring investigators one step closer to identifying new 
metastasis-targeting therapeutics to treat patients with advanced cancer. 
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